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Abstract 
Magnesium (Mg) and its alloys have been widely explored for orthopaedic applications 
due to its biodegradable nature, biocompatibility and closely related mechanical 
properties with bone. However, rapid degradation of Mg alloys under physiological 
conditions is a major challenge for biomedical industries and clinicians. Amongst the 
various methods employed, deposited coatings have been widely favoured to enhance the 
corrosion resistance and compatibility of the Mg alloys. 
This study focused on developing multifunctional coatings on AZ31 Mg alloy having a 
corrosion resistant, osteoinductive and antibacterial properties for orthopaedic 
applications.  The aim of this study was achieved through the following objectives: 
- Fabrication of corrosion resistant and biocompatible PLGA-silane coatings on AZ31.  
- Preparation of Biomimetic Hyaluronic acid functionalized silane coatings on AZ31.  
- Fabrication of osteoinductive and antibacterial Hyaluronic acid-lysozyme composite 
coatings on AZ31. 
- Effect of hyaluronic acid molecular weight and Mg2+ on osteoblast functions in vitro. 
Overall, this body of work presented: 
- Successful assembly of multilayer PLGA coating associated with the amine-
terminated MTES-TEOS- APTES silane on the AZ31 Mg alloy. 
- PLGA-silane coating improved the corrosion resistance of AZ31 Mg alloy in DMEM 
by ~2 of magnitude (impedance magnitude and corrosion current density) as 
confirmed by the electrochemical corrosion studies. Similarly, immersion studies 
showed ~5-fold increase in the corrosion resistance of PLGA-silane coated AZ31 Mg 
alloy over uncoated AZ31 equivalents.  
- In comparison to the uncoated AZ31 substrate, osteoblasts showed ~2 to 4-fold 
increase in the proliferation and differentiation of osteoblast cells cultured on the 
PLGA-silane coated AZ31 substrates for 14 days.  
- To further evaluate the corrosion resistant properties of silane coated-AZ31 Mg alloy 
in the high corrosive electrolyte, the electrochemical corrosion and immersion 
studies were conducted in HEPES buffered DMEM. The EIS analysis showed an 
increase in the magnitude of impedance by ~ 2 order of magnitude for MTES-TEOS- 
APTES modified AZ31 substrate when compared to the uncoated AZ31 equivalents. 
-    
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- To improve the cytocompatibility of AZ31 Mg alloy by providing a biomimetic 
environment, high molecular weight hyaluronic acid (HA) was coupled to the amine-
terminated MTES-TEOS-APTES modified AZ31 substrate. The high molecular 
weight HA enhanced the proliferation and differentiation of osteoblasts cells by ~ 4 
to 6-fold as compared to the uncoated AZ31 Mg alloy.  
- Furthermore, the effect of high and low molecular weight of HA and Mg2+ on 
osteoblast functions was evaluated. It was observed that the high molecular weight 
HA and Mg2+ synergistically improve the proliferation and differentiation of 
osteoblast cells by stimulating intracellular calcium ions.   
- The concerns of bacterial colonisation on Mg-based biodegradable alloy without 
compromising osteoblast functions was addressed by modifying the amine 
terminated silane coating with HA-lysozyme (HA-LZ) composite. LZ component of 
composite significantly reduced the colonisation of S.aureus in a concentration-
dependent manner by ~ 30 fold when compared to the uncoated AZ31 equivalents. 
Whereas, HA component of the composite maintained the osteoblasts cellular 
response in terms of adhesion, proliferation and differentiation.   
Hence, the developed multifunctional coatings improved the corrosion resistance, 
osteoinductive and anti-bacterial properties of the AZ31 Mg alloy. 
 
All work in this thesis has been published. 
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Overview of the thesis 
Problem statement 
Mg and its alloys have several advantages over conventional orthopaedic implant 
materials such as stainless steel, titanium and its alloys, ceramics and biodegradable 
polymer and cobalt-chrome alloys. These advantages include their biocompatibility, 
similar mechanical properties (Young modulus) to that of natural bone and osteogenic 
potential of Mg2+ ions. However, the major concerns preventing their clinical applications 
are rapid degradation under physiological conditions, thereby producing an elevated level 
of hydrogen gas and drastic pH increase in the surrounding tissues. This develops a bio-
incompatible environment and hinders the bone regeneration process. Another major 
problem is the implant associated microbial growth, which causes orthopaedic implant 
failures. 
In order to reduce the rapid degradation of Mg and its alloys, several strategies such as 
alloying elements and passivation treatments (plasma electrolytic oxidation, anodization 
and alkaline hydrothermal treatment) have been explored. Alloying elements may 
improve the corrosion resistance and mechanical properties, but they may cause toxicity 
to the cells. The passivation treatments are unable to improve the corrosion over a suitable 
time period and also affect the mechanical properties of Mg alloys. Therefore, surface 
coatings have been considered as an effective approach to enhance the corrosion 
resistance as well as biocompatibility of Mg and its alloys.  
 
Aims of the study 
The aim of this study is to design multifunctional coatings which not only reduce the 
corrosion resistance but also show osteogenic and antibacterial properties which enhance 
the bone regeneration and prevent the implant associated microbial infections. 
a) The rapid degradation of Mg alloy is a major challenge, especially during the early 
period of implantation period (2-3 weeks) which creates toxicity towards the 
surrounding tissue. Interestingly, Mg2+ stimulates the functions of osteoblast cells 
at an optimum concentration ranging from 5 mM to 15 mM. Therefore, the target 
of the study is to optimally control the degradation of AZ31 Mg alloy using sol-
gel silane coating during early immersion period. It is desired to achieve the 
stability of the coating for a minimum period of 21 days so that rapid degradation 
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of the AZ31 Mg alloy could be controlled, thereby providing optimum for the 
growth of osteoblast cells. 
b) The cytocompatibility of the coating plays an important role in osteointegration 
of the implant material including Mg and its alloys. Therefore, this problem is 
addressed by functionalizing the corrosion resistant sol-gel coating with 
biocompatible synthetic aliphatic polyester (e.g PLGA) or biopolymers (e.g 
hyaluronic acid) to improve the adhesion, proliferation and differentiation of 
osteoblast cells.  The aim of functionalising these bioactive polymers is to enhance 
the response of osteoblast cells during the rapid degradation phase of the AZ31 
Mg alloy.  
c) The susceptibility of medical implant surfaces to the risk of microbial growth is 
one of the major causes of orthopaedic implant failure. Therefore, the aim of this 
study is to develop a bioactive composite coating using biopolymers such as 
hyaluronic acid and lysozyme, which not only prevents the early colonisation of 
bacterial cell adhesion on the surface but also improve the osteoblastic activity. 
d) Hyaluronic acid has been used to functionalise the implant surface to improve the 
osteoblastic activity and osteointegration. However, the role of the molecular 
weight of hyaluronic acid functionalised on the surface and extracellular Mg2+ 
concentration in regulating the osteoblast cell response has not yet been studied. 
Therefore, the effect of hyaluronic acid of different molecular weight 
functionalised on sol-gel silane coated AZ31 Mg and Ti alloy on osteoblast 
functions was evaluated.   
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Outline of the thesis 
a) The first chapter is a literature review, which covers various aspects of corrosion 
behaviour of Mg and its alloys under physiological conditions and strategies to 
improve their corrosion resistance and biocompatibility for orthopaedic 
applications. This chapter has been published: This chapter has been published: 
S Agarwal, J Curtin, B Duffy, S Jaiswal, Materials Science and Engineering: 
C, 68, 1, 2016, 948–963. 
b) The second chapter describes analytical techniques such as fluorescence 
spectroscopy, Fourier transforms infrared spectroscopy (FTIR), Inductively 
coupled plasma optical emission spectroscopy (ICP-OES), Scanning electron 
microscopy (SEM), Fluorescence microscopy, Atomic force microscopy and 
Potentiodynamic polarisation, electrical impedance spectroscopy. This chapter 
also explains the different biochemical assays to assess the cytocompatibility and 
antimicrobial activity. 
c) The third chapter presents the fabrication of multilayer PLGA coating associated 
with amine terminated MTES-TEOS- APTES organosilane on AZ31 Mg alloys. 
This chapter includes the systematic investigation of in vitro corrosion protection 
and biocompatibility of PLGA-silane coating on the AZ31 Mg alloy. In this 
chapter, PLGA-silane coating improved the corrosion resistance of the AZ31 Mg 
alloy in DMEM which was confirmed by the electrochemical corrosion and long-
term immersion studies. Furthermore, MC3T3E1 osteoblast cells showed 
improved adhesion, proliferation and differentiation on the PLGA-silane coated 
AZ31 Mg alloy substrate as compared to the uncoated AZ31 equivalents.  
This chapter has been published:  Agarwal. S., Morshed, M., Labour, M.N., 
Hoey, D., Duffy, B., Curtin, J. and Jaiswal. S, RSC Advances, 2016 6(115), 
113871-113883. 
d) The fourth chapter describes the preparation of hyaluronic acid functionalized 
silane multifunctional coatings on AZ31 Mg alloy. Distinct functions of the 
coatings have been presented, where silane coating enhances the corrosion 
resistance and hyaluronic acid improves the cytocompatibility of osteoblast cells. 
In this chapter, an electrochemical corrosion study showed that sol-gel silane 
coatings maintained the corrosion protection of AZ31 Mg alloy in a corrosive 
medium (HEPES-buffered DMEM). The functionalisation of hyaluronic acid 
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significantly improved the functions of osteoblast cells when compared to the 
uncoated AZ31 as well as PLGA-silane coated surface. This improved bioactivity 
on the HA-silane coated substrate confirmed two aspects of the coatings (a) an 
efficient corrosion protective function of sol-silane coating in HEPES-buffered 
DMEM and (b) hyaluronic acid provided a biomimetic environment to osteoblast 
cells.   
This chapter has been published:  Agarwal. S., M., Labour, M.N., Hoey, D., 
Duffy, B., Curtin, J. and Jaiswal.S, Journal of Materials Science: Materials in 
Medicine (2018) 29:144.  
e) The fifth chapter presents the fabrication of hyaluronic acid-lysozyme composite 
coating on silane coated AZ31 Mg alloy. The combined antibacterial and 
osteoinductive activity of hyaluronic acid-lysozyme composite were determined. 
In this chapter, the lysozyme component of the hyaluronic acid-lysozyme coating 
showed a concentration-dependent significant reduction of S.aureus adhesion on 
the surface when compared to the respective controls and uncoated AZ31 Mg 
alloy. Furthermore, composite coated surface significantly enhanced the 
osteoblast cell adhesion, proliferation and differentiation when compared to the 
respective control and uncoated AZ31 Mg alloy. Notably, osteoblast functions 
observed on hyaluronic acid was comparable to that on the hyaluronic acid-
lysozyme composite coated surface. These results indicated that lysozyme-
composite coating reduced the bacterial cell colonisation without affecting the 
hyaluronic acid induced osteoinductive activity. 
This chapter has been published: Agarwal, S., Riffault, M., Hoey, D., Duffy, 
B., Curtin, J. and Jaiswal, S. ACS Biomaterials Science & Engineering, 2017, 
3(12), 3244-3253. 
f) The sixth chapter describes the hyaluronic acid molecular weight and Mg2+ 
dependent growth of osteoblasts. In this study, the osteoblastic activity of low and 
high molecular weight of HA functionalised on silane coated AZ31 Mg 
(extracellular Mg2+ dependent) and Ti alloy (control) was determined. The 
osteoblast cellular response such as adhesion, proliferation, differentiation and 
intracellular Mg2+ and Ca2+ were evaluated. The findings of this study suggested 
that low molecular weight hyaluronic acid enhanced the proliferation of osteoblast 
cells when compared to the high-molecular weight hyaluronic acid. On the other 
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hand, high molecular weight hyaluronic acid and Mg2+ synergistically enhanced 
the differentiation of osteoblast cells when compared to the low-molecular weight 
hyaluronic acid which is attributed to the upregulated intracellular Ca2+ 
concentration. Therefore, there are sufficient benefits of the use of HA with 
appropriate molecular weight to modify the surface of biomedical implants for 
orthopaedic applications. The work described in this chapter has been 
published: Agarwal, S., Duffy, B., Curtin, J. and Jaiswal, S. ACS Biomater. 
Sci. Eng., 2018, 4 (11), 3874–3884 
g) The seventh chapter concludes the present work and overviews future work. 
 
Based on the present study, our research group secured national funding 
through Science Foundation Ireland and the Department of Business, 
Enterprise and Innovation  
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Chapter 1  
 
Literature review 
 
 
 
In this chapter, some general and specific aspects of Mg alloys will be introduced and the 
effect of alloying elements on corrosion behaviour and biocompatibility properties will 
be summarised. Furthermore, the influence of polymeric deposit coatings, namely sol-
gels, synthetic aliphatic polyesters and natural polymers on these properties of Mg and its 
alloy for orthopaedic applications are presented. Finally, the osteoinductive and 
antimicrobial activities of Mg-based biomaterials for orthopaedic applications will be 
presented. 
 
This chapter has been published: S Agarwal, J Curtin, B Duffy, S Jaiswal, Materials 
Science and Engineering: C, 68, 1, 2016, 948–963. 
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1.1 Introduction 
Metallic orthopaedic implants are used for the replacement and/or regeneration of 
damaged hard tissues [1]. Metallic implants are preferred for their high mechanical 
strength and toughness which make them superior to the polymer and polymer-ceramic 
composites [2]. Orthopaedic metallic implants can be broadly classified into permanent 
and biodegradable implants [2]. Metals such as stainless steel, titanium and cobalt-
chromium alloys have been employed as permanent implants [3]. However, there may be 
some problems associated with using such permanent metallic implants [4,5]. The first 
involves the incompatibility of the mechanical properties of metallic alloys and natural 
bone such as metal alloys having greater elastic modulus to that of bone [6]. Under in 
vivo conditions, the mechanical mismatch between bone and implants leads to a clinical 
phenomenon called stress shielding [7]. In stress shielding, the implant carries much of 
the bulk load and the surrounding bone tissue experiences reduced load stress. This 
triggers the resorption of surrounding bone tissue [7]. The second problem associated 
with permanent implants is mechanical wear and corrosion with long-term implantation 
in the body.  This results in the release of toxic metal ions (chromium, nickel, cobalt etc.) 
in the body which can trigger undesirable immune responses, thereby reducing the 
biocompatibility of metallic implants [8]. These drawbacks have encouraged researchers 
and clinicians to look at biodegradable implants, which once used, only remain for an 
appropriate time to fix the damage. 
Biodegradable metals have several advantages when used in orthopaedic temporary 
implants (screws, pins etc.) [6]. The mechanical properties of Mg and its alloys such as 
Young’s modulus of elasticity (E= 41-45 GPa) and density (1.74-1.84 g/cm3) are known 
to be similar that of bone (E= 15-25 GPa and density= 1.8-2.1 g/cm3). This is lower than 
other biodegradable materials such as Iron-Manganese (Fe-Mn) and Zinc (Zn) based 
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alloys [2] . Furthermore, the Mg ion is a common metabolite of the body with a daily 
consumption range of 250-300 mg/day and are naturally stored in bones [9]. Therefore, 
amongst biodegradable metals, the biocompatibility (low toxicity to the bone-related cells 
and maintain bone functions) and resemblance of mechanical properties of Mg and its 
alloy with bone make it suitable for orthopaedic applications. 
Ceramics which are inorganic non-metallic materials that have been employed in hard 
tissue engineering applications are collectively known as Bioceramics [10]. Bioceramics 
possess desirable properties for biomedical applications such as (i) thermo-chemically 
stability, (ii) good wear resistance and (iii) are easily mouldable. Additionally, they are 
biocompatible, non-toxic and non-immunogenic  [11,12]. Ceramics have been used 
commercially in various applications like coatings on implants, maxillofacial 
reconstruction and drug delivery devices [12,13]. However, bioceramics like 
hydroxyapatite (HAP) are brittle and possess low tensile strength when compared to Mg-
based alloys [12].  
Polymeric materials have been employed for tissue engineering applications due to their 
ductility, biocompatibility and biodegradable properties. Polymers are composed of small 
repeating monomers which give the polymer its characteristic properties. The degree of 
cross-linking of monomers determines the physiochemical nature of polymers [14]. In 
general, polymeric materials are broadly classified into synthetic and natural polymers.  
Synthetic polymers such as aliphatic polyester (polylactic acid, polyglycolic acid, poly 
co-(lactic-co-glycolic acid)) can be synthesized in controlled conditions to regulate 
properties such as molecular weight and derivatization. These advantages of synthetic 
aliphatic polyesters enable their use in biomedical applications.  Natural polymers such 
as collagen and protein-based gels, hyaluronic based derivatives, polysaccharide chitosan 
and heparin-based scaffolds have been successfully used in various tissue engineering 
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applications [15]. Natural polymers provide biomimetic environment and may encourage 
expeditious tissue healing by directing cell adhesion and function. Both classes of 
polymers can be chemically modified to produce tuneable scaffold and biomedical 
implants with controlled degradation rates [16]. Moreover, several reports showed that 
the by-products of biodegradable polymers are highly biocompatible [17]. These 
polymers can be engineered into various shapes and sizes, such as disks, rods, pellets, 
plates, films and fibres as required. Some applications include biodegradable sutures, 
bone grafting materials, pins, screws and load-bearing orthopaedic devices [18]. Despite 
possessing many desirable properties, polymers have low mechanical strength when 
compared to bioceramics and metal implants, thereby hindering their applications in hard 
tissue engineering. Typically, yield strength at break should be higher than the yield 
stress, which can be observed for metals and bioceramics. However, Perego et al showed 
a deviation from this convention for PLA [34].  Therefore polymers have been largely 
employed in soft tissue engineering and low-load bearing medical devices [18]. 
Comparatively, Mg and its alloys have advantages over polymers due to mechanical 
strength closer to bone.  
From the above discussion, it can be observed that Mg-based alloys have mechanical 
properties (density, yield strength, tensile strength, elongation to break and elastic 
modulus) similar to that of natural bone as compared to other biodegradable alloys, 
permanent implants, ceramics and polymers as shown in Table 1. Despite many 
advantages, the major limitation of Mg-based alloys as biomedical materials is their high 
corrosion rate [19]. Corrosion results in the formation of H2 gas; which if rapidly absorbed 
can lead to a balloon effect (gas pocket formation surrounding the implant) in vivo [20]. 
Additionally, a shift in alkaline pH in the region surrounding the corroding surface is also 
a concern for biomedical applications [20].  
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 Table 1. Mechanical properties of Mg and its alloys 
Tissue/Surgical Implants 
Density 
(g/cm
3
) 
Yield 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Elongation to 
break (%) 
Elastic 
Modulus 
(GPa) 
Ref 
Bone 1.8-2.1 104-121 110-130 0.7-3 15-25 [21] 
Biodegradable metal alloys  
 
Mg  
Pure Mg 1.74-2.0 65-100 90-190 2-10 41-45 [1] 
AZ31 1.78 185 263 15-23 45 [22], 
[23] AZ91 1.81 160 230 2.511 45 
WE43 1.84 170 220 2-17 44.2 [24] 
Fe  
Fe20Mn 7.73 420 700 8 207 [25] 
Fe35Mn ---- 230 430 32 --- 
Zn  Zn–Al–Cu 5.79 171 210 1 90 [26] 
Non-degradable metal/composite 
implants 
 
 
Stainless Steel SS316L 7.9 190 490 40 200 
 
[27] 
Titanium 
alloys 
Ti-6Al-4V 4.43 880 950 14 113.8  
[28] Ti-6Al-7Nb 4.52 800 900 10 105 
Chromium-
cobalt alloys 
CoCr20Ni15Mo7 7.8 240-450 450 -960 50 195 - 230 
 
[29] 
Bioceramics 
Alumina Ceramics 4 --- 400-580 0.12 260 – 410  
[30] 
 
Synthetic 
hydroxyapetite 
3.15 --- 40 – 200 ---- 70 – 120 
Natural and synthetic polyesters  
 
Natural and 
synthetic 
polyesters 
Collagen (Rat tail) --- ---- 2.6-605 7.40-26.74 5 – 11.5 
[31] 
PLGA 
1.30-
1.34 
3.8-26.6 13.9-16.7 5.7 1.69 
[32] 
PCL 1.145 8.37-14.66 
68.45-
102.7 
22.8-28.3 281-686 
[33] 
PLA (67Kda) 
PLA-59Kda 
 
1.8 
1.64 
 
70 
68 
 
59 
58 
 
7.0 
5.0 
 
3750 
3750 
 
[34] 
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There are some strategies to improve the corrosion behaviour and biocompatibility of Mg 
alloys: 
a) Optimising the composition and microstructure, including grain size, crystalline 
structure phase and texture of the base metal through the development of 
manufacture process/methods. 
b) Apply protective polymer deposit coatings with suitable physiochemical 
properties. 
1.2 Degradation mechanism of Mg and its alloys 
The usual degradation of biomedical metals is through the corrosion process. Generally, 
this process involves electrochemical reactions to produce oxides, hydroxides and H2 gas 
species. In physiological conditions, the corrosion reactions of biodegradable metals 
including Mg and its alloys, involve the following anodic dissolution of metals and 
cathodic reduction reactions [6]. 
                       𝐌 → 𝐌𝐧+ + 𝐧𝐞− (𝐚𝐧𝐨𝐝𝐢𝐜 𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧) ……… Eq 1 
                      𝟐𝐇𝟐𝐎 + 𝟐𝐞
− →  𝐇𝟐 + 𝟐𝐎𝐇
− (𝐜𝐚𝐭𝐡𝐨𝐝𝐢𝐜 𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧)…  Eq 2 
                   𝐌𝐧+ + 𝐧𝐎𝐇− → 𝐌(𝐎𝐇)𝒏 (𝐨𝐯𝐞𝐫𝐚𝐥𝐥 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧)…… Eq 3  
Fig 1-1 illustrates the degradation mechanism of Mg and its alloy under physiological 
conditions.  In general, immediately after contact with moisture/ body fluids, Mg is 
oxidised to form cations following an anodic reaction (Eq-1). The generated electrons are 
consumed for reduction of water corresponding to cathodic reactions (Eq-2). These 
reactions occur randomly over an entire surface, where galvanic couples form due to 
differences in electrochemical potential between the metal matrix and intermetallic 
phases or with organic molecules adsorbed on the surface that leads to the dissolution of 
biodegradable Mg and its alloys (Fig 1-1 (a) and (b)) [35]. Furthermore, the physiological 
 Chapter 1  
7 
 
conditions are a highly corrosive environment to Mg and its alloys due to dissolved 
oxygen, proteins and electrolyte ions (chloride and hydroxide ions) [35].  
 
Figure 1-1 Schematic diagram for Mg (BM: biomaterial) corrosion in 
electrolyte/medium [6] 
In this environment, pure Mg is susceptible to corrosion due to its high electrochemical 
potential (E˚= +2.37V for Eq-1), which results in the migration of ions from the metal 
surface to the surrounding fluid. These electrochemical reactions result in the formation 
of the hydroxide layer (M (OH)n) on the surface of Mg and its alloys  (Fig 1-1(c)) (Eq-3). 
When this metal oxide covers over the entire surface, it acts as a passive layer or kinetic 
barrier which prevents the further migration of ions or chemical reactions across the metal 
surface [35]. However, this layer is slightly soluble and susceptible to breakdown, 
particularly in the presence of chloride ions, that subsequently lead to the pitting corrosion 
(Eq-4) [36]. 
𝐌𝐠(𝐎𝐇)𝟐 + 𝟐𝐂𝐥
− →  𝐌𝐠𝐂𝐥𝟐 + 𝟐𝐎𝐇
−.................. Eq. 4 
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During the degradation process, local pH of the solution increases resulting in the re-
passivation of the surface, thereby again depositing 𝐌𝐠(𝐎𝐇)𝟐 layer on the surface. This 
results in the deposition of dissolved calcium and phosphates onto to the 𝐌𝐠(𝐎𝐇)𝟐 layer, 
reducing the degradation rate of Mg alloy. During the implantation period, adherent cells 
proliferate on the degraded products of the corroded Mg alloy (Fig 1-1d). 
Additionally, the corrosion of Mg and its alloys produce H2 gas. Initially, the rapid 
formation of H2 gas bubbles occurs due to the enriched chloride environment, which can 
disappear after the initial weeks following surgery [37]. Song et al. postulated that a 
hydrogen release rate of 0.01 ml.cm-2.day-1 can be tolerated by the body and does not pose 
a serious threat [38]. The corrosion in body fluids is influenced by various factors such 
as pH, concentration and types of ions, protein adsorption on the orthopaedic implant and 
influence of biochemical activities of surrounding tissues [39–41].  Typical forms of Mg 
corrosion encountered in physiological conditions are discussed in the following sections. 
1.2.1 Galvanic corrosion 
Galvanic corrosion takes place when two dissimilar metals with different electrochemical 
potential come in contact with each other in presence of an electrolyte [1]. The less noble 
metal acts as an anode which corrodes rapidly producing by-products around the contact 
site [42]. Galvanic corrosion of Mg is the primary issue for orthopaedic applications. In 
the galvanic series, Mg is the most active metal, and always an active anode, if it makes 
contact with other metals acting as cathode [42,43]. Consequently, the Mg alloy implant 
is preferentially corroded. In addition, an internal galvanic event occurs due to the 
presence of impurities or intermetallic elements in the Mg matrix. 
1.2.2 Pitting corrosion 
Pitting is a form of localized corrosion and associated with the breakdown of passivation 
layers in simulated body fluids (SBF) [42] . It is a serious form of corrosion when 
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compared to another process since the surface pits are difficult to observe due to the 
presence of degradation product [44]. The pits are highly corrosive and perforate the 
metal matrix. In general, after initial nucleation on the surface, impurities in the Mg alloy 
microstructure assist in further corrosion due to the galvanic differences in materials [45]. 
Moreover, the combination of physiological and Mg+ ions from anodic dissolution 
species further accelerate the growth of the pit [45]. Once the pitting initiates, the Mg 
component can corrode in a very short period of time, which in the case of orthopaedic 
applications would reduce the load-bearing capacity of implants. Additionally, pitting 
increases internal localised stresses which can potentially form cracks [1]. The 
development of stress corrosion cracking (SCC) and metal fatigue cracks in the pits can 
lead to implant failure under normal loading conditions. 
1.3 Factors affecting the corrosion resistance of Mg and its alloy 
1.3.1 Buffer systems and Inorganic Ions 
In the physiological conditions, several buffers are involved to maintain the neutral pH 
condition. The commonly used corrosion prototype mediums are SBF and cell culture 
medium which consist of buffers such as HEPES, Tris–HCl and HCO3-/CO2. These 
chemical components significantly affect the corrosion of Mg and its alloys [41] . The 
HEPES and Tris-HCl regulate the change in the pH by consuming the OH- ions and affect 
the formation of corrosion product, consequently accelerating the dissolution of Mg, as 
shown in Eq-3.  The HCO3
-/CO2 imparts buffering system in the human body which not 
only utilise OH- ions but also induce the precipitation of MgCO3 which contributes to the 
protection against corrosion by developing the passivation layer on Mg [42]. 
Furthermore, the presence of inorganic ions in the body fluids influence the degradation 
of Mg and its alloys primarily by two manners: (a) the abundance of Cl- ions in 
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physiological conditions, is aggressive in the removal of passivation layer from the 
surface and leading to pitting corrosion and (b) the presence of 𝐇𝐏𝐎𝟒
𝟐−/ 𝐏𝐎𝟒
𝟐−, 
𝐇𝐂𝐎𝟑
−/𝐂𝐎𝟑
𝟐− anions and Ca2+ ions form calcium phosphate and carbonate salt precipitate 
which protect the erosion of passivation layer on Mg and its alloys, thereby preventing 
the emergence of pitting corrosion [46].  
1.3.2 Mechanical stress 
The attractive high strength of biodegradable Mg alloys as compared to biodegradable 
polymers makes them promising for load-bearing orthopaedic applications. Potential 
biodegradable biomedical devices would be exposed to a complex stress environment in 
vivo, depending upon the implantation site, and would be expected to function under 
various mechanical stresses, including fluid shear stress, compression etc.  
Furthermore, time-dependent changes in the integrity of the mechanical properties of 
metal under prolonged mechanical stress is also a crucial factor [47]. Adequate metal 
implant mechanical strength is required to assist the healing and is important for 
postoperative recovery. As the degradation of biomaterial proceeds, the degeneration of 
mechanical integrity is expected. The mechanical loads can accelerate this process 
because of both corrosion and stress that lead to stress corrosion cracking (SCC) and 
corrosion fatigue, thereby causing implant failure [48].  The cyclic stress develops the 
formation of microscopic cracks on the surface and also damages the protective passive 
layer, while the chloride environment in body fluids further significantly increases crack 
growth rate [46]. When the loading stress exceeds the threshold of SCC, the crack grows 
to a critical size resulting in the fracture of the metallic implant. This infers that the 
environment can significantly reduce the fatigue limit of Mg alloys over an implantation 
period, producing considerable shorter failure times of implants. However, in case of 
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coated magnesium alloy, the loss of mechanical properties of the metal occurs at slow 
rate. Tan et al., showed that Si-coated AZ31 substrate degraded more slowly and retained 
bending load, >80 % of the initial load after 12 weeks of implantation [108] . There are 
very few studies on the tribology properties of coated-Mg alloy.   
1.3.3 Effects of alloying element on mechanical and corrosion properties  
The Mg-based biodegradable substrates can be divided into four major groups: (a) pure 
Mg, (b) Al-containing alloys (AZ91, AZ31, LAE422, AM60 etc.) (c) Rare earth elements 
(AE21, WE43 etc.), and (d) Al-free alloys (WE43, MgCa 0.8, MgZn6 etc.). These 
alloying elements improve the mechanical and physical properties of Mg alloy for 
orthopaedic applications by (a) optimising grain size, (b) increasing corrosion resistance, 
(c) providing mechanical strength by the formation of intermetallic states and (d) eases 
the manufacturing process of Mg alloys [1]. The compositions of some Mg-based alloys 
are given in Table 2. 
Table 2 Compositions of Mg-based alloys 
Elements 
(% wt.) Ca Al Mn Zn Li Nd Zr Y Mg Other trace elements  
  
Ref. 
Mg alloys 
AZ31 - 2.4 0.4 0.8 - - - - 96.7 
Cu-0.008,Fe-0.003, 
Be-0.005 
[20] 
[39] 
[50] 
AZ91 - 9.0 0.13 0.5 - - - - 90.37 
Cu-0.003,Fe-0.014, 
Be-0.002 
WE43 - - - - - 
2.4-
3.2 
0.4 
3.7-
4.3 
92.1-
93.5 
- 
[51] 
LAE442 - 2.2 0.2 0.2 3.9 2.0 - - 91.5 - [52] 
AM60 - 6.0 0.13 0.1 - - - - 93.77 
Cu-0.008,Fe-0.004, 
Be-0.005 
[51] 
MgCa0.8 0.8 - - - - - - - 99.2 - [52] 
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The characteristic impurities in Mg alloys are copper (Cu), nickel (Ni), iron (Fe) and 
beryllium (Be). Typically, Cu is limited to 100-300 ppm, Ni should not exceed 20-50 ppm 
and Fe and Be are limited to 35-50 ppm and 5 ppm respectively [49]. These impurities 
should be strictly controlled under toxic limits for biomedical applications. 
1.4 Pathophysiology and toxicology of alloying elements used for biodegradable Mg-
based orthopaedic implants 
The released metallic ions resulting from the corrosion of biodegradable Mg alloys may 
induce systemic toxicity to human, as well as localised toxicity to the peri-implant cells. 
Table 3 summarises the pathophysiology and toxicology of Mg and the common alloying 
elements. Generally, toxic element ions released in the body could be tolerated below a 
threshold level, while excess release in the body will have adverse effects [53]. As Mg is 
the most abundant element present in the body, it shows very low toxicity, however, in-
depth biological studies are still required. Therefore, the amount of alloying element 
utilised for the manufacture of Mg-based biomedical implants needs to be optimised with 
respect to corrosion rates and the physiological environment at implant sites.  It is 
essential that biomedical implants should be designed to control the localised release of 
metal ions below threshold levels. The concentration of released metal ions into tissues 
is influenced by various factors like (a) interfacial space between metal and implants, (b) 
fluid flow shear stresses between the biomedical implant and bone, (c) variation in pH 
and (d) local blood supply [54]. 
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Table 3 Pathophysiology of alloying elements ([11,55–57]) 
Elements Effect on the 
alloying element 
The normal 
amount 
present in 
the human 
body 
Pathophysiology Toxicology 
TD50 of 
Bone-related 
cells 
(mol/L) 
  
Mg 
  
------ 
25 g 
Normal blood serum level 
0.73-1.06 mmol/L 
Required for ATP synthesis. 
activator of many enzymes; 
co-regulator of protein 
synthesis, the stabiliser of 
DNA and RNA 
Disorder in 
magnesium 
homeostasis leads to 
nausea, renal failure, 
impaired breathing. 
  
73× 10
−3
 
Ca 
Induce Corrosion 
resistance in Mg-
Ca alloys 
1100 g 
Normal serum level 0.919-
0.993 mg/L 
Control muscle contraction, 
maintain homeostasis of bone, 
hormones and 
neurotransmitter release 
regulator 
Dysregulation of 
calcium levels in the 
body leads to kidney 
stones, 
Hypoparathyroidism, 
cardiac unrest 
>50× 10
−3
 
Al 
Acts as a 
passivating 
element and 
improve corrosion 
resistance 
<300 mg 
Normal blood serum level 
2.1-4.8 µg/L. 
Excess amounts lead 
to neurotoxicity, 
Alzheimer's, 
accumulation in bone 
leads to decreases 
osteoclast viability. 
>5× 10
−3
 
Zn 
Improves 
compatibility with 
bone by modifying 
yield stress and 
Elastic modulus. 
Decreases H2 gas 
release 
2 g 
Normal blood serum level 
12.4-17.4 µmol/L 
Essential elements for the 
immune system. 
Excessive amounts 
lead neurotoxic, 
cramps and diarrhoea 
9.28 × 10
−5
 
Mn 
Improve corrosion 
resistance 
12 mg 
Normal blood serum level < 
0.8 µg/L 
Activator of various enzymes 
Excessive amounts 
cause  psychiatric and 
motor disturbances 
4.59 × 10
−5
 
Li 
Improve corrosion 
resistance 
-- 
Normal blood serum level 2-4 
ng/g 
Used in the treatment of 
depressive disorders 
Overdose causes 
impaired kidney 
function and 
respiratory disorders 
1.32 × 10
−2
 
Cu 
Increase the 
strength of 
Magnesium cast 
-- 
normal blood serum level 74-
131 µmol/L 
Involved in the respiratory 
chain and enzyme co-factors 
Causes hypotension, 
jaundice,  melena etc. 
4.15 × 10
−5
 
Zr 
Improve tensile 
strength, ductility 
and corrosion 
resistance 
<250 mg Low systemic toxicity 
Deposited on bone 
and cationic form 
cause deposition on 
bone 
1.64 × 10
−3
 
Y 
Improve ductility 
and corrosion 
-- Blood serum level < 47 µg 
Higher concentration 
accumulate in liver 
and gall bladder 
2.54 × 10
−4
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The biological effects of released metal ions from biodegradable medical implants affect 
the cells of the surrounding bone tissue. Table- 3 summarises the toxic dose at 50% cell 
viability (TD50) of bone-related cells (MC3T3E1 and MG63 cell lines). From Table 3, 
the alloying elements are divided into mild, moderate and severe toxic elements [58].  The 
mild toxic elements include Mg, Ca, Li, Al and Zr. However, some reports showed that 
mild toxic elements like Al (500 nM) at very low concentration induce bone-related cell 
proliferation[59].  Moderate toxicity elements include Y, whereas Zn, Cu and Mn are 
severe toxic elements. Thus, moderate or mild toxic elements should only be used to 
significantly improve the corrosion resistance to make Mg-based alloy orthopaedic 
implants clinically feasible. Additionally, other strategies such as polymer deposited 
coatings on Mg-based substrates have also been employed to prevent its rapid 
degradation, thereby facilitating the controlled exposure of these metal ions into the body 
[6]. 
1.5 Effect of polymeric deposit coatings on Mg alloys degradation and 
biocompatibility  
In general, the healing process of bone consists of three phases; inflammatory, reparative 
and remodelling. In the inflammatory phase, the immune system of the body responds 
against the foreign body i.e. metallic implant fixed in the body [60]. In the reparative 
phase, integration of the implant with new bone and regeneration of tissue takes place. 
Remodelling phase is one of the longest phases of the healing process. For the 
regeneration of bone, this process takes a minimum of 12 weeks, and unfortunately, most 
of the Mg-based orthopaedic implants can degrade within this period [6]. Therefore, there 
is a need to increase the corrosion resistance of Mg-based alloys. 
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A potential method for enhancing the corrosion resistance of Mg alloy without altering 
the bulk properties of the material is through protective polymeric coatings. Typically, 
the bulk properties of Mg regulate the mechanical integrity, but the surface properties 
play important roles in various physio-chemical processes like the interaction of body 
fluids, adhesion of biomolecules and cells with biomedical implants, which initiate the 
corrosion process [6]. Therefore, the coating should be biocompatible, but also degrade 
at a slower rate than that of Mg and its alloys. Polymeric deposit coatings are attractive 
since they possess good biocompatibility with the body and have a range of degradation 
rates. Although, the coatings are susceptible to the delamination during immersion period. 
The mechanism by which coating retards the onset of Mg alloy corrosion and changes the 
mode of corrosion is elucidated in Fig 1-2.  
 
Figure 1-2 (a) Schematic diagram of degradation of bare or uncoated and coated Mg 
alloy, (b) surface condition of coated Mg alloy during initial immersion period and 
(c) degradation of protective coating [61]. 
For bare or uncoated alloy, corrosion generally follows the parabolic curve since it is a 
diffusion-controlled process. When the surface is coated, Mg alloy follows the sigmoidal 
corrosion law (Fig 1-2a). During the initial immersion period, a low rate of corrosion is 
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observed due to the protective effect of the coating, which covers over the surface (Fig 1-
2b). As the immersion progresses, the protective coating deteriorates (Fig 1-2c) and the 
reactive surface is exposed to the corrosion medium, thereby accelerating the degradation 
of the Mg alloy. Later, deposition of corrosion products (self-passivation) acts as a barrier 
against corrosion. These are two competing processes i.e. break down of the protective 
layer and self-passivation continues until most of the protective layer is degraded [61].   
This section discusses the role of deposited coatings (sol-gel, synthetic aliphatic 
polyesters and natural polymers) in improving the corrosion resistance and 
biocompatibility of Mg alloys. Polymers applied as coatings on Mg-based biomaterials 
for orthopaedic applications are shown in Table 4, accompanied by their degradation 
products and corrosion behaviour of the polymer coatings. 
1.5.1 Sol-gel coatings 
The sol-gel process is a technique of creating solid materials from a chemical suspension 
of colloidal particles (sol) to produce an integrated network (gel) with diverse 
characteristics, through a series of hydrolysis and condensation polymerization reactions 
[62]. This processing methodology has facilitated the fabrication of inorganic and hybrid 
materials with controlled features at the nanoscale. In brief, silicon/metal alkoxides 
(M(OR)) are used as precursors for a sol-gel synthesis  which involves four stages (a) 
hydrolysis, (b) condensation and polymerisation of monomers to form chains and 
particles, (c) particle growth and (d) agglomeration of the polymer structures followed by 
the network formation throughout in liquid medium which increases viscosity to form a 
gel [63]. In fact, the hydrolysis and condensation reactions start simultaneously, once the 
hydrolysis reaction has been initiated [64]. These reactions yield by-products such as 
water and alcohol. These processes are influenced by initial reaction conditions such as 
pH, the molar ratio of water to precursor solution, temperature and solvent composition 
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[65].  This wet gel can be dried under various conditions to produce a xerogel with 
residual porosity. Heating the xerogel further under controlled conditions can produce a 
glass or ceramic. Before the gelling point, the colloidal solution can be used directly to 
coat various substrates by classical techniques like dip coating, spin coating and spraying.  
The schematic of the steps involved in the sol-gel process and their products are shown 
in Fig 1-3. According to available literature, silane-based sol-gel coatings have been used 
widely as anti-corrosive and biocompatible coatings on Mg alloy for orthopaedic 
applications [62]. There are several reasons for using silane as anti-corrosive coatings 
such as (a) Si-O-Si network (b) lower susceptibility to galvanic reactions with Mg, (c) 
greater adhesive properties, (d) easily chemically modifiable and (e) less cytotoxic in 
nature [62]. The use of sol-gel for the protection of Mg-based alloys against corrosion has 
been well reviewed [36,62]. 
 
Figure 1-3 Schematic diagram showing the sol-gel process and its various products 
[66] 
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The sol-gel undergoes full hydrolysis and partial condensation occurs before deposition 
on the substrate seen in Fig 1-4. The sol-gel can be deposited by a number of methods 
including dip coating, spin coating, roll coating, spraying and electrodeposition. Upon 
deposition solvent evaporation occurs and the condensation reaction proceeds forming a 
dense network. Further densification can be accelerated by thermal or UV curing 
methods. The adhesion of organo-silane molecules to magnesium-based substrates by a 
metallosiloxane bond (Me-O-Si) has been confirmed [36,62].  
 
Figure 1-4 Sol-gel coating process 
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1.6 Synthetic aliphatic polyester coatings 
In general, polymeric implants for orthopaedic applications have not been found suitable 
due to poor mechanical properties [1,67]. Therefore, such polymers are generally 
deposited as anticorrosive coatings on the orthopaedic implant. Usually, these polymeric 
materials enhance the corrosion resistance of Mg-based metals by isolating the device 
from the fluidic and corrosive environment of the body [1,14]. The biocompatible 
properties of polymers are critical because their presence at the interphase of implant and 
body environment which could elicit the immunological response. Therefore, selecting 
the appropriate polymer coating is crucial in improving the corrosion resistance and 
biocompatibility of orthopaedic metals, including Mg and its alloys. 
There are several advantages of polymers as they can be easily modified chemically, 
physically and mechanically, enabling their use in a wide range of biomedical 
applications [68,69].   
Synthetic aliphatic polyesters such as polylactic acid (PLA), poly-co-lactic-glycolic acid 
(PLGA), polycaprolactone (PCL), polyethyleneimine (PEI) and many other polymers 
have been used in various biomedical applications [70]. These polymeric materials are 
attractive coatings on Mg and its alloys to control the initial rate of degradation, as their 
degradation rate is based on their molecular weight [70].  In particular, lactic and glycolic 
acid-based polymers such as PLA and PGA, have been studied extensively as corrosion 
resistant coatings for orthopaedic applications. Similarly, significant work has been 
carried out on copolymers of lactide and glycolide i.e PLGA [71]. A copolymer of 50% 
lactide and glycolide degrades faster as compared to the corresponding homopolymer 
[70]. PCL also degrades slower than PLA [72]. Therefore, using a blend of polymers a 
suitable system can be designed with a selected corrosion rate. The polymeric deposit 
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coatings on orthopaedic Mg devices can also enhance the mechanical strength, with 
nontoxic degradation products enabling osteoinductive and osteogenic environments 
[68,69,73]. However, many of the currently available polymers do not fulfil the 
requirement and would require chemical modifications, if they are to be applied for such 
applications. This section discusses the corrosion resistant and biocompatibility 
properties of selected and important aliphatic polyester-based polymers coating on Mg 
and its alloys. 
1.6.1 Poly lactic acid 
Biodegradable polymers such as polylactic acid (PLA) have been explored extensively 
for biomedical application. PLA is highly biocompatible, semi-crystalline and 
hydrophobic in nature [74]. It undergoes hydrolytic degradation and the by-products such 
as lactic acid is easily metabolised in the body without exhibiting any toxicity. However, 
a major drawback of PLA as a load bearing implant for orthopaedic applications is that it 
possesses poor mechanical properties as compared to bone [1]. On the other hand, it can 
be used as an anti-corrosion coating on Mg alloys to slow down the hydrolytic 
degradation rate and the evolution of H2 gas (Table 4) [75]. However, it’s performance is 
dependent on the concentration of PLA and the application technique [76]. 
1.6.2 Poly (lactic-co-glycolic) acid 
PLGA (Poly(lactic-co-glycolic)acid)) copolymers are FDA approved for clinical 
applications mainly due to their excellent biocompatibility [74]. They are hydrolytically 
degraded into glycolic and lactic acid which are easily assimilated by metabolic pathways 
[77]. The physical, mechanical, chemical and degradation properties of PLGA can be 
engineered by altering the ratio of the two-co-monomers. Several compositions of 
copolymers of glycolic acid and lactic acid have been investigated. These copolymers are 
of usually two types (a) (l) LA/GA (b) (dl) LA/GA. The composition of (l) LA/GA ranges 
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of 20 to 70 % and of 0 to 70% for (dl) LA/GA are amorphous in nature [78]. Reed et al. 
showed that (l) LA/GA co-polymers are more resistant to hydrolysis [79]. The LA/GA 
(30/70) has a higher water absorption capacity and more susceptible to hydrolysis, while 
the LA/GA (50/50) copolymer is most unstable with respect to hydrolysis. These 
advantages of PLGA have been exploited for important applications such as corrosion 
protection and drug delivery. The corrosion protection performance of PLGA modified 
Mg alloys in different electrolytes in terms of corrosion current density and corrosion 
potential is given in Table 4.  
1.6.3 Poly caprolactone 
Polycaprolactone (PCL) is the most studied polymer in the family of polylactone [74].  It 
degrades slower than PLA and is useful for drug delivery as well as anti-corrosive 
coatings. The homopolymer PCL has a degradation time about 24 to 36 months under in 
vivo conditions. The rate of hydrolysis can be altered by co-polymerising with other 
polymers like valerolactones, dl-lactide etc [74].  For example, copolymers with epsilon-
caprolactone and dl-lactide have been synthesised to yield a polymeric material with 
higher degradation rates (e.g. biodegradable sutures). PCL is considered to be a nontoxic 
biodegradable material and suitable as a protective coating (Table 4) on Mg-based alloy 
for orthopaedic applications.   
1.7 Natural polymers coatings 
Natural polymers such as collagen, chitosan, stearic acid and serum albumin have been 
studied as coatings on the surface of Mg and its alloys for anti-corrosive as well as 
biocompatible properties [80].  In comparison to sol-gel and synthetic poly-esters, natural 
polymers exhibit excellent biocompatibility due to their biomimetic nature [81]. For 
example, extracellular cell matrix (ECM) components possess cell-specific domains such 
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as RGD (Arg-Gly-Asp) sequence which improve cell attachment [81]. Therefore, natural 
polymer-based coatings on implanted material enhance the interactions between the 
implant surface and surrounding tissue matrix, thereby expediting the regeneration of 
tissues [82]. These polymers are also capable of undergoing surface modifications, 
hydrogel scaffold synthesis and housing drugs for delivery [83]. Currently, the corrosion 
resistance of biopolymers is poor when compared to sol-gel and synthetic-polyester based 
coatings, and an improvement would require in-depth research work. The list of natural 
polymers coated on Mg and its alloy to study the corrosion resistance is given in Table 4. 
This section reviews the surface modifications of Mg and its alloys by natural polymers 
coatings to improve the corrosion resistance and biocompatibility.  
1.7.1  Collagen coatings 
Collagen is the major component of extracellular materials of bone matrices. Many 
reports have demonstrated that collagen type-I provides a favourable surface for cell 
adhesion, functions and cell proliferation of bone related-cells [84]. It is expected that a 
collagen coating on Mg and its alloys may be suitable for corrosion resistance, although 
very few reports are available. In previously reported literature, the collagen was applied 
for the secondary stabilisation of Mg-5Zr and Mg-5Zr-Ca alloys under in vivo conditions 
[84]. In addition, it has also been explored to develop the hydroxy-apatite conversion 
coating which reduced the release of Mg2+ by ~ 7 fold as compared to the uncoated AZ31 
equivalents immersed in HBSS over a period of 100 h [85].   
1.7.2 Chitosan coatings 
Chitosan coatings are generally non-toxic and can play an important function as an 
adhesive basal matrix for growing cells during the peri-implant healing process while 
enhancing the corrosion resistance of biodegradable metal [86]. It also showed good 
adherence to AZ91 Mg alloys and offered protective layer leading to high corrosion 
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resistance. Chitosan coating on Mg alloy increased the corrosion resistance with 
immersion time due to the deposition of a protective passivation layer. In general, surface 
modifications with natural polymers have shown to improve the corrosion resistance and 
biocompatibility properties of Mg and its alloys but literature reports for orthopaedic 
applications are limited. This indicates that the development of these coatings is in its 
infancy. As natural polymers are abundant, other kinds of natural polymers such as 
hyaluronic acid, lysozyme, alginate agar, dextran, chitin, chondroitin sulphate etc. offer 
a wealth of coating opportunity. 
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Table 4 Corrosion studies of polymers coated on Magnesium alloy. 
Polymers/Composites 
Degradation 
products 
Magnesium alloy 
Substrate 
Icorr 
(μA/cm2 
,unless 
Indicated) 
Ecorr 
(V) 
Corrosion 
Medium 
Coating Method Ref. 
Synthetic polyesters 
 
Poly Lactic acid Lactic acid PLA-AZ31 7.72 -1.57 
SBF Dip coating [75] 
  
PLA-MAO-AZ31 1.83 -1.5 
  
Mg-1.21Li-1.12Ca-1.0Y 1.7 -- Hanks’ buffer 
 
[87] 
PLGA 
d.l-lactic acid  and  
glycolic acid Mg-6Zn 0.085 -1.44 0.9% NaCl Dip coating [61] 
  
AZ31-PLGA 10 % 5.2 -1.469 
         DMEM Dip coating [71] 
  
AZ31-PLGA 20 % 6.05 -1.45 
  
Mg4Y-PLGA 10 % 8.09 -1.485 
  
Mg4Y-PLGA 20 % 6.85 -1.469 
  
PLGA 50:50 1.12 -1.52 
DMEM Dip coating [88] 
  
PLGA 75:25 1.56 -1.44 
Poly(capro-lactone) Caproic acid MAO–4PCL duplex coated 0.81 −1.72 
Hanks’ buffer Dip coating [89] 
  
Mg MAO–7PCL duplex coated Mg 0.0045 −1.53 
  
Mg- PCL 2.5 wt% 7 -- 
DMEM Spin coating [90] 
  
Mg- PCL 5 wt% 0.1 -- 
  
Mg- PCL 7.5 wt% 0.02 -- 
  
PCL-AZ91-LPM Reduced 1.44 
SBF Spray coating [33] 
  
PCL-AZ91-HPM 
 
1.14 
Linear Poly-ethylene imine 
Ethylene glycol and 
amine AZ91D-PEI/PSS/8HQ/PSS 24.82 -1.732 m-SBF Spin coating [91] 
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Sol-gel coatings 
DEPETES& BTESPT - Mg-6Zn-Ca -1(M) 
  
m-SBF 
  
  
M-DEPETES:1BTESPT 1.20× 10
−2
 -1.39 
Dip coating [92] 
  
M-DEPETES:2BTESPT 7.24x10
−3
 -1.35 
  
M-1DEPETES:3BTESPT 2.45 x10
−3
 -1.37 
  
M-1DEPETES:4BTESPT 7.59 x10
−4
 -1.38 
TiO2 - Mg-MAO-TiO2 12.5 -1.93 Hanks’ solution Dip coating [93] 
Natural Polymers 
 
Chitosan 
Glucosamine  and keto-
olligosacchraide Chi/MAO/Mg–Zn–Ca-120V 14 -1.549 Na2PO4+NaOH Dip coating [94] 
  
Chi/MAO/Mg–Zn–Ca-140V 0.59 -1.499 Na2PO4+ NaOH Dip coating [34] 
  
MAO-WE43-chitosan-polystyrene-LBL 2.796 -1.295 SBF Spin coating [95] 
  
AZ91E-5%  chitosan 0.322 -1.562 
Synthetic Sweat Dip coating [86] 
  
AZ91E-10% chitosan 0.136 -1.535 
  
AZ91E-15% chitosan 0.116 1.483 
HA-chitosan 
Glucosamine  and keto-
olligosacchraide HA-5 wt.% chitosan-AZ31 15.1 -1.601 SBF 
 
[96] 
  
HA-10 wt.% chitosan- AZ31 31.4 -1.581 
 
Spray coating 
 
  
HA-20 wt.% chitosan-AZ31 50.9 -1.586 
   
Stearic acid 
and magnesium state 
Collagen 
Stearic acid 
Hydroxylysine/proline/
hydroxyproline AZ31 4 -1.71 Hanks’ solution Dip coating [97] 
 
AZ31 
0.00223 -1.48 SBF 
 
Electrospinning 
[98] 
  
3.741 -1.46 Dip coating 
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1.8 Molecular mechanism of Mg2+ inducing bone formation 
Bone development involves osteogenesis, angiogenesis and osteoclastogenesis [99]. The 
hierarchy of the bone precursor cells is mesenchymal stem cells, osteoprogenitor cells, 
pre-osteoblast cells, osteoblast cells and osteocytes (a mature form of osteoblast cells). 
Mesenchymal stem cells are pluripotent while osteoprogenitor cells are committed to the 
expansion of the lineage of proliferated osteoblast cells with transitional pre-osteoblast 
cells. Osteocytes are terminally differentiated osteoblast cells to be embedded within bone 
lacunae that play a role in phosphate and calcium homeostasis and mechanosensation 
functional adaptation (Fig 1-6).  It is desirable that coated or uncoated Mg alloys should 
not only possess the corrosion resistance but also induce the osteogenic activity for 
enhanced healing of the bone injury.  
The exact molecular mechanism/cell signalling of Mg2+ effect on osteoblast cells activity 
is not known properly, but a possible mechanism is depicted in Fig 1-5.  Yoshizawa et al. 
reported the stimulation effect of magnesium ions on human bone marrow stem cells 
(hBMSCs) for osteogenic activity [99]. In this study, the molecular mechanisms of 
intracellular Mg ions effect on the osteogenic activity of hBMSCs with or without 
osteoinductive growth factors were evaluated. The [Mg2+] ranging from 0 to 10 mM was 
incubated with hBMSCs for 3 weeks with or without osteoinductive medium and 
evaluated for osteogenic activity by screening various osteogenic markers (ECM 
mineralisation and gene expression). The ECM mineralisation and collagen type X 
expression were increased at 10mM of [Mg2+] in the abovementioned conditions 
Furthermore, the mechanism of intracellular cell signalling was investigated by analysing 
the protein production of the hypoxia-inducible factor (HIF)-1α and 2α (transcription 
factors of COL10A1), vascular endothelial growth factor (VEGF) (activated by HIF-2α) 
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and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1α 
(transcription coactivator of VEGF). The results showed that 10mM [Mg2+] ions 
upregulate the expression of COL10A1 and VEGF via HIF-1α in undifferentiated cells, 
and osteogenic cells via PGC-1α transcription factor. From this study, it is observed that 
VEGF plays an important role in the process of defining osteoblastic lineage.  
 
Figure 1-5. Schematic hypothesized intracellular signalling cascade of Mg2+ 
stimulation of bone-related cells.  
Another very important process is angiogenesis in the development of new bone. New 
blood vessels bring oxygen, nutrients and serve as a route for inflammatory cells and 
bone-like/precursor cells to reach the injury site. Most notably, VEGF produced by 
inflammatory cells and hBMSC, induce and enhance the growth of blood vessels in 
fracture bone tissue. VEGF has three isoforms A, B, and C that are homo-and 
heterodimers which bind to a dimeric receptor complex of 2 receptors, VEGFR1 (Flt-1) 
and VEGFR2 (Flk-1) [100]. 
In the fracture healing process, pro-angiogenic VEGF factor concentrations are elevated 
at early post-fracture condition [99]. As previously mentioned, VEGF factors are secreted 
by inflammatory cells recruited at an injury site [99].  Secondly, its expression can be 
induced by hypoxia conditions, where HIF-1α acts as a transcription factor for VEGF 
expression [99]. In addition, VEGF activates several other pathways including 
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intracellular and vascular adhesion molecules (ICAMs and VCAMs), eNOS expression, 
basal fibroblast glilal factors and matrix metalloproteins (Fig 1-6).  
 
Figure 1-6 A schematic showing the dual action of Mg2+ on bone forming activity by 
stimulating osteogenesis and angiogenesis [105]. 
From the above discussion, it can be concluded that communication between osteoblasts 
and endothelial cells is essential for bone fracture repair (Fig 1-6). Furthermore, 
osteoclastogenesis also plays a very important role in bone remodelling. Janning et al, 
investigated the effect of osteoblast and osteoclast cell proliferation by implanting 
cylinders of pure Mg(OH)2 into rabbit femur condyles for 2–6 weeks [100]. Results 
showed an initial increase in bone volume (Bone volume/ tissue Volume) in the vicinity 
of Mg (OH)2 implant surface at 4 weeks, which was equal to 6 weeks of control. It is 
suggested that osteoclast surface per bone surface ratio decreases significantly in the first 
four weeks, while increases in the osteoid surface to bone surface ratio was observed. At 
the sixth week, the osteoclast surface to bone surface ratio reached was similar to that of 
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the control. Thus, the enhanced bone formation and decreased bone resorption activity 
resulted in the higher bone mass formation around the Mg(OH)2 implant.  
1.9 Anti-biofilm activity of polymers coated on Mg-based biomedical materials 
Despite considerable advancement in prevention and treatment of implant associated 
microbial infections, the risk of implant failure due to the lifelong bacterial colonisation 
on the implant [101]. Infection related with prosthetics joints (hip or knee replacement) 
is usually less than 2%, but it increases considerably to 5-40% after revision surgery 
[105]. Similarly, 5% of fixation implants suffer failure due to the implant-associated 
infections, whereas the incidence may increase significantly to 30% after fixation of open 
fractures [105]. In future, it is expected that the incidence of infection rates associated 
with orthopaedic devices will increase in future because detection method of microbial 
films formation showed tremendous improvement over a few decades [105-106].   
The complex interactions between the pathogenic organisms, implant devices and host 
immune system are the origin of many devices associated infections. Surface properties 
including surface hydrophilicity, hydrophobicity and surface charge play important roles 
in initial adhesion and proliferation of bacteria. Thus, the optimal design for infection 
resistance is a challenging issue and must satisfy a broad range of requirements like 
optimal broad-spectrum antimicrobial activity, preventing biofilm formation and 
biocompatibility.  In order to counter this problem, researchers have focussed on different 
areas of polymer application as its antimicrobial nature, drug releasing agent, composite 
synthesis with inorganic/organic antimicrobial agents (Metals ions/ metal 
nanoparticles/polymeric nanoparticles) [102]. However, Mg ions were found to be 
moderately antimicrobial active, and are more prone to biofilm formation and thus very 
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few publications have been observed that are pertinent to Mg-based alloys for orthopaedic 
applications. 
Robinson et al, studied the antimicrobial activity of Mg2+ ions against Escherichia coli, 
Pseudomonas aeruginosa and Staphylococcus aureus [103]. The Mg2+ions induced a 
change in pH and its effect on antibacterial activity was studied. The change in pH caused 
by Mg2+ was adjusted to neutral to study the antibacterial effect of concentration and pH 
independently. It was observed that antibacterial activity is independent of concentration, 
but pH shift to alkali was attributed to the antibacterial activity of Mg2+ ions. However, 
the generation of an alkaline environment caused toxicity to surrounding tissues and thus 
alone Mg-based materials are not an effective antibacterial agent. 
Li et al, studied the drug delivery, antibacterial property and cytocompatibility of 
gentamycin loaded PLGA nanoparticles on porous Mg scaffold [104]. The prime 
objective of this work was to achieve sustained drug release of antibiotics at local sites of 
bone defects. The results showed that the PLGA drug loaded gentamycin showed higher 
drug releasing efficiency (28-33%) than uncoated gentamycin loaded Mg scaffold (2-
3%). The sustained drug release was monitored for more than 14 days, and it inhibited 
biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis. The 
biocompatibility of hBMSC demonstrated the cytocompatibility with PLGA loaded Mg 
scaffold compared to Mg alone. Hence, this strategy was found to be a promising strategy 
for sustained/controlled drug delivery systems to prevent orthopaedic implant-associated 
infections.  
Tian et al, investigated the antimicrobial activity and biocompatibility of HA coupled 
antimicrobial peptide (AMP) (RRWPWWPWRR-NH2) coated Mg alloy (AZ91) [113]. 
Additionally, the biodegradation of Mg alloy was determined by the change in the weight 
of the alloy. The loading efficiency of AMP in HA was ~11 µg/cm2 and the release of the 
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peptide was monitored for 7 days. The antimicrobial activity was efficient against 
S.aureus with 50% inhibition after 4 days and sustained antimicrobial activity for 7 days. 
Furthermore, it enhanced the proliferation and alkaline phosphatase activity of hBMSC. 
Under in vivo conditions, antimicrobial peptide coated Mg alloy implant in femoral 
condyle showed new bone formation and anti-inflammatory effects. 
1.10 Summary 
Despite of the immense potential of biodegradable Mg alloys for orthopaedic 
applications, the major disadvantage is their high corrosion rate, thereby creating a bio-
incompatible environment in the surrounding tissues. In order to overcome these 
drawbacks, strategies such as the effect of alloying elements and polymeric surface 
modifications of Mg and its alloys have been discussed. It was observed that alloying 
elements can improve the corrosion resistance of Mg-based alloys. But, the 
biocompatibility of these alloying elements on bone related cells is an important factor, 
and the implant should not show cell toxicity. 
Recent research on the effect of polymer deposit coatings on corrosion behaviour and 
biocompatible properties of Mg alloys shows that sol-gel and synthetic polyester based 
coatings have significantly improved the corrosion resistant. Numerous studies also 
highlighted the improvement in corrosion properties of natural polymer coatings by 
incorporating the synthetic polymers. Therefore, novel strategies need to be designed, 
which could exploit the multifunctional coatings for the development of potential 
biodegradable orthopaedic Mg based implants. 
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Chapter 2  
 
 
Analytical techniques 
 
This chapter overviews the principles of the various spectroscopic, microscopic and 
electrochemical analytical techniques such as Fluorescence spectroscopy, Fourier 
transform infrared spectroscopy (FTIR), inductively coupled plasma optical emission 
spectroscopy (ICP-OES), Scanning electron microscopy (SEM), Atomic force 
microscopy (AFM), Contact angle measurement. This chapter also discusses the various 
in vitro biochemical assays to analyse the cytocompatibility of osteoblast cells and 
antibacterial activities. 
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2.1 Spectroscopy 
Spectroscopy is the study of the interaction between light radiation and matter as a 
function of wavelength. Spectroscopy refers to the use of a beam of light dispersed 
according to its wavelength or frequency. The type of spectroscopy depends on the 
physical quantity measured.  
2.1.1 Fluorescence spectroscopy 
Operator: Sankalp Agarwal  
Fluorescence spectroscopy involves the emission 
of light at higher wavelengths (Emission 
wavelength) that occurs within nanoseconds after 
the absorption of shorter wavelength light 
(Excitation wavelength). The mechanisms by 
which electronically excited molecules come to 
ground state are shown in Fig 2-1 [2]. The 
absorption of a photon takes the molecule from the 
ground state (singlet state, S0) to either first excited 
state (singlet state S1) or second excited state (S2). 
Then the excited molecule relaxes to the lowest 
energy level (vibrational level) of the first excited state. It can relax from the singlet 
excited state to the ground state either by emitting a photon or without emitting photons. 
The emitted fluorescence photons give information about intensity (number of photons 
released), spectrum, polarization and their time dependence, important parameters that 
one can use for the characterisation of samples [3]. 
 
 Figure 2-1 Jablonski diagram 
showing the energy levels and 
various processes in an 
electronically excited molecule [2] 
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This technique has become popular for its biochemical and medical applications. 
Fluorescence spectroscopy has been used to identify cells and tissues based on 
endogenous or exogenous chromophores [4].In this study, the bisBenzimide fluorescent 
dye was used to quantify the DNA of MC3T3E1 osteoblast cells by fluorescence 
spectroscopy cultured over a period of 21 days in differentiation medium.  
2.1.2 Fourier transform infrared spectroscopy 
Operator: Sankalp Agarwal  
FTIR spectroscopy is a technique used to detect the presence of functional groups in the 
sample. It involves the detection in the infrared region and uses the Fourier transform 
technique for spectral detection and analysis. In this study, sol-gel coating and bio-
functionalisation were characterised using FTIR.  
Molecular bonds vibrate at different frequencies. Depending on the type of bonds in a 
molecule, there are several specific frequencies at which it can vibrate. In general, the 
atoms in a molecule vibrate about a mean position. If there is a net change in the dipole 
moment of a molecule due to this vibrational motion, then such mode of vibration is said 
to be infrared (IR) active [5]. The vibrating molecule absorbs energy only from the 
specific frequency of radiation with which it can coherently interact. Such absorption is 
known as resonating frequencies which are characteristic of the structure of a particular 
molecule.  The principles of IR can be explained by classical mechanics [5]. The classical 
model consists of a simple ball and spring model wherein diatomic molecules with two 
masses, m1 and m2, are connected by a spring. A system of masses joined by springs has 
a number of fundamental modes of vibration each of which has a particular natural 
frequency. 
According to Hooke's law when the spring is displaced, 
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                                                             𝑭 =  −𝒌𝒙                                              Eq. 5 
Where, F = opposing restoring force; k = force constant; x = displacement from the 
equilibrium position. This is a simple harmonic equation (Eq. 5) wherein the frequency 
(𝝊) of vibration is given by the relation (Eq. 6). 
                                  (𝝊) =
𝟏
𝟐𝝅
 √𝒌/µ                                                     Eq. 6 
Where μ is the reduced mass of atoms present in a compound and k is the force constant 
related to the particular vibration using simple laws of mechanics. The characteristic 
frequencies of some compounds are listed in Table 5.  
Table 5. Characteristic frequencies of different compound types [5]. 
Bond Compound type Frequency range, cm
-1
 
C-H Alkanes 2960-2850(s) stretch 
  
1470-1350(v) bending 
C=C Alkenes 1680-1640 stretch 
C≡C Alkynes 2260-2100 (w,sh) stretch 
C=C Aromatic ring 1600, 1500(w) stretch 
C-O Alcohol, Ether, Carboxylic acids, Esters 1260-1000(s) stretch 
C=O Aldehyde, Ketone, Carboxylic acid 1760-1670(s) stretch 
 
Monomeric-Alcohols, Phenols 3640-3160(s,br) stretch 
 
Hydrogen-bonded-Alcohols, Phenols 3600-3200(b) stretch 
N-H Amines 1650-1580 (m) bend 
 
O-H 
 
Carboxylic acids 
3000-2500(b) stretch 
3500-3300(m) stretch 
C-N Amines 1340-1020(m) stretch 
Si-O-Si Siloxane 1200,1075 (v), 
Si-OH Silanol 960 (v) 
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Types of vibration modes  
The resonating frequencies are also related to bond strength and mass of the associated 
atom. These frequencies of vibrations for a particular bond type are associated with a 
number of vibration modes (Fig 2-2). In order to be an IR active vibration mode, a 
molecule must be associated with the change in dipole moment. A molecule can vibrate 
in different ways called vibrational mode.  For a molecule with N number of atoms, 
numbers of vibrational modes of linear molecules are given by 3N – 5 degrees of 
vibrational modes, where non-linear molecules have 3N – 6 degrees of vibrational modes. 
The vibrational modes are classified as either stretching or bending. Stretching vibrational 
modes are categorized as being either symmetrical (movement in the same direction) or 
asymmetrical (movement in opposite directions). Bending vibrations modes are classified 
as scissoring, rocking, twisting, or wagging [5]. 
 
Figure 2-2 Different types of vibrational modes [5] 
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2.1.3 Inductively coupled plasma optical emission spectroscopy (ICP-OES) 
Operator: Sankalp Agarwal  
ICP-OES determine trace elements in the different type of samples. In this study, ICP-
OES was used to determine the rate of Mg2+ ions release from the uncoated and coated 
AZ31 substrates in the electrolyte for different test durations.  
In ICP-OES, the liquid sample is introduced into the nebulizer chamber along with argon 
(Ar) gas through the small aperture in the form of tiny droplets that form a mist of μm-
sized particles (Fig 2-3). Larger droplets are removed through a drain, while smaller 
particles travel with the Ar flow and enter the torch. The torch unit of an ICP creates a 
plasma. At the core of the inductively coupled plasma, the temperature can reach 9000 
ºC. At this temperature, the sample undergoes evaporation, atomisation, and 
excitation/ionisation. The plasma-induced excited/ionised atoms to relax and emit 
photons of characteristic energy for a particular atom or ions. Thus, the wavelength of 
photons can be used to identify an element and quantified [6].   
 
Figure 2-3 Overview of ICP-OES 
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The inductively coupled plasma torch 
The torch unit of an ICP produces a sustained plasma. The RF generator is used to set up 
an electric and magnetic field inside the torch to produce a mixture of cations and 
electrons through collision.  Since the energy adds up to the plasma by RF-induced 
collision, it is known as inductive coupling and hence the plasma is known as ICP [7].   
So, the function of the torch is to (1) evaporate the solvent (water), (2) atomise the atoms 
(break the ionic bonds and form gaseous state atoms), and (3) excite or ionise the atoms 
[8]. 
2.2 Microscopy 
A microscope is used to magnify objects by means of lenses that are not visible to the 
naked eye. In general, microscopy involves the refraction, reflection and diffraction of 
electromagnetic radiation/electron beam by the specimen and their collection as scattered 
radiation or signal to create an image. There are different types of microscopes with 
resolution ranging from 10-4 m to 10-12 m [9].  
In this study, two different types of microscopes were used. Scanning electron microscope 
with EDX was used to observe cell morphology, surface morphology and elemental 
composition of the AZ31 Mg substrates. Fluorescence microscopy was used to observe 
live and dead osteoblast cells, which are represented by green and red fluorescence 
respectively. 
2.2.1 Scanning electron microscope (SEM) 
Operator: Sankalp Agarwal  
In scanning electron microscopes electrons are emitted from a metal filament tip and are 
then accelerated under an applied potential towards the specimen to produce the emission 
signals. The emission of electrons from the tip can be due to thermionic, field emission 
     Chapter 2 
    
50 
 
or a combination of both. Modern electron microscopes utilise field emission sources due 
to the enhanced brightness and emission current stability achievable over thermionic 
sources. Field emission of electrons from the tip occurs due to the influence of a strong 
electric field (109 V/m) electrons. 
Using a series of lenses and apertures a fine probe of electrons with energies typically up 
to 30keV is focused on a specimen and scanned along a pattern of parallel lines, Figure 
2-4. The generated signals are collected to form an image or to analyse the sample surface. 
Under vacuum, electrons generated by a field emission source are accelerated in a field 
gradient. The beam passes through electromagnetic lenses, focussing onto the specimen. 
As a result of this bombardment, the different types of electrons are emitted from the 
specimen. A detector catches the emitted electrons and an image of the sample surface is 
constructed by comparing the intensity of these secondary electrons to the scanning 
primary electron beam [9]. Finally, the image is displayed on a monitor. 
 
Figure 2-4 SEM instrument (Hitachi SU70) and schematic working of SEM 
     Chapter 2 
    
51 
 
A major advantage of SEM is that most samples, with the exception of biological samples, 
can be studied with little preparations. In general, it is important that the sample should 
be electrically conductive, so that incident electrons are earthed. The accumulation of 
electron on a non-electrical conductive surface causes a charge build-up, which degrades 
the SEM image [10]. In order to avoid such problems, conductive materials are used to 
coat the specimens such as gold, gold/palladium alloy, platinum, iridium, tungsten, 
chromium and graphite either by low vacuum sputter coating or by high vacuum 
evaporation [10]. 
In combination with the Energy Dispersive X-Ray Spectroscopy, elemental quantification 
of a given sample can be analysed (Fig 2-5). The depth of the electron penetration into 
the sample will emit a variety of electron/x-rays as shown in Fig 2-5 (a).These, in turn, 
will depend on the properties of substrates and thus can be used for the characterisation 
[11].  
 
Figure 2-5. (a) Interaction of electron beam with specimen and (b) Example of EDX 
elemental map of sol-gel silane coated Mg alloy.  
EDX works by detecting the X-rays that are produced by the interaction of an electron 
beam with a sample. Upon interaction, the atoms of the samples are excited by the 
electron beam, thereby producing X-rays to discharge the excess energy [11]. This energy 
of X-rays represents emission intensity which is proportional to the concentration of the 
(b)(a)
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elements in the particle and plot the distribution of the identified elements. DOT MAPs 
can be created from the spectra where a coloured pixel is assigned to the image if a certain 
element is detected within the segment of the sample. A chemical map can then be 
constructed for the sample being analysed as seen in Fig 2-5 (b).  
2.2.2 Fluorescence microscopy 
Operator: Dr. Marie-Noelle Labour  
Fluorescence microscopy is a form of optical microscopy which uses fluorescence to 
reveal the structure of fixed and living biological specimens instead of absorption, phase 
or interference of light [12]. In this microscopy, the specimen is either tagged with a 
fluorescent probe or itself possesses the property, is illuminated with an excitation 
wavelength, causing them to emit light of longer wavelengths (emission wavelength). 
The illuminated light is separated from the emitted light through an emission filter to 
observe the fluorescent specimens [13]. 
 
Figure 2-6 (a) Typical setup and working of fluorescence microscopy and (b) 
Fluorescence image of live-dead osteoblast cells on Ti substrate.  
Typically, basic components of a fluorescence microscope are a light source (mercury-
vapour lamp or xenon arc lamp), the excitation filter, dichroic mirror and emission filters 
(Fig 2-6(a)). These filters are chosen to match the excitation and emission characteristic 
(b)(a)
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of fluorophore-tagged to the specimen [12]. Multi-colour fluorescent images can be 
generated by superimposing many single-colour images as presented in Fig 2-6 (b) [12].    
2.2.3 Atomic force microscope 
Operator: Dr. Luke O’Neil 
AFM is a powerful technique used for the topological studies in x, y as well as z-direction 
at a sub-micro scale. It utilizes a silicon or silicon nitride tip at the end of a cantilever that 
moves over the sample in a raster scan and bends in response to the force between the tip 
and the sample (Fig 2-7)[14]. AFM can measure various forces which include mechanical 
contact force, van der Waals forces, capillary forces, chemical bonding, electrostatic 
forces, magnetic forces etc [15].   
 
Figure 2-7 Schematic working of AFM [1] 
Originally a scanning tunnelling microscope was used to monitor the bending of the 
cantilever, but now, an optical lever technique is employed for the purpose. As the 
cantilever bends, light from the laser is reflected onto the split photo-diode. The difference 
in the signal is used as a measure of the bending of the cantilever. A device made of 
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piezoelectric ceramic (PZT) in the form of the scanner is used to control the movement 
of the tip or the sample. The scanner is capable of sub-angstrom-level resolution in the x, 
y or z-direction [15]. Depending upon the application AFM commonly operated in 
contact and tapping modes [16]. The most commonly used method is the contact mode 
AFM where the tip remains in close contact with the sample during the process of 
scanning. The tapping mode is generally used for the imaging of soft samples which are 
poorly immobilized. In this mode, the tip oscillates at its resonating frequency and is 
positioned over the sample so that it contacts the sample for a short time interval during 
oscillation. AFM has many advantages over electron microscopy that it's a non-
destructive method and can be performed in both air and aqueous environment to examine 
the surface topography at sub-nanometer resolution. As the sample does not need to be in 
a vacuum for analysis, live bacteria can be viewed in situ. 
2.3 In vitro corrosion testing techniques  
2.3.1 Potentiodynamic polarisation  
This technique is a commonly used method to measure Mg corrosion. In the study, this 
method was used to study the electrochemical corrosion of AZ31 modified substrates in 
the electrolyte (cell culture medium). The potentiodynamic polarisation involves 
sweeping a potential to increase the reaction at the working electrode surface (samples) 
and record the resulting current [17]. Therefore, results from this technique provide 
information about the electrochemical behaviour of a metal in a given electrolyte. The 
potentiodynamic polarisation is representing in a plot of potential versus current density 
(E vs log i) which can be divided into oxidation (anodic) and reduction (cathodic) 
reactions, depending upon the polarity of the polarising signal (Fig 2-8). From the co-
ordinate of the point where the linear region of each reaction meets, Ecorr and icorr values 
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can be analysed, and this method is referred to as Tafel-plot analysis. The schematic 
polarisation curve is shown by Tafel plot (Fig 2-8). The dotted line is the accumulated 
data and the solid line represents linear approximations, which can be used to estimate 
current density (icorr) and corrosion potential (Ecorr) by Tafel fit analysis. The current 
density obtained from Tafel fit is proportional to the corrosion rate of the substrate.  
 
Figure 2-8 Polarisation curve with Tafel fit [17]. 
The potentiodynamic test is performed, once the open circuit potential (OCP) stabilises. 
The potential at which the current balances the cathodic and anodic reaction is said to be 
OCP. OCP can be recorded between the reference and working electrodes without passing 
current through the counter electrode, but a long time may corrode the Mg surface [18, 
19].  
2.3.2 Electrochemical impedance spectroscopy   
The EIS technique is based on the mechanism and properties of the electrical double layer 
(EDL) [17, 20]. It forms on the structure surface when it is placed in a solution. (Fig 2-
9(A)). More specifically in Mg metal, this phenomenon occurs when metal ions diffuse 
away from the surface under the influence of water molecules and leave the negatively 
charged electrons behind (Fig 2-9(B)).  This negatively charged surface begins to attract 
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the released ions. These ions along with positively charged ions in the electrolyte are 
attracted to the negative surface charge. Consequently, an electrolyte layer consisting of 
metal and electrolyte ion form next to the surface is referred to as EDL (Fig 2-9(C)). 
 
Figure 2-9 Electrical double layer formation- (A) Surface in the electrolyte, (B) 
release of ions in the electrolyte and (C) positively charged ions attracted to surface 
During the experiment, polarisation is applied which forces the ions to move either to the 
working or counter electrode, in order to maintain electrical neutrality. This perturbs the 
EDL equilibrium and causes the layer to establish a new equilibrium as the AC potential 
frequency changes (105 to 10-2 Hz). In a corrosion resistant surface, the EDL will be less 
active, indicating an increase in impedance IZI. The impedance has an equivalent physical 
meaning as the resistance, which changes with the angular frequency of the applied 
voltage. EIS data can be expressed in three common types Nyquist plots, Bode magnitude 
plots and Bode phase plots.  
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Figure 2-10 (A) Nyquist plot- W is the angular frequency (Hz), Rs is the electrolyte 
resistance (Ω), REDL and CEDL are the charge transfer resistance and capacitance, 
and (B) Represents bode plots. 
The Nyquist or complex plot presents the impedance magnitude for the real (Re(Z)) and 
imaginary (Im(Z’)) frequency. It is possible to fit an appropriate equivalent circuit to 
determine the number of time constants, resistance and capacitance (Fig 2-10A). 
However, this plot does not display the dependence of impedance on the frequency of the 
signal. To relate the impedance with frequency, it is usually necessary to show Bode plots, 
in which the magnitude of impedance (log |Z|) and phase is plotted against the log values 
of corresponding frequencies (Fig 2-10B). From the Bode plot, the corrosion behaviour 
of metal can be assessed by the value of |Z|. Higher values of impedance |Z|) imply the 
substrate is more corrosion resistant [21]. 
2.3.3 Hydrogen evolution measurement 
Hydrogen evolution (H2 gas) testing is an inexpensive and reliable technique, which has 
been widely adopted to study the corrosion behaviour of Mg and its alloys [22-25]. It 
involves the volumetric measurement of H2 gas release from a corrosion site. In this 
method, burette filled with the test electrolyte placed on the top of the sample. The H2 gas 
generated during corrosion reaction accumulates in the burette and displaces the solution 
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inside the burette (Fig 2-11). This provides a direct correlation of the volume of H2 gas 
produced. According to Eq-2, 1 mol of corroded Mg will produce in 1 mol of H2 (g). 
However, the stoichiometry of the redox equation, producing elemental hydrogen is not 
fully understood and therefore not 100% efficient. Therefore, the volume of H2 (g) 
produced does not directly correlate to the Mg ions. In addition, this method has several 
disadvantages such as leakage of H2 due to experiment setup and changing atmospheric 
pressure.  
 
Figure 2-11 H2 gas evolution test setup 
Immersion testing is another method to determine the rate of corrosion derived by the 
mass loss of Mg substrates [26]. The mass loss is determined by weighing the sample 
before and after the test (Eq. 7). Alternatively, the release of Mg2+ions released in the 
electrolyte can be quantified by ICP-OES.  
Corrosion rate = mass loss/ (surface area x day) …………….Eq. 7 
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2.4 In vitro assessment of cell cytotoxicity  
2.4.1 MTT assay 
The MTT assay is a colourimetric method for determining the cell metabolic activity [27].  
This assay can be used to measure the cell cytotoxicity (loss of viable cells) or cell 
proliferation (increase number of viable cells) of potential cytotoxic and bioactive agents. 
The MTT assay involves measuring the activity of NAD(P)H-dependent cellular 
oxidoreductase enzymes under the defined condition, reflecting the presence of viable 
cells. These enzymes reduce the tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to its insoluble purple coloured formazan crystals. (Fig 2-
12). These crystals can be dissolved in dimethyl sulfoxide (DMSO), a solution of sodium 
dodecyl sulfate in the diluted HCl or an acidified ethanol solution. The absorbance of the 
coloured solution can be determined by spectrophotometer. In this study, the cytotoxicity 
of different concentration of Mg2+ ions on MC3T3E1 osteoblast cell was evaluated by 
MTT assay. 
 
Figure 2-12 Mitochondrial reduction of MTT to blue Formazan product [27] 
2.4.2 DNA quantification by fluorescence assay 
There are several methods to quantify the double stranded DNA (dsDNA), however, some 
have limitations such as interfering absorbance of contaminating molecules nucleotides, 
(Yellow colour) (Violet colour)
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RNA and phenol. The fluorescent bisbenzimide (Hoechst) dye circumvents many of these 
problems [28-31].  It works with purified and crude DNA extract.  However, the 
quantification of DNA in the crude extract requires high salt concentration. The Hoechst 
33258 fluorescent itself in the solution loosely binds to A-T pairs of dsDNA of minor 
groove, resulting in the increase of fluorescence emission at 460 nm. This assay is 
sensitive for a concentration of 10 ng/ml to 10 μg/ml of DNA. 
2.4.3 Alkaline phosphatase assay (ALP assay) 
Alkaline phosphatase plays an important role in the hard tissue formation which is highly 
expressed in the mineralised cells [32]. It is an early stage marker of MC3T3E1 osteoblast 
cell differentiation. The mechanism by which this enzyme performs its function is still 
not completely understood [32]. It appears that this membrane-bound enzyme acts by 
increasing the localised concentration of inorganic phosphate, a mineralisation promoter, 
and decreases the extracellular concentration of pyrophosphate, an inhibitor of 
mineralisation. In this study, the differentiation of osteoblast cells was determined by 
measuring the intracellular ALP activity using a para-nitrophenyl substrate (p-NPP). ALP 
enzyme in the crude cell lysate hydrolyses the p-NPP to produce chromogenic para-
nitrophenol, which corresponds to the ALP activity of differentiated osteoblast cells (Fig 
2-13) [33].  
 
Figure 2-13 Reaction of ALP activity assay 
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2.5 In vitro assessment of antibacterial activity   
2.5.1 Spread plate assay 
In this study, antibacterial activity and efficiency of bacterial cell adhesion were 
determined by spread plate assay. In this method, the surface was exposed to the bacteria 
for a specific time period and incubated at 37 ⁰C. Then, the adhered or viable bacteria on 
the surface were dislodged using ultrasound in PBS and serially diluted, before spreading 
on the agar plate and incubated overnight at 37 ºC [34]. The number of colonies represents 
viable count and expressed as colonies forming unit/ml (Eq. 8) [34] 
 𝑽𝒂𝒊𝒂𝒃𝒍𝒆 𝒄𝒐𝒖𝒏𝒕 = 𝐍𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐜𝐨𝐥𝐨𝐧𝐢𝐞𝐬 ÷ 𝐯𝐨𝐥𝐮𝐦𝐞 𝐩𝐥𝐚𝐭𝐞𝐝 (𝐦𝐥) × 𝐝𝐢𝐥𝐮𝐭𝐢𝐨𝐧 𝐟𝐚𝐜𝐭𝐨𝐫 ….Eq. 8 
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Chapter 3  
 
Improved corrosion protection and biocompatibility of PLGA- silane 
coating on AZ31 Mg alloy for orthopaedic applications 
 
This study reports a multi-step procedure to fabricate novel corrosion resistant and 
biocompatible PLGA-silane coating on the magnesium (Mg) alloy AZ31. The first step 
involves alkaline passivation followed by the dip coating in a methyltriethoxysilane 
(MTES) and tetraethoxysilane (TEOS) mixture to produce a crosslinked siloxane coating. 
The second step is to impart an amine functionalization to the silane-modified surface by 
using 3-aminopropyl-triethoxy silane (APTES) for promoting adhesion of the acid 
terminated poly-(lactic-co-glycolic) acid (PLGA) as a final coating step. Static contact 
angle measurements, Fourier transform infrared spectroscopy and scanning electron 
microscopic analysis confirmed the successful assembly of coatings on the AZ31 Mg 
alloy. An electrochemical corrosion study, measurement of magnesium ion release, pH 
changes and hydrogen evolution showed enhanced corrosion protection of coated 
substrate over uncoated AZ31 Mg alloy. An MTT assay, live-dead cells staining, DNA 
quantification and alkaline phosphatase activity assay were used to measure the 
biocompatibility, proliferation and differentiation of MC3T3-E1 osteoblast cells. The 
application of such coatings on the biodegradable Mg alloys enhanced their corrosion 
resistance and biocompatibility.  
The work described in this chapter has been published: Agarwal. S., Morshed, M., 
Labour, M.N., Hoey, D., Duffy, B., Curtin, J. and Jaiswal.S, Enhanced corrosion 
protection and biocompatibility of a PLGA–silane coating on AZ31 Mg alloy for 
orthopaedic applications. RSC Advances, 2016 6(115), 113871-113883. 
 Chapter 3   
65 
 
3.1 Introduction 
Conventional metals such as 316L stainless steel, titanium and cobalt-chromium based 
medical grade inert alloys are used as permanent orthopaedic implants in order to 
immobilize fracture and restore damaged bone [1]. Over the past decade, there has been 
increasing interest to replace these permanent alloys with biodegradable magnesium (Mg) 
and its alloys which not only degrade under in vivo conditions but also exhibit low toxicity 
and similar mechanical properties to natural bone [2]. Research to date has shown that 
Mg and its alloys can be potentially used for orthopaedic fracture fixation such as fixation 
plates, rods and screws. Such temporary implants can remain for the appropriate time to 
support the bone fracture recovery before degrading and being absorbed by the body. 
Biodegradable metallic implants reduce the complications associated with permanent 
implants such as a potential inflammatory response, physical irritation and implant 
removal surgery [3]. However, the potential clinical applications of Mg-based alloys have 
been delayed due to their rapid electrochemical dissolution under physiological 
conditions, resulting in the elevated release of hydrogen gas and pH changes, which create 
a bio-incompatible environment to the surrounding tissue [3]. In addition, rapid 
degradation can lead to the early loss of mechanical stability of Mg-based implants, 
thereby structural failure before the healing process has progressed sufficiently [2]. 
Therefore, it is important to have controlled degradation in tandem with the improved 
biocompatibility of Mg alloys for the orthopaedic implant.  
Several strategies have been employed to improve the corrosion resistance and 
biocompatibility of Mg alloys such as alloying elements, passivation and surface coatings 
[4]. Variation of the alloying elements may improve the original mechanical properties 
and enhance the corrosion resistance but are not likely to improve the biocompatibility of 
Mg alloys.  These elements may induce cytotoxicity depending on the locally released 
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concentration or systemic accumulation of alloying elements [4]. Apart from alloying, 
surface modifications or passivation of Mg alloys using other routes such as alkaline 
hydrothermal treatment, micro-arc oxidation (MAO) and ion implantation have been 
investigated to improve the corrosion resistance [2]. However, these surface 
modifications alter the mechanical properties and are unable to protect the Mg alloys over 
extended periods in the corrosive environment [5, 6]. Therefore, surface coatings are now 
being investigated as an effective approach with the potential to improve the corrosion 
resistance and biocompatibility of Mg alloys.  
Silanes and biodegradable aliphatic polyester coatings have been widely used for 
enhancing the corrosion resistance and biocompatibility of Mg and its alloys [7, 8]. 
Organosilanes are materials with the general formula R’ (CH2)n Si (OR)3, where R and 
R’ are hydrolysable alkoxy and organic functional groups respectively [9]. When 
organosilanes are hydrolysed with water, silanol groups (Si-OH) form facilitating the 
attachment with hydroxy-activated metal (M-OH) via the formation of thermal and 
chemically stable Si-O-M bond [8, 10]. The silanol group can also undergo cross-linkage 
via Si-O-Si siloxane bond, resulting in the formation of a protective layer chemically 
attached to metal [8]. The utilization of organosilane based coating have been widely 
explored to enhance the corrosion resistance of Mg-based alloy for biomedical implants 
applications [11, 12]. However, to date, these coatings have not been shown to improve 
the biocompatibility of the implant which affects the osseointegration and bone growth. 
Coatings of biodegradable aliphatic polyesters have previously been used for improving 
the biocompatibility as well as corrosion resistance of Mg-based alloys [13]. Amongst 
several aliphatic polyesters, poly(lactide-co-glycolide) (PLGA) coatings are FDA-
approved for use on implants. The polymer displays good biocompatibility and is widely 
used as a delivery vehicle for bioactive molecules as its by-products are metabolically 
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digestible and provide some corrosion resistance [13]. Therefore, there is an opportunity 
to combine chemistries as a multifunctional corrosion-resistant biocompatible coating on 
Mg-based alloys.  
In this study, a novel multi-layer PLGA-organosilane coating on AZ31 Mg alloy was 
developed. To the best of the authors’ knowledge, this is the first report where 
organosilanes and the aliphatic polyester (PLGA) are used together to develop corrosion 
resistant and biocompatible coatings on Mg alloys. The organosilanes explored for this 
study were (MTES-TEOS) and APTES. The MTES-TEOS organosilane corrosion 
resistant coatings have been previously employed on stainless steel and Mg alloys [14-
16][44]. The APTES treatment on MTES-TEOS coated surface provides an amine 
terminated surface which interacts electrostatically with the acid terminated PLGA 
coating (Fig 3-1). 
 
Figure 3-1 A schematic representation is showing the steps involved in PLGA-silane 
coating on AZ31 Mg alloy. The alkaline passivated AZ31 alloy (step- a) was coated 
sequentially with MTES-TEOS (step- b), APTES (step- c) and PLGA (step– d) to 
improve the corrosion resistance and biocompatibility of AZ31 Mg alloy. 
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The organosilane and PLGA coating enhances the corrosion resistance due to the 
formation of Si-O-Si bonds and PLGA as a physical barrier which together prevents 
electrolyte penetration to the AZ31 Mg alloy. Furthermore, improved biocompatibility of 
the coated substrate over uncoated AZ31 has been observed with the murine osteoblast 
cells.  
3.2 Experimental 
3.2.1 Materials  
AZ31 alloy sheets were obtained from Shaanxi Taipu Rare Metal Materials Ltd, China 
and composition are confirmed by SEM EDX (Table 6). Methyltriethoxysilane (MTES) 
and tetraethoxysilane (TEOS), 3-aminopropyl-triethoxy silane (APTES), poly-(lactic-co-
glycolic) acid (PLGA) mol wt 30,000-60,000, phosphate buffer saline (PBS), Dulbecco's 
Modified Eagle's Medium (DMEM), fetal bovine serum (FBS), Penicillin-streptomycin 
antibiotics, 1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and dimethyl 
sulfoxide (DMSO) were purchased from Sigma Aldrich. Milli-Q water was used to 
prepare solutions.  
Table 6 Composition of AZ31 Mg alloy determined by SEM-EDX 
 
3.2.2 Surface modifications of AZ31 Mg alloy  
3.2.2.1 Treatment of AZ31 with NaOH 
AZ31 Mg alloy 2 mm thick sheets were cut into 20 x 30 mm or 10 x 20 mm pieces and 
polished progressively by finer SiC paper from 400 to 1200 grit. The samples were 
cleaned ultrasonically in acetone for 30 mins and air dried. These polished samples were 
Elements Mg  Al  Si  Ca  Mn  Fe  Cu  Zn  
At. 
Weight% 96.37 2.45 0.1 0.03 0.22 0.05 0.05 0.74 
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immersed in 5 N NaOH for 2 h at 60 °C and then cleaned with deionised water [17]. 
These hydroxide- treated AZ31 are referred to as AZ31-OH. 
3.2.2.2 Preparation of silane and PLGA coatings on AZ31 Mg alloy  
The MTES and TEOS sols were prepared in the ethanol solution containing 0.04 N nitric 
acid as a catalyst [44]. A molar ratio of MTES/TEOS of 2/1 was used with R=2.3 (where, 
= [H2O]/ [MTES+TEOS]). The MTES-TEOS sol was clear and stable having a viscosity 
of 1.63 mPa at room temperature (Table 7). The APTES sol was prepared using 400 mM 
APTES in ethanol solution with R = 4.5 (R = [H2O]/ [APTES]) with a viscosity of 1.82 
mPa at room temperature (Table 8). The pre-treated AZ31 substrates (AZ31-OH) were 
dip-coated in the MTES-TEOS sol, dried with hot air (heat gun) and cured at 120 °C for 
1h. Subsequently, MTES-TEOS treated AZ31(AZ31-MT) substrates were dip coated in 
the APTES sol and cured at 120 °C for 1 h to achieve the amine-terminated AZ31-MT-A 
substrates. The PLGA coating was prepared by dipping the AZ31-MT-A substrates in 2% 
and 4 %w/v carboxylic acid-terminated PLGA solution in dichloromethane (Figure 3-1). 
The resultant substrates were denoted as AZ31-MT-A-P. These two concentrations of 
PLGA were screened to optimise corrosion protection of AZ31 Mg alloy. To get the 
maximum coating thickness, the withdrawal speed of the dip coating was fixed at 80 
mm/min (max. speed of dip coater) 
Table 7 Formulation of MTES-TEOS sol-gel  
Sol-gel 
MTES 
(ml) 
TEOS 
(ml) 
HNO
3
 
(0.04N) 
(ml) 
Ethanol 
(ml) 
Total 
volume 
(ml) 
Stirred at 
room 
Temperature  
overnight 
R= 
[H2O]/[MTES-
TEOS] 
MTES-TEOS-
2:1 
16 9 5 20 50 
2.3 
Molarity 1.6 0.8 5.5   --        -- 
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Table 8 Formulation of APTES sol-gel  
Sol-gel APTES 
(ml) H2O (ml) 
Ethanol 
(ml) 
Total volume 
(ml) Stirred at 
room 
Temperature  
For 1 h 
R =[H2O]/[APTES] 
APTES 4.7 1.7 43.6 50 
4.5 
Molarity 0.424 1.88    --          -- 
 
3.2.3 Characterisation of AZ31 modified samples   
All modified (AZ31-OH, AZ31-MT, AZ31-MT-A and AZ31-MT-A-P) and uncoated 
AZ31 substrates were investigated using attenuated total reflection infrared spectroscopy 
(ATR-IR). The IR spectra were recorded over a scan range of 4000 to 600 cm-1. The 
wettability of samples was determined by static water contact angle measurements (FTÅ-
200 system) using the sessile drop method (2µl, milli-Q water) [12]. The surface 
morphology of coatings was studied by scanning electron microscope (Hitachi SU-70 
FESEM with EDX and WDX). The chemical compositions of the coatings were studied 
using energy-dispersive X-ray spectroscopy (EDS, Oxford Instruments). To determine 
the thickness of AZ31-MT-A-P coatings by SEM, samples were embedded in an epoxy 
resin which was cured, progressively ground (80-1,200 grit) and finally polished (9, 6 and 
1µm) to a smooth surface. Before SEM and EDX analysis, all samples were coated with 
Au-Pd sputter coating system (Cressington 208HR Sputter Coater. The adhesion of 
PLGA-silane coating was determined by Crosshatch tape test (ASTM F2452). Firstly, the 
samples were subjected to cross cut (1 mm lattice) by a sharp blade. The specified tape 
was placed over crosscut and pressed the tape down onto the surface with sufficient 
pressure. After 10 to 30 seconds, tape was pulled from the surface and check for the 
delamination of the coating [46].     
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3.2.3.1 Electrochemical corrosion measurements 
All in vitro degradation tests were performed at 37 ± 0.5 °C in DMEM. Electrochemical 
measurements were carried out by using 1285 Solartron potentiostat equipped with a 1287 
frequency analyser with a standard three-electrode setup comprising of a saturated 
calomel electrode (SCE) as a reference electrode, a platinum mesh auxiliary electrode, 
and the test sample (with 1 cm2 exposed area) as a working electrode. Potentiodynamic 
polarization curves were recorded with a scan rate of 5 mv/s. Corrosion current density 
and corrosion potential were determined using Corrview software. Electrochemical 
impedance spectra (EIS) of all the samples were conducted over a range of 100 KHz to 
0.01 Hz at the measured open circuit potential with an AC amplitude of 10 mV. A stable 
open circuit was established prior to conducting the electrochemical measurements. This 
is the maximum frequency range can be applied by the above-mentioned instrument. The 
high and low frequencies will allow to study the mass and charge transfer electrochemical 
reactions occur during the corrosion of modified and uncoated AZ31 Mg alloy substrates. 
The equivalent electrical circuits (EECs) were designed using Zview software. First, 
values for each parameter of the circuit was determined using standard circuits available 
in the software.  
3.2.3.2 Immersion experiment, pH changes and Hydrogen evolution measurement  
In order to determine the magnesium ion (Mg2+ ion) concentration and pH of the medium, 
the coated and uncoated AZ31 substrates were immersed in DMEM with a surface-to-
volume ratio of 20 ml. cm-2 at 37 ± 0.5 °C for 21 days [18]. The Mg2+ ion release 
experiment was conducted as per ASTM G31 standards [18]. The pH value (Thermo-
scientific Orion 3 Star pH meter) of DMEM was monitored at different immersion 
periods. The release of Mg2+ ions in DMEM at the different periods was determined using 
an inductively coupled plasma optical emission spectrometer (Varian Liberty150, ICP-
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OES) [17]. The immersion medium was refreshed every 2nd day to maintain a stable 
composition. The changes in the surface morphology and the composition of the coated 
AZ31-MT-A-P substrate after 7, 14 and 21 days were determined by SEM-EDX and 
ATR-IR.  
The evolution of hydrogen gas was monitored by placing the samples in DMEM at 37 ± 
0.5 °C under an inverted funnel connected to graduated burette and measuring the 
medium level-up to 14 days.  The ratio of the surface area-to-the volume of DMEM was 
kept constant at 10 cm2. L-1 [19, 20].  
3.2.4  Cytocompatibility   
3.2.4.1 Indirect cell viability test  
The MTT assay was used to determine the cytotoxicity of surface modified AZ31 
samples. The test was performed by using an indirect method, where the extracts were 
used for culturing the cells. Initially, each face of the samples was sterilised by UV 
radiation for 40 minutes. This sterilisation procedure was followed for all the cell culture 
experiments conducted in this PhD work. The samples (10 x 20 mm) were placed in serum 
and antibiotic free DMEM at 37 °C in a 5% CO2 humidified atmosphere for 72 h with a 
surface area/extract medium ratio 1.25 ml. cm-2 in accordance to ISO 10993-12 [21]. The 
extracted medium was centrifuged (Eppendorf) at a relative centrifugal force (RCF) of 
15294 g for 10 minutes and the supernatant was filtered through a 0.22 μm filter 
(Millipore, Merck). All extracts were stored at 4 ˚C for further use.   
The murine pre-osteoblast cell line (MC3T3-E1) (passage number between 10 to 20) was 
utilized for all in vitro experiments including cell cytotoxicity study. This cell line has 
been used as a model system in bone biology. Cells were cultured under 37 °C, 5% CO2 
and 95% relative humidity in DMEM containing 10% fetal bovine serum and 1% 
penicillin and streptomycin. Cells were seeded in 96 well-plates with the cell density of 
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104 cells.ml-1 and incubated for 24 h. After 24 h, the culture medium was replaced with 
the extracted medium of different dilutions (50%, 25% and 10%) added with 10% FBS, 
1% penicillin and streptomycin (P/S) and incubated for 1, 3 and 5 days. Culture mediums 
with 10% DMSO and without extracted medium were considered as positive and negative 
controls respectively.  After the incubation, the extracted medium was replaced with fresh 
culture medium containing MTT dye (100 μl serum-free medium with 25 μl of 5 mg.ml-
1 MTT dissolved in PBS) for 4 h to prevent the interference of magnesium ions with the 
tetrazolium salt [21]. The culture medium with MTT was discarded after the incubation 
and 100 μl of DMSO was added to each well to dissolve the formazan crystal. The 
absorbance of the samples was recorded using the Synergy multi-mode microplate reader 
at a wavelength of 570 nm. To determine the percentage cell viability, the following 
equation was used: 
Percentage cell viability (%) = Absorbance (sample)/ Absorbance (negative control) x 100 
3.2.4.2 Live/dead cell staining 
Cells were seeded (2.5x 104 cells.cm-2 ) and maintained as described earlier for 1, 3 and 
5 days before the live-dead staining was performed. Calcein AM (eBioscience 65-0853) 
and propidium iodide (eBioscience 00-6990) were dissolved in DMSO (1mg/ml) and 
used at a 1:500 ratio in DMEM containing 10% FBS and 1% Penicillin/Streptomycin 
(P/S). Cells cultured on the experimental substrates were washed with PBS and incubated 
in a fluorescent dye for 20 minutes at 37 °C. After incubation, the cells were rinsed with 
PBS and imaged using an Olympus IX83 epifluorescence microscope fitted with a 10X 
objective lens. For each substrate, images were taken from two to four sites to determine 
cell adhesion.  
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3.2.4.3 Cellular morphology imaging by SEM 
The morphology of osteoblast cells on coated and uncoated AZ31 Mg alloy substrates 
was observed after 1, 3- and 5-day(s) culture. Osteoblast cells at a density of 2.5x 104 
cells.cm-2 were seeded onto the substrates (10 x 20 mm) in complete DMEM medium 
(1cm2 = 1.25 ml). The medium was refreshed every day. After incubation, samples were 
washed with PBS, fixed with formalin and dehydrated in alcohol gradients. The samples 
were placed on aluminium stubs and sputter coated with Au-Pd and observed in SEM. 
For each substrate, images were taken from at least three sites on to determine the cell 
adhesion and morphology. 
3.2.4.4 DNA quantification 
The DNA quantification of MC3T3E1 osteoblast cells was assessed as a measure of cell 
proliferation. Cells were cultured onto the coated and uncoated AZ31 substrates at a 
density of 2.5x 104 cells.cm-2 for 3, 7 and 14 days in a differentiation medium. The 
differentiation medium was prepared by adding 50 µM ascorbic acid, 100 nM 
dexamethasone and 10 mM β-glycerophosphate in DMEM. After 3, 7 and 14 days of 
culture, substrates were rinsed with PBS and cells were lysed by using cell lysis buffer 
(10mM Tris-HCl, 0.5 mM MgCl2, 0.1% Triton X-100 at pH 7.4). The fluorescent dye, 
bis-Benzimide H 33258 (Hoechst 33258, Sigma Aldrich) was used to measure the cellular 
DNA according to manufacturer’s instruction (DNA quantification kit, Fluorescence 
assay, Sigma Aldrich). Calf thymus DNA was used for the standard curve and 
fluorescence level was measured using a Spectramax-M3 microplate reader (Molecular 
Devices). 
3.2.4.5 Alkaline phosphatase (ALP) assay  
The differentiation of osteoblast cells was determined by measuring intracellular ALP 
activity using a para-nitrophenyl substrate (p-NPP, Sigma). After 3, 7- and 14-days cells 
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were cultured in the differentiation medium and then were lysed and incubated with p-
NPP substrate for 1 h at 37 °C. The enzymatic reaction was stopped by adding 1N NaOH 
and the ALP activity was determined by measuring the absorbance of para-nitrophenol 
(p-NP) at 405 nm wavelength using the microplate reader. A standard curve of different 
p-NP concentrations was prepared by diluting in 0.02N NaOH. The chromogenic para-
nitrophenol product formed was normalised against total protein concentration and the 
total protein content was measured using the bicinchoninic acid (BCA) protein assay kit 
(Sigma Aldrich). 
3.2.5 Statistical analysis 
All the experiments were carried out thrice in triplicates. All data are expressed as mean 
± S.D. The differences between the groups were analysed using one-way analysis of 
variance (ANOVA) followed by Tukey post hoc test. Statistical significance was 
considered at **p < 0.01 and *p < 0.05.  
3.3 Results and Discussion 
3.3.1 Characterisation of surface modified AZ31 Mg alloy 
The ATR-IR spectrum of the surface modified AZ31 Mg alloys are shown in Fig 3-2. To 
facilitate the organosilane coating, the AZ31 Mg alloy was passivated with sodium 
hydroxide to generate hydroxide layer (AZ31-OH) on the surface which is indicated by 
the band at 3694 cm-1 [17]. The MTES-TEOS coating on the passivated substrate was 
evident by IR bands around 1045-1127 cm-1and 1270 cm-1, corresponding to Si-O 
asymmetric stretching of Si-O-Si bond [22] and absorption vibration of Si-CH3 of MTES 
respectively [14]. Subsequent coating with APTES increases the intensity of siloxane 
band with an appearance of a new band at 1570 cm-1, which is assigned to the vibrational 
mode of amine group [22].  
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Figure 3-2 ATR- IR of uncoated and AZ31 modified substrates. 
The bands at 3295 cm-1and 3368 cm-1 are related to the asymmetric and symmetric 
stretching modes of NH2 group respectively [23]. Broadening of the band at 1570 cm
-1 
was observed when the amine-functionalised silane substrate was coated with PLGA and 
most of the amine peaks became obscured, indicating the presence of an electrostatic 
interaction occurred [24, 25]. The presence of the Si-CH3 band (1270 cm
-1) in all coated 
substrates indicates the presence of methyl groups which imparts some hydrophobicity to 
the coating [16, 26].   
Fig.3-3 shows the effect of the surface modifications observed by the surface wettability 
of AZ31 modified substrates.  
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Figure 3-3 Contact angle measurements of uncoated and AZ31 modified surfaces. 
One way ANOVA is followed by post-hoc Tukey test with a significance level of ** 
p < 0.01 with respect to AZ31 alone.  
The bare AZ31 surface presents with a water contact angle of 74.6 ± 0.9°. The treatment 
with NaOH increases the surface hydrophilicity of bare AZ31 due to the presence of a 
hydroxyl layer with a water contact angle of 29.1 ± 1.8°.  As expected, the MTES-TEOS 
coating increases the surface hydrophobicity due to the presence of the methyl groups and 
siloxane bond with a water contact angle of 77.9 ± 1.3° [14, 22]. Subsequent coating with 
APTES (AZ31-MT-A) decreases the contact angle to 46.4 ± 2.1° which is attributed to 
the presence of the amine group on the surface [12]. Further modification with PLGA re-
establishes the relative hydrophobicity with an increase in water contact angle to 68.2 ± 
1.5°.   It can be observed that the surfaces are significantly different (p < 0.01) at each 
stage of the functionalization. These results along with ATR-IR analysis confirm the 
sequential functionalization of the AZ31 alloy coating.   
Fig 3-4, shows the SEM images of uncoated and coated substrates (a) AZ31 (polished), 
(b) AZ31-MT, (c) AZ31-MT-A, (d) AZ31-MT-A-P and (e) cross-section of AZ31-MT-A-
P. 
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Figure 3-4 SEM images of (a) AZ31, (b) AZ31-MT, (c) AZ31-MT-A, (d) AZ31-MT-
A-P and (e) cross section of AZ31-MT-A-P. 
The coated substrates (Fig 3-4: (b)-(d)) showed a homogenous and crack-free surface. In 
addition, delamination of coatings was not observed on the AZ31 coated surface. Fig 3-4 
(e) shows the cross-section of the AZ31-MT-A-P substrate with the coating thickness of 
1.61 µm.  
Furthermore, adhesion of coatings with the AZ31 Mg substrate was determined by the 
cross-hatch tape test and the photographs of the coated specimen after the tape adhesion 
shown in Figure 3-5. The silane coating adheres well with the surface without peeling off 
(Fig 3.5 (b)), which meets the standard for the tape adhesion test (Coating retention > 
99%: Met the requirement) [46]. 
 
Figure 3-5 Optical images of AZ31-MT-A (a) before and (b) after the cross-hatch 
test. 
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Therefore, the combined results of ATR-IR, contact angle measurement and SEM 
analysis confirm the successful assembly of PLGA-silane coating on the surface of AZ31 
substrates. 
3.3.2 In vitro corrosion and degradation behaviour of AZ31 substrates 
3.3.2.1 Electrochemical corrosion measurements 
Figure 3-6 shows the potentiodynamic plots for the uncoated and coated AZ31 alloys in 
DMEM at 37 ⁰C.  
 
Figure 3-6 Potentiodynamic polarization curves of AZ31 alone, AZ3-OH, AZ31-MT, 
AZ31-MT-A and AZ31-MT-A-P substrates. 
The corrosion current density (icorr) and corrosion potential (Ecorr) obtained from 
potentiodynamic polarization curves are presented in Table 9. All three coated substrates 
AZ31-MT, AZ31-MT-A and AZ31-MT-A-P, as well as the AZ31-OH conversion 
coating, showed lower corrosion current densities along with a progressively more anodic 
corrosion potential than the uncoated AZ31 alloy. Compared with AZ31, the passivated 
AZ31-OH inhibits both anodic and cathodic reactions.  
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Table 9 Corrosion potential and corrosion current density derived from plots for 
AZ31 alone, AZ3-OH, AZ31-MT, AZ31-MT-A and AZ31-MT-A-P surfaces. 
Substrates Ecorr (V) icorr (A/cm2) 
AZ31 -1.679 ± 0.021 17.9 ± 0.128 
AZ31-OH -1.652 ± 0.008 15 ± 0.056 
AZ31-MT -1.677 ± 0.003 0.987 ± 0.039 
AZ31-MT-A -1.612 ± 0.009 0.26 ± 0.049 
AZ31-MT-A-PLGA-2% -1.561 ± 0.002 0.214 ± 0.047 
 
However, it has been reported that the alkaline passivated film would be unable to provide 
any corrosion resistance even for short period due to its instability in the chloride-rich 
aqueous medium [27]. The maximum improvement can be seen in AZ31-MT-A-P coated 
substrate, as observed by a decrease in corrosion current density by nearly 84 folds when 
compared with the uncoated equivalent. Also, the corrosion potential (Ecorr) of AZ31-MT-
A-P substrate was ~120 mV nobler as compared to the bare AZ31 alloy, implying less 
susceptibility to corrosion. Further, the corrosion resistance of PLGA coating at 4% w/v 
loading has also been performed, which showed lower corrosion resistance when 
compared to 2% PLGA coated AZ31-MT-A substrates as shown in Fig. 3-7. Similar 
results were also reported by Li et al., who explained that a highly concentrated loading 
of PLGA produces thick poor quality coatings [29].  This enhanced corrosion resistance 
can be attributed to the combined barrier performance of the siloxane network (MT-A) 
and PLGA coating for electrolyte penetration.  This slows the anodic dissolution reactions 
and blocks the mass transport of Mg2+ ions [27]. In addition, the formation of Si-O-Mg 
bonds at the interface also prevent some anodic reactions [28]. EIS measurements are 
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used to study the corrosion behaviour of uncoated and coated AZ31 substrates and are 
represented in the Bode plots in Fig. 3-8.  
 
Figure 3-7 Potentiodynamic polarization curves of AZ31-MT-A, AZ31-MT-A-2% 
PLGA and AZ31-MT-A-4% PLGA 
Fig. 3-8 (a) clearly shows that the magnitude of impedance at the lowest frequency 
(ǀZǀ0.01Hz) gradually increases with successive coating applications. In parallel, the phase 
bode plot also displays an increase in the broad crest wave toward -90º, suggesting 
improvement in corrosion resistance of AZ31 Mg alloy. Such features have been 
observed in corrosion resistant coatings on Mg alloys [14, 35, 36]. The ǀZǀ0.01Hz value of 
passivated AZ31-OH substrate is ~7.4 x 103 Ω.cm2, which is slightly higher than the 
AZ31 alone AZ31 (~4.8 x 103 Ω.cm2). With further modification, the progressive increase 
in the ǀZǀ0.01Hz value of ~2.2 x105 Ω.cm2 for AZ31-MT to ~ 5.8 x 105 Ω.cm2 and ~1.44 
x106 Ω.cm2 for AZ31-MT-A and AZ31-MT-A-P have been observed respectively. 
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Figure 3-8 (a) Bode plots for AZ31 alone, AZ3-OH, AZ31-MT, AZ31-MT-A and 
AZ31-MT-A-P surfaces, equivalent circuits used to fit experimental data (b) coated 
and (c) AZ31 and AZ31-OH substrates. 
In addition, the phase angle Bode plots for all coated samples were characterised with 
two-time constants. One time constant at high frequency refers to the capacitive response 
or barrier component of the organo-silane (MT and MTA) and PLGA (MT-A-P) coatings, 
and the second time constant at low frequencies can be assigned to the diffusion process 
of electrolytes in the coatings. 
The AZ31 and AZ31-OH substrates are characterised by two capacitive responses at high 
and medium frequencies (suppressed response) with additional inductance at a very low 
frequency (< 0.1Hz). This low-frequency inductance is commonly observed in uncoated 
Mg alloys, indicating the presence of surface adsorbed species like Mg(OH)+ and 
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Mg(OH)2 [37, 38]. Although the interpretation of EIS data for magnesium alloy is 
controversial, the current explanation has been generally adopted [35, 38, 39].  
The EIS spectra of coated and uncoated substrates were analysed based on the electrical 
equivalent circuits which fit best with the experimental data. The best fit comprised of 
two-time constants respectively as shown in Fig.3-8 (b) and (c) respectively. The 
equivalent circuit consists of Rs (solution resistance), Ccoat one of the constant phase 
element (CPE) components, expresses coating capacitance and Rcoat is the resistance of 
the coating. Cdl, another component of CPE, represents the capacitance of the electrical 
double layer at vulnerable region and a charge transfer resistance Rct. For AZ31 and 
AZ31-OH substrates, all CPEs and resistances are related to the hydroxide film on the 
surface. The RL and L represent the inductive resistance and inductance respectively for 
AZ31 and AZ31-OH substrate. However, data for these two components has not been 
shown as Ccoat, Rcoat, Cdl and Rct are the elements of interest which are comparable to 
corresponding coated substrates. Moreover, low-frequency inductance has not been 
observed in any of the coated surfaces. The equivalent circuits were selected based on 
literature available for corrosion of uncoated and coated Mg alloys [39-41]. The fitting 
parameters are given in Table 10. It is observed that the Rcoat and Rct for coated substrates 
gradually increase with every layer of coating on AZ31 Mg alloy. Rct is a measure of 
corrosion resistance of alloy samples coated with silane or PLGA-silane. It increased for 
the AZ31-MT-A-P coated substrate to 5.6467 x 108 Ω.cm2 as compared to AZ31 alloy at 
768.5 Ω.cm2. Once exposed to the electrolyte, a thin film of Mg (OH)2 develop on the 
AZ31 Mg alloy. This can act as an initial passivation layer, but it is susceptible to 
electrolytic attack, especially chloride ions [25]. 
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Table 10 Parameters of uncoated and coated substrates calculated from the fitting 
of the experimental impedance spectra (Value ± % error)     
 
The alkaline passivated AZ31-OH showed enhanced corrosion resistance compared to 
AZ31 alloy (Table 10), but it also susceptible to the degradation in the corrosive medium 
[25] [42, 43]. The capacitance of a coated substrate is related to the area exposed to the 
electrolyte. The relatively low capacitance (Ccoat and Cdl) of AZ31-MT-A-P compared to 
the AZ31 bare alloy (as well as those for other coated substrates), implies that the active 
area of corrosion with PLGA-silane coating is considerably decreased. As established by 
potentiodynamic polarization and EIS tests in DMEM, the PLGA– silane coating showed 
superior corrosion resistance compared to the others tested. This enhanced corrosion 
resistance offered by silane and PLGA coatings can be attributed to the defect-free 
coatings and combined physical barrier performance of the siloxane network of MT-A 
organo-silane and PLGA coating to electrolyte penetration which is in agreement with 
the SEM images, FTIR spectrum and lower capacitance values [12, 13]. This results in 
the slowdown of anodic dissolution reactions (𝐌𝐠 → 𝐌𝐠𝟐+ + 𝟐𝐞−) and charge transfer 
AZ31 Substrates AZ31 AZ31-OH AZ31-MT   AZ31-MT-A AZ31-MT-A-P 
Rs (Ω.cm
2
) 150.1± 3.05 349 ± 2.565 250.1 ± 14.21 398 ± 12.308 1251± 3.083 
C
coat
-T (x 10
-8
 F cm
-2
) 1280.2 ± 2.08 386.6 ± 3.39 3.074 ± 2.963 2.845± 4.005 1.34 ± 1.659 
C
coat
-P 0.636± 5.16 0.725± 1.756 0.774 ± 0.351 0.785± 0.517 0.833± 0.206 
R
coat
 (x 10
5
 Ω.cm
2
) 0.05679± 3.57 0.0755 ± 6.756 1.4694 ± 1.518 3.9657± 2.841 9.7297 ± 1.091 
C
dl
-T (x 10
-6 
 F cm
-2
) 290.02 ± 4.27 55.858± 5.28 4.476 ± 9.109 1.101 ±14.25 0.302 ± 5.977 
C
dl
-P  0.946 ± 2.94 0.97± 5.54 0.650 ± 6.748 0.832± 8.73 0.972± 2.960 
R
ct 
 (Ω.cm
2
) 768.5 ± 4.39 1371± 6.73 82394±5.248 2.453x 10
5 ± 7.36 5.646x 10
8 
±2.762 
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associated with cathodic reactions ( 𝟐𝐇𝟐𝐎 + 𝟐𝐞
− →  𝐇𝟐 + 𝟐𝐎𝐇
−), which blocks the 
mass transport of Mg2+ ions and release H2 gas, as observed from lower icorr values and 
anodic shift of Ecorr [12]. According to previous reports, these electrochemical corrosion 
studies for Mg-based alloys should be complemented by the other measurements such as 
Mg2+ ion release and hydrogen gas evolution [19, 38] Since, the AZ31-MT-A-P coated 
substrate presents the greatest corrosion resistance, hereafter, further long-term 
degradation and biocompatibilities studies have been performed with AZ31-MT-A-P 
substrate and uncoated AZ31 (i.e without any modification) as a control. 
3.3.2.2 Immersion study 
The rate of Mg2+ ions release from the coated and uncoated AZ31 samples in DMEM up 
to 21 days was analysed by ICP-OES as shown in Fig. 3-9 (a). From the uncoated 
substrate, the Mg2+ ion release rate up to day 7 increases from 0.068 ± 0.002 mM/h/cm2 
to 0.125 ± 0.003 mM/h/cm2, thereafter drastically decreases to 0.026 ± 0.003 mM/h/cm2 
at day 21. In contrast, the coated AZ31-MT-A-P substrate had a very slow and steady 
release of Mg2+ ions ranged from 0.024 ± 0.002 mM/h/cm2 to 0.009 ± 0.001 mM/h/cm2 
between day 1 and 21 respectively.  It can be observed that the average rate of Mg2+ ions 
release from the coated surface is 0.016 mM/h/cm2 which is much lower than the release 
from uncoated surface 0.071 mM/h/cm2. These results clearly demonstrate that the release 
rate of Mg2+ ions from the coated substrate was markedly reduced compared to uncoated 
one. Furthermore, the pH changes of AZ31-MT-A-P and uncoated AZ31 in DMEM over  
a period 21 day is shown in Fig. 3-9 (b). The pH of both the substrates is alkaline, but the 
coated AZ31-MT-A-P was lower alkaline when compared to the uncoated AZ31 alloy. 
The pH of the coated substrate increases gradually then decreases with immersion time, 
unlike uncoated alloy which showed a rapid increase in pH followed by a gentle decrease. 
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Figure 3-9 (a) ICP-OES measurement of Mg ions release, (b) pH change and (c) rate 
of H2 gas release from AZ31 and AZ31-MT-A-P over a period of 21 and 14 days 
respectively. 
The trend of Mg2+ release from the coated substrate was consistent with the observed pH 
change. The rate of hydrogen gas evolution from AZ31 and AZ31-MT-A-P in DMEM 
has been performed for 14 days as shown in Fig. 3-9 (c).  The results confirmed that the 
rate of H2 gas evolution is much higher for uncoated AZ31 than the coated AZ31-MT-A-
P substrate.  The uncoated AZ31 alloy showed a characteristically high corrosion rate 
until day 7 with 0.084 ± 0.004 ml/h/cm2 of H2 gas release. This was followed by a slower 
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corrosion rate for the remaining period with 0.041 ± 0.003 ml/h/cm2 of H2 gas release up 
to day 14. For AZ31-MT-A-P, a slow gradual decreasing release of H2 gas was observed 
throughout the period of 14 days dropping from 0.015 ± 0.007 ml/h/cm2 to 0.008 ± 0.001 
ml/h/cm2. Based on the downward trend of H2 release from the uncoated surface, it is 
expected that the corrosion rate may attain levels of the coated substrate at later period, 
therefore, we evaluated the evolution of H2 gas release for 14 days instead of 21 days. 
Moreover, the rapid degradation happens during the early stage of implantation (2-3 
weeks) which is also the minimum time required to heal a damaged bone tissue, we 
limited our study to control the degradation for same period [46, 47]. Therefore, the 
timelines of 14 and 21 days for evaluating the corrosion resistance and biocompatibility 
of modified AZ31 Mg alloy were found to be suitable and adopted in this study. Overall, 
the average rate of H2 gas release over a period 14 day for the coated surface (0.011 
ml/h/cm2) is much lower when compared to the uncoated surface (0.062 ml/h/cm2). These 
results showed that the PLGA-silane coating controlled the degradation of AZ31 Mg 
alloy.  
Furthermore, the stability of the coating was evaluated by SEM and EDX analysis of 
corrosion resistant AZ31-MT-A-P substrates for various elements at different times as 
shown in Fig. 3-10 (a-c). Here, we have not studied the SEM-EDX analysis of the 
uncoated AZ31 substrate as the dynamics of degradation in physiological conditions has 
been well explored.   
The SEM images showed that with an increase in immersion time from day 7 to 21, the 
crack formation on the coating surface also increases. The spot EDX analysis and 
elemental mapping of silicon (Si), phosphorus (P) and calcium (Ca) of the coated 
substrate were performed to assess the corrosion products formed on the sample and the 
presence of coating component (Si). The spot EDX elemental analysis around the cracks 
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of the coated surface, as shown within the table in Fig 3-10 are rich in Ca, P, Mg and O. 
Here, a higher content of Ca-P deposition with low Si content near the cracks were 
observed with the immersion time of 7, 14 and 21 days. 
 
Figure 3-10 Surface morphology and EDX mapping of AZ31-MT-A-P immersed in 
DMEM for days (a) 7, (b) 14 and (c) 21 respectively.  EDX was performed near 
cracks as denoted by arrows. 
The EDX elemental mapping of day 7, 14 and 21 indicated the presence of Si, P and Ca. 
From the EDX maps, a weak signal of Si element has been observed near the cracks (as 
shown by arrows), whereas at the same site strong signal of P (indicated by arrows) can 
be observed on day 14 and 21. The spot EDX analysis and elemental mapping indicate 
the degradation of coating and the formation of the protective layer, as observed from the 
weak Si signal (a component of silane coating) and Ca-P deposition respectively. 
Furthermore, the degradation of PLGA coating was determined by IR analysis of –C=O 
band at 1760 cm-1 (Fig 3-11).  On day 21, the –C=O band was not detectable, indicating 
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the hydrolysis of the PLGA coating.  Previous reports showed that PLGA is susceptible 
to hydrolytic degradation, thereby failing to offer long-term corrosion resistance alone 
[13, 29].  
 
Figure 3-11 ATR-IR of the AZ31-MT-A-P substrates aged in DMEM for 7, 14, and 
21 days. 
The possible reasons for the increased development of cracks in the coated AZ31 alloy 
with immersion time are due to the electrolyte (DMEM) penetration into the coating and 
subsequent corrosion of underlying alkaline treated-Mg alloy with the release of Mg2+ 
ions at the site of corrosion. This leads to the degradation of the surface coating as 
observed from weak Si signals, which is a component of organosilane coating from EDX 
analysis and disappearance of PLGA IR band, indicating the degradation of PLGA– 
organosilane coating over time. However, the delamination of the coating has not been 
observed, confirming the stability of the coating. It is well known that the hydroxide layer 
on the AZ31 does not provide long-term corrosion resistance [17]. Therefore, it is 
expected that efflux of Mg2+ ions will primarily occur at the site of cracks. This leads to 
the localized increase in pH, thereby forming the protective layer arising from Ca-P 
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deposition, reducing the corrosion rate of Mg alloy [30]. This was observed from the 
SEM-EDX analysis of coated substrate (Fig. 3-10 a-c). This prevents the further chemical 
reaction across the metal surface and reduces the corrosion of Mg alloy, which is also 
evident by the reduced rate of magnesium ions release, H2 gas evolution and pH change 
with an increase in immersion time for both coated and uncoated surfaces (Fig. 3-9). 
Previous reports also showed that degradation layer during the corrosion process which 
consists of calcium phosphate precipitates and other corrosion products reduced the 
degradation rate of the Mg-based alloy in vitro with time [30, 31]. Since the organosilane 
coating on the AZ31 Mg alloy has not been completely degraded, this controlled 
degradation of the coated AZ31 substrate could be attributed to the stability of coating as 
well as in situ formations of such protective layers.      
3.3.3 Cytocompatibility 
The indirect cytotoxicity of the uncoated and coated AZ31 alloy was performed for the 
different duration (day 1, 3 and 5) using MTT assay as shown in Fig 3-12.   
 
Figure 3-12 Cell viability of MC3T3E1 osteoblast cells cultured in the extracts of 
AZ31 and AZ31-MT-A-P substrates over 5 days of incubation period.  Arrows are 
indicating the % extracts (v/v) which corresponds to its logarithmic values on the x-
axis.  
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A non-linear regression analysis of cell viability of neat or diluted extracts of coated and 
uncoated substrates was plotted. Based on corrosion studies, rapid degradation of Mg 
alloy can be observed in the first week of the immersion period. Therefore, cell cytotoxic 
assays was evaluated over a period of 5 days. The cell viability results for the coated 
AZ31-MT-A-P substrate using 100% of the extract (Mg2+ ions concentration is 17.69 ± 
0.12 mM, pH 8.03 ± 0.04) is significantly higher than the uncoated AZ31 alloy (Mg2+ ion 
concentration is 58.01 ± 0.26 mM, pH 8.76 ± 0.09) and with further dilution of extracts. 
It was observed that the cell viability is markedly higher for all days with 100% extract 
of the coated AZ31 substrate as compared to the uncoated AZ31 alloy. In addition, no 
reduction in cell viability was observed with the diluted extracts from 25 % to 10% of the 
coated substrate for all days. On the contrary, the uncoated AZ31 alloy extracts showed 
higher cytotoxicity with all extracts. It is known that cells viability is very sensitive to 
environmental fluctuation, especially changes in pH due to the faster degradation of bare 
AZ31 alloy [2]. This increased the pH of the bare AZ31 extraction medium, detrimentally 
affected the cells. Several reports have shown that elevated levels of Mg2+ ions at high 
pH can cause osmotic shock to osteoblast cells that lead to cell death [19, 32]. Hence, it 
can be concluded that the coated AZ31 substrates demonstrate controlled degradation and 
provided a biocompatible environment for osteoblast cell proliferation.    
Fig. 3-13 shows the pre-osteoblasts directly cultured on uncoated AZ31, coated AZ31-
MT-A-P substrates for 1, 3 and 5 days, and then stained with calcein AM and propidium 
iodide.  From day 1 to 5, the coated substrate (Fig 3-13 (d-f)) demonstrated a marked 
increase in live cell density (green fluorescence) when compared to uncoated AZ31 alloy 
Fig 3-13 (a-c), indicating that cells are proliferating faster. Very few dead cells (red 
fluorescence) were observed on the coated surface over uncoated AZ31 alloy, indicating 
the enhanced biocompatibility of the AZ31-MT-A-P surface. 
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Figure 3-13 Fluorescence microscopic images of live-dead MC3T3E1 cells attached 
to AZ31 (a-c) and AZ31-MT-A-P (d-f) for day 1, 3 and 5 respectively. (Scale bar is 
100 μm) 
SEM images of the fixed osteoblast cells on uncoated AZ31 alloy and coated surface at 
day 1, 3 and 5 post seeding are shown in Fig 3-14 (a-f).  The cells were grown on the 
AZ31 alloy surface on day 1 (Fig 3-14 a) have attached (indicated by red arrows) while 
dead or distorted shaped (yellow arrows) osteoblast cells were also observed. This 
observation is similar to the live/dead staining of osteoblasts adhered AZ31 substrate on 
day 1. With increased duration of culture exposure, greater localised attachment of 
osteoblast cells can be observed on the AZ31 surface (Fig 3-14 b and c). In contrast, the 
attachment of osteoblast cells is delocalised on the AZ31-MT-A-P substrate following as 
with the increase in the incubation period from day 1 to 5 (Fig 3-14 (d-f)).  A distinct 
morphology of osteoblast cells cannot be observed on day 5 (Fig 3-14 f), because of the 
dense coverage of confluent osteoblast cells which intercalate with each other. These 
results indicate that the PLGA component of the coated surface facilitates the greater 
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osteoblast cells adhesion and proliferation, thereby enhancing the biocompatibility of the 
coating. Several reports have shown that the application of PLGA as a biocompatible 
coating on Mg-based alloy enables the osteoblast cell attachment and proliferation [13, 
29]. In comparison to other studies [13, 29], the present study showed better cell 
attachment and morphology, greater cell-to-cell interactions and improved proliferation 
without any signs of localised cell growth on the surface due to the evolution of H2 gas 
bubbles, which affects the adhesion of the cells. These observations are supported by the 
results of live-dead fluorescent images of osteoblast cells cultured on these substrates 
under the same conditions. Hence, it can be concluded that the coated AZ31-MT-A-P 
substrate is more biocompatible than uncoated AZ31 alloy.  
 
Figure 3-14 SEM images of fixed MC3T3E1 osteoblast cells cultured on AZ31 (a-c) 
and AZ31-MT-A-P (d-f) substrates after incubation of 1, 3 and 5 day(s). (Red and 
yellow arrows are indicating attached cells and dead or distorted shaped osteoblast 
cells respectively.) 
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Furthermore, the proliferation and differentiation of the osteoblast cell were determined 
for 14 days. The reasons for adopting this timeline include (a) evaluating the osteoblastic 
activity during the corrosion period (as studied above), (b) ALP is an early stage marker, 
which express during day 3 to 7, thereafter intracellular level decreases and (c) the 
timelines for evaluating the total DNA was also adopted in accordance with the 
expression levels of intracellular ALP.   
The DNA content of osteoblast cells cultured on the uncoated AZ31 and AZ31-MT-A-P 
substrates for day 3, 7 and 14 was measured by fluorescence assay as shown in Fig 3-15.  
 
Figure 3-15 Quantification of total DNA content and ALP activity of osteoblast 
cultured on uncoated AZ31 and coated AZ31-MT-A-P substrates for 3, 7 and 14 
days. One way ANOVA with post-hoc Tukey test with significance level of ** p < 
0.01 between the samples showing folds of DNA content and ∆∆ p < 0.01 signifies 
ALP activity. 
The concentration of DNA is the direct measure of cells that attach and proliferate on a 
substrate surface. The initial cell attachment on the coated AZ31-MT-A-P substrate was 
nearly 4 fold higher relative to AZ31 equivalent, whereas it decreased between day 7 and 
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14. This is due to the increase in DNA concentration for AZ31 substrates at the later 
stages of the culture period. It is reported that the formation of a passivation layer slows 
down the corrosion rate of Mg alloy with the incubation time, thereby supporting the 
growth of cells [30, 33]. This DNA quantification study is consistent with the cell viability 
assay and live/dead staining qualitative results which indicated that the cell viability and 
proliferation are higher on the coated surface when compared to the uncoated AZ31 
surface. 
Osteoblasts express ALP in the early stages of osteoblastic commitment and are actively 
involved in the mineralisation of the extracellular matrix through the generation of 
phosphate ions from the hydrolysis of organic substrates [34]. The differentiation of 
osteoblast cells on the coated and uncoated AZ31-MT-A-P substrate was evaluated up to 
14 days using ALP as an early stage marker. The ALP activity of osteoblast cells cultured 
on the uncoated AZ31 and coated AZ31-MT-A-P substrates is presented in Fig 3-15. The 
osteoblasts that adhered to the coated surface showed significant higher ALP expression 
(p < 0.01)  when compared to the uncoated AZ31 alloy over a culture duration of 14 days. 
The enhanced proliferation of cells is the likely reason for greater cell differentiation on 
the coated AZ31-MT-A-P surface as PLGA does not have an intrinsic property to 
stimulate the osteoinductive activity [17, 34]. Hence, the multilayer PLGA-silane coating 
is a promising way to improve the osteointegration of Mg-based implants.  
3.4 Conclusion 
A novel multi-layered PLGA-silane coating on a biodegradable Mg alloy has been 
developed. The corrosion resistance of AZ31 alloy was considerably improved with every 
step of coating. The AZ31-MT-A-P coated substrate showed enhanced and long-term 
corrosion resistance over uncoated AZ31 alloy while keeping the conditions necessary 
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for biocompatibility. The stability of the coatings as well as in situ formations of a 
protective layer played an important role in the controlled degradation of the coated AZ31 
alloy. The coated AZ31 Mg alloy showed good osteoblastic cytocompatibility, allowing 
cell adhesion, proliferation and differentiation when compared to the uncoated equivalent. 
The cytocompatibility results indicate that the PLGA coating facilitates better cell 
adhesion and proliferation, thereby enhancing the biocompatibility of the coating. These 
results indicate that the proposed coating for Mg alloys is a promising strategy to improve 
the corrosion resistance and cellular integration with the surrounding tissue.  It can also 
potentially serve to deliver desired drugs, growth factors and other bio-active molecules 
at the site of implantation during the coating degradation process (such as PLGA), 
expediting the bone healing process. In addition, the amine group of the sol gel coating 
can also be used to functionalise biopolymers having a carboxylic acid group to improve 
the cytocompatibility of the biodegradable implants for orthopaedic applications. 
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Chapter 4  
 
Enhanced corrosion resistance and cytocompatibility of biomimetic 
hyaluronic acid functionalised silane coating on AZ31 Mg alloy for 
orthopaedic applications   
       
This work reports the corrosion resistant and cytocompatible properties of the hyaluronic 
acid-silane coating on AZ31 Mg alloy. In this study, the osteoinductive properties of high 
molecular weight hyaluronic acid (HA, 1-4 MDa) and the corrosion protection of silane 
coatings were incorporated as a composite coating on biodegradable AZ31 Mg alloy for 
orthopaedic applications. The multi-step fabrication of coatings first involved dip coating 
of a passivated AZ31 Mg alloy with a methyltriethoxysilane-tetraethoxysilane sol-gel 
(AZ31-MT), followed by 3-aminopropyl-triethoxy silane (AZ31-MT-A) to create an 
amine-functionalised AZ31-MT-A surface. The amine functionalised surface facilitated 
the immobilisation of HA via EDC-NHS coupling reactions at two different 
concentrations i.e 1 mg.ml-1 (AZ31-MT-A-HA1) and 2 mg.ml-1 (AZ31-MT-A-HA2). The 
corrosion resistance and cytocompatibility of these coated surfaces were evaluated. The 
corrosion studies showed an enhanced corrosion resistance of HA functionalised silane 
coated AZ31 substrate over the uncoated equivalent alloy. Furthermore, the 
cytocompatibility studies showed HA concentration-dependent improvement of 
osteoblast cellular response. 
The work described in this chapter has been published:  Agarwal. S., M., Labour, 
M.N., Hoey, D., Duffy, B., Curtin, J. and Jaiswal, Journal of Materials Science: 
Materials in Medicine (2018) 29:144 
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4.1 Introduction 
In chapter 3, the fabrication of PLGA-silane coatings on AZ31 Mg and their effectiveness 
in enhancing the corrosion resistance and biocompatibility of Mg alloy was studied. The 
amine group of the silane (AZ31-MT-A) coating was used to facilitate the fabrication of 
stable PLGA coating on its surface. The corrosion resistance properties of the silane 
coating observed in DMEM (non-buffered), controlled the degradation of Mg alloy which 
provided the appropriate condition for the growth of osteoblasts, whereas PLGA provided 
a bioactive surface for improved osteoblasts’ adhesion, proliferation and differentiation. 
Since the biological fluids are stabilised by a buffer system, it is important to study the 
corrosion resistance properties of the silane coating in similar conditions. In addition, 
osteoblast functions can be further improved by providing biomimetic conditions (E.g use 
of extracellular matrix components including hyaluronic acid for the fabrication of 
bioactive coatings).   
In general, the effectiveness of an orthopaedic implant in restoring damaged bone is 
determined by the bone-implant interaction which is characterised by the tight bond 
between the implant and bone surfaces, thereby minimising the risk of an implant 
loosening over time [1]. In order to enhance the biological acceptance of orthopaedic 
implants, functionalisation of the extracellular matrix (ECM) components has been 
widely employed. Hyaluronic acid (HA) is one of the major components of the 
extracellular matrix which is involved in cell adhesion, proliferation and differentiation. 
In previous studies, HA immobilised on the implant substrates (e.g. titanium alloy) has 
not been reported as an effective promoter of osteoblastic activity [27,28]. Moreover, the 
rationality of employing HA of different molecular weights for surface modification has 
not yet been considered. According to Zhao et al, the osteoinductive activity of bone-
related cells increases in response to the high molecular weight of HA [3]. Therefore, it 
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is important to consider the molecular weight of HA to modify the surface for different 
applications.   
In this study, the aim is to develop a coating system where HA is bound via a silane 
modified surface to deliver a corrosion resistance and cytocompatible coating on AZ31 
Mg alloy for orthopaedic applications. Therefore, the functionalisation of high molecular 
weight HA with silanes coated on the biodegradable AZ31 Mg alloy is proposed for the 
first time in the present work. The silanes involve an initial MTES-TEOS treatment, 
followed by APTES to deliver an amine terminated surface which can be coupled to HA 
through EDC-NHS coupling reactions. The corrosion resistance of the coated surface was 
evaluated in HEPES buffered DMEM. Furthermore, the effect of HA on the osteoblast 
cellular response was evaluated.  
4.2 Experimental 
4.2.1 Materials  
AZ31 alloy sheets were obtained from Shaanxi Taipu Rare Metal Materials Ltd, China. 
Methyltriethoxysilane, tetraethoxysilane, 3-aminopropyl-triethoxy silane, Hyaluronic 
acid from rooster comb (1-4 MDa), phosphate buffer saline (PBS), Dulbecco's Modified 
Eagle's Medium/Nutrient F-12 Ham (DMEM/F-12), fetal bovine serum (FBS), Penicillin-
streptomycin antibiotics, phosphatase substrate and bisBenzimide H 33342 
trihydrochloride, NHS (N-hydroxysuccinimide), EDC (1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide) and MES (2-(N-Morpholino)ethanesulfonic acid) 
buffer were purchased from Sigma Aldrich.  
4.2.2 Surface modification of AZ31 Mg alloy 
4.2.2.1 Treatment of AZ31 with NaOH 
As mentioned previously in section 3.2.2.1 
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4.2.2.2 Preparation of hyaluronic acid functionalised organosilane coating on AZ31 
Mg alloy  
4.2.2.3 Preparation of organosilane coating (AZ31-MT-A) on AZ31 Mg alloy 
Preparation of organo-silane coating is mentioned in section 3.2.2.2 
4.2.2.4 HA conjugation to organo-silane coating  
High molecular weight HA was functionalised onto AZ31-MT-A by a carbodiimide-
mediated coupling reaction as detailed in a previous study [4]. The final concentrations 
of HA used to functionalise the AZ31-MT-A samples are 1 mg.ml-1 and 2 mg.ml-1 with 
the resultant samples denoted as AZ31-MT-A-HA1 and AZ31-MT-A-HA2 respectively 
(Fig 4-1). It is not possible to coat hyaluronic acid beyond 2 mg.ml-1 concentration 
because, at higher concentrations, high molecular weight HA becomes a gel-like solution. 
This also prevents the complete solubilisation of HA. Moreover, due to the high viscosity, 
it was difficult to prepare a reproducible and uniform coating of HA. 
 
Figure 4-1 Schematic representation is showing the steps involved in the hyaluronic 
acid-silane coating on AZ31 Mg alloy. The alkaline passivated AZ31 alloy (step- a) 
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was coated sequentially with MTES-TEOS (step- b), APTES (step- c) and hyaluronic 
acid (step– d) to improve the corrosion resistance and cytocompatibility of AZ31 Mg 
alloy. 
The effective concentration of HA immobilised on the surface was determined by the 
Morgan-Elson fluorometric enzyme assay [5]. The AZ31-MT-A-HA1 and AZ31-MT-A-
HA2 substrates were exposed to the hyaluronidase enzyme for an appropriate time at 37.5 
ºC. Then, the enzyme solution was collected and incubated in a boiling water bath for 5 
minutes to inactivate the enzyme. After cooling to room temperature, 25 µl of tetraborate 
reagent (0.8 M K2B4O7.4H2O) was added and incubated for 3 minutes in a boiling water 
bath to start the Morgan- Elson fluorometric reaction. After cooling to room temperature, 
0.75 ml of 10 %w/v DMAB (p-Dimethylaminobenzaldehyde) reagent was added and 
incubated for 20 minutes at 37.5 ºC. The release of N-acetyl glucosamine was measured 
by fluorescence (Ex/Em: 545/604 nm) while the concentration of HA functionalised was 
determined by using a standard curve of HA. 
4.2.3 Characterisation of AZ31 modified samples  
In addition to the characterisation techniques mentioned in the section 3.2.3, Atomic force 
microscopy (Asylum MFP-3D-BIO, USA) was used to determine surface roughness with 
a scan area of 20 x 20 µm. For each substrate, images were taken from at least three sites 
on two independent samples to determine the surface roughness. 
4.2.3.1 Electrochemical corrosion studies 
All in vitro Mg alloy degradation tests were performed at 37 ± 0.5 °C in HEPES-buffered 
DMEM (15 mM HEPES). Electrochemical impedance spectroscopy measurements were 
conducted as detailed in section 3.2.3.1  
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4.2.3.2 Immersion experiment, pH changes and H2 gas evolution measurement 
All parameters and method employed to conduct immersion experiment and pH 
measurements are mentioned in section 3.2.3.2. The immersion medium employed for 
this study is HEPES-buffered DMEM.  
The rate of H2 gas release was monitored by placing the samples in HEPES buffered 
DMEM at 37 ± 0.5 °C under an inverted funnel connected to graduated burette and 
measuring the medium level within the burette for up to 10 days.  The ratio of the surface 
area-to-volume of DMEM was kept constant at 10 cm2. L-1 [6].  
4.2.4 Cytocompatibility 
4.2.4.1 Cellular morphology imaging by SEM 
Cellular morphology imaging by SEM was performed according to the methods described 
in sections 3.2.4.3 
4.2.4.2 Live/dead cell staining 
Live/dead cell staining was performed according to the methods described in section 
3.2.4.2 
4.2.4.3 DNA quantification 
The total DNA content was determined according to the methods described in section 
3.2.4.4 
4.2.4.4 Alkaline phosphatase (ALP) assay  
ALP activity was determined as per methods described in the section 3.2.4.5 
4.2.5 Statistical analysis 
All the experiments were carried out thrice in triplicates. All data are expressed as mean 
± S.D. The differences between the groups were analysed using one-way analysis of 
variance (ANOVA) followed by Tukey post hoc test. Statistically significance was 
considered at **p < 0.01 and *p < 0.05. 
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4.3 Results and discussion 
4.3.1 Characterisation of AZ31 modified surface 
In order to bond with the silane coating, the AZ31 surface was passivated with NaOH to 
produce surface hydroxy groups. The AZ31-OH was sequentially treated with hydrolysed 
MTES-TEOS and APTES sols to prepare a two-layer silane coating through siloxane 
bond formation. Following exposure of the MTES-TEOS sol, the ATR-IR spectrum (Fig. 
4-2) shows bands around 3694 cm-1, 1045-1127 cm-1 and 1270 cm-1 which are attributed 
to -OH groups (Fig. 4-2b), Si-O asymmetric stretching of -Si-O-Si- and Si-CH3 (Fig. 4-
2c) of MTES respectively [7].   
 
Figure 4-2 ATR-IR of spectra (a) AZ31 alone, (b) AZ31-OH, (c) AZ31-MT, (d) 
AZ31-MT-A, (e) AZ31-MT-A-HA1, (f) AZ31-MT-A-HA2, (g) HA alone 
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Subsequent coating with APTES increases the intensity of -Si-O-Si- band with the 
emergence of new bands at 1570 cm-1, 3295 cm-1and 3368 cm-1 (Fig. 4-2d) which are 
associated with asymmetric and symmetric stretching modes of the NH2 group 
respectively [7] [8]. The amino silane surface was then functionalised with HA through 
EDC-NHS coupling reactions at increasing concentrations. The effective concentrations 
of the bound HA obtained from Morgan-Elson assay for AZ31-MT-A-HA1 and AZ31-
MT-A-HA2 substrates were found to be 45.45 ± 0.05 µg.cm-2 and 66.77 ± 0.25 µg.cm-2 
respectively. 
The amide I (a shoulder band), amide-II band and stretching vibrations of carboxylate 
C=O  of  HA are indicated at 1670 cm-1 (Fig. 4-2-g3), 1540 cm-1  (Fig. 4-2-g2) and 1604 
cm-1 (Fig. 4-2-g1) respectively [9]. With the HA functionalisation, the bands of amide I 
(Fig. 4-2-f3 and 4-2-e3) and amide II bands (Fig. 4-2-f2, 4-2-e2) can be observed 
prominently (showed in the magnified inset.). Moreover, the carbonyl HA band (Fig. 4-
2-g1) and APTES amine band (Fig. 4-2-d4) cannot be observed in the resultant spectra 
indicating successful coupling at the surface.  
Furthermore, AFM was used to observe the topography of surface modifications as shown 
in Fig. 4-3. The surface roughness (Ra) of the AZ31 and AZ31-OH substrates was 74.5 ± 
8.2 nm and 62.2 ± 3.9 nm respectively. The Ra values of AZ31-MT and AZ31-MT-A 
coated surface were found to be 43.1 ± 0.5 nm and 45.7 ± 0.82 nm respectively. The Ra 
values then decreased considerably for AZ31-MT-A-HA1 and AZ31-MT-A-HA2 
substrates to 4.86 ± 0.07 nm and 7.84 ± 0.39 nm respectively, significantly lower than the 
bare AZ31 alloy alone. The fibrils pattern of HA can be observed which most likely 
results from drying induced aggregation of HA chains [10]. 
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Figure 4-3 Surface morphology of uncoated and coated substrates was determined 
using AFM for (a) AZ31, (b) AZ31-OH, (c) AZ31-MT-A, (d) AZ31-MT-A-HA1 and 
(e) AZ31-MT-A-HA2. (Arrows are indicating aggregation of HA chains) 
The effect of surface modifications also changes the wettability of the surfaces as shown 
in Fig. 4-4.  
 
Figure 4-4 Contact angle of AZ31 modified substrates. One-way ANOVA with post-
hoc Tukey test with significance level of ** p < 0.01 at every step of modification 
except for HA modification. For AZ31-MT-HA1 and AZ31-MT-HA2 test of 
significance was performed with AZ31 alone. 
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Compared to the AZ31 alloy, the water contact angle showed significant changes after 
every step of modification (passivation treatment and silane). After HA functionalisation, 
the AZ31-MT-A-HA1 and AZ31-MT-A-HA2 showed a significant decrease in contact 
angle having values 43.4º ± 1.4 and 41.3º ± 6.3 respectively when compared to the AZ31 
alone. 
4.3.2 In vitro corrosion and degradation studies 
4.3.2.1 Electrochemical impedance spectroscopy  
The EIS data of uncoated and coated AZ31 substrates are shown in Bode impedance plots 
in Fig. 4-5(a).  
 
Figure 4-5 Bode plots of (a) AZ31 alone, AZ3-OH, AZ31-MT, AZ31-MT-A, AZ31-
MT-A-HA1 and AZ31-MT-A-HA2 surfaces, and (b) equivalent circuits used to fit 
experimental data; coated and uncoated (AZ31 and AZ31-OH substrates) 
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The impedance (ǀZǀ0.01Hz) increases gradually with every step of the silane coating. When 
compared to the AZ31 alloy, the impedance of AZ31-MT-A increased by nearly two 
orders of magnitude, indicating effective protection of AZ31 alloy. Although ǀZǀ0.01 Hz 
decreases for AZ31-MT-A-HA1 and AZ31-MT-A-HA2 substrates, it is still higher than 
the AZ31 substrate. The analysis of the EIS spectra was performed based on the proposed 
electrical equivalent circuits (EEC) depicted in Fig. 4-5(b) which fit best with the 
experimental data and parameters are given in Table 11.  
Table 11 Parameters of uncoated and coated substrates calculated from the fitting 
of the experimental impedance spectra (Values ± % error) 
Substrates AZ31 AZ31-OH AZ31-MT AZ31-MT-A AZ31-MT-A-HA1 AZ31-MT-A-HA2 
Rs (Ω.cm2) 430 ± 2.01 412 ± 8.92 421.1 ± 11.12 
460 ± 9.83 
453 ± 10.02 430 ± 7.71 
CPEcoat-T (x 10-8 F cm-2) 700.98 ± 1.97 605.49 ± 1.27 22.92 ± 3.01 4.385 ± 5.001 13.263 ± 3.12 6.422 ± 2.403 
CPEcoat-P 0.739 ± 3.631 0.740 ±2.02 0.667 ± 0.386 0.739± 0.646 0.632 ± 2.16 0.751 ± 0.269 
Rcoat (x 105 Ω.cm2) 0.01435 ± 6.721 0.0181 ± 4.926 0.5191 ±8.50 1.5591 ± 6.12 1.191 ± 4.961 0.5638 ± 5.903 
CPEdl-T (x 10-6  F cm-2) 124.07 ± 2.06 71.72± 2.73 7.289± 2.21 4.571 ± 1.90 3.187 ± 8.896 7.136 ± 16.789 
CPEdl-P 0.805 ± 5.110 0.878 ± 4.18 0.679 ± 8.512 0.778 ±11.856 0.948 ± 3.535 0.879 ± 9.302 
Rct  (Ω.cm2) 575 ± 6.27 633 ± 7.76 24775 ±3.43 57543 ± 4.91 52195 ± 2.36 30999 ± 6.718 
 
Bodes phase angle plots for all coated substrates are characterised by high and low 
frequencies time constants which correspond to the response of charge transfer and mass 
diffusion-controlled reactions respectively. The AZ31 and AZ31-OH substrates are also 
characterised by two capacitive responses at higher and medium frequencies with an 
additional inductance at low frequency (< 0.1Hz). The inductance is related to adsorbed 
intermediate species during corrosion [11]. The EEC consists of a solution resistance Rs, 
a constant phase element of electrolyte/coating layer (CPEcoat (Qcoat)) and a double 
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electrical layer presence in the metal/coating (CPEdl (Qdl)) interfaces (as seen under non-
ideal conditions). Rcoat and Rct are the coating and charge transfer resistances respectively. 
The EECs were selected based on the available literature for the corrosion of uncoated 
and coated Mg alloys [24, 27].  
As shown in Table 11, Rcoat and Rct gradually increase for AZ31-MT and AZ31-MT-A 
substrates before decreasing for the HA modified surfaces. Rct which is a measure of 
corrosion resistance of coated AZ31 substrates suggests a considerable increase in 
corrosion resistance for AZ31-MT-A substrate (57 KΩ.cm2) as compared to other 
modified substrates and bare AZ31 alloy (575 Ω.cm2). Similarly, the coating capacitance 
(CPEcoat and CPEdl) for the AZ31-MT-A substrate is lowest amongst all those tested, 
implying that the corrosion activity of the AZ31-MT-A substrate is substantially 
decreased. 
This improved corrosion resistance of AZ31-MT-A substrate in buffered DMEM can be 
attributed to physical barrier performance of the siloxane coating network to electrolyte 
penetration [13]. This results in retarding of the anodic dissolution reactions and 
preventing the mass transport of Mg2+ ions and H2 gas release [7] [13]. In a previous 
report, γ-APS-BTSE treated AZ31 Mg alloy showed lower corrosion resistance than the 
present AZ31-MT-A model [14]. However, coating with increasing concentrations of HA 
was unable to enhance the AZ31 Mg alloy corrosion resistance. This may be due to the 
silane coating saturated with the electrolyte (MES buffer, pH 5.5) during the covalent 
coupling reaction [14]. This hinders the physical barrier function to resist electrolyte 
penetration. Moreover, it is known that HA modifications have been used to impart the 
surface hydrophilicity due to its excellent water absorption properties [15]. From the 
electrochemistry results, HA functionalisation on AZ31-MT-A substrate does not offer 
any additional corrosion resistance. Therefore, further degradation studies have been 
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performed with the corrosion resistant component (AZ31-MT-A) of the HA-silane 
coating.   
4.3.2.2 Immersion experiment, pH changes, and H2 evolution studies 
Fig. 4-6 (a) shows the Mg2+ ion release rate, pH change and evolution of H2 gas from the 
coated AZ31-MT-A and uncoated AZ31 substrates aged in HEPES buffered DMEM for 
21 and 10 days respectively. The explanations regarding the timelines adopted for these 
experiments and exclusion of AZ31 as a control in Fig 4-6 (b) are mentioned in Chapter 
3 (section 3.3.2).  
 
Figure 4-6 (a) ICP-OES measurement of Mg ions release rate, pH change and rate 
of H2 gas release from AZ31 and AZ31-MT-A over a period of 21 and 10 days 
respectively, and (b) Electron micrograph and EDX mapping of AZ31-MT-A 
substrate immersed in HEPES buffered DMEM for 7, 14 and 21 days.   
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The coated AZ31-MT-A substrate showed a very slow and steady release of Mg2+ ions 
which was ~8 fold (0.0015 mM/hr) lower when compared to uncoated AZ31 alloy (0.013 
mM/hr) until day 9. For the remaining immersion period, the Mg2+ ion concentration 
decreases thereafter to ~ 2.5-fold (0.001 mM/hr) lower than the uncoated AZ31 
equivalents (0.003 mM/hr). This occurs mainly due to the decrease in the Mg2+ ion release 
rate from the uncoated AZ31 alloy. This result would confirm that the controlled 
degradation of coated AZ31 Mg alloy, especially during the initial period, plays an 
important role in maintaining physiological conditions required for bone healing.  
Furthermore, the pH changes of HEPES buffered DMEM containing uncoated and AZ31-
MT-A coated substrates for 21 days showed that the AZ31-MT-A substrate was less 
alkaline as compared to the uncoated AZ31 alloy. The pH of the AZ31-MT-A substrate 
increases gradually until day 9 (pH 8.19 ± 0.03) and remains unchanged for the remaining 
immersion time (pH 8.23 ± 0.05), whereas AZ31 alloy exhibits a sudden increase in pH 
until day 9 (pH 8.43± 0.04) and then stabilises for the remaining period (pH 8.49 ± 0.05).  
The rate of hydrogen gas evolution was measured from AZ31 and AZ31-MT-A substrates 
in HEPES buffered DMEM for 10 days. The coated substrate released less H2 gas over 
10 days (from 0.045 ml/h to 0.019 ml/h) when compared to uncoated AZ31 (from 0.22 
ml/h to 0.055 ml/h). Therefore, the coated AZ31-MT-A surface displayed superior 
performance (in terms of pH change, H2 and Mg
2+ ions release) when compared to the 
uncoated AZ31 substrate. The difference was especially apparent during the early period 
of immersion. 
Furthermore, the surface profile of the AZ31-MT-A substrate in buffered DMEM for 
different times was evaluated by SEM-EDX as illustrated in Fig. 4-6 (b). The coated 
substrate shows increasing crack incidence over time and evidence of corrosion debris. 
The EDX mapping and elements quantification (inset tables) of the aged coated substrate 
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are rich in carbon (C), calcium (Ca), oxygen (O) and phosphate (P). A protective layer 
containing a relatively high content of O, C, Ca and P deposits were observed on the 
coated substrate from day 7 to 21.  In addition, a weak signal of Si observed on day 21, 
which may indicate the degradation of the silane coating.  
The possible reasons for the crack formation and increased deposition of corrosion by-
products on the coated AZ31 alloy with the immersion time include electrolyte 
penetration into the coating and subsequent corrosion of the underlying passivated AZ31 
alloy with the release of Mg2+ ions at the site of corrosion [16]. This results in the 
degradation of the silane coating over a period of time. However, the complete 
degradation of the silane coating has not been observed (Si EDX mapping). Generally, 
hydroxide passivated AZ31 surface is unable to provide long-term corrosion resistance in 
the chloride-rich environment [17]. This leads to the efflux of Mg2+ ions from the cracks 
which react with water to form an alkaline environment and produces Mg (OH)2 and H2 
gas [18]. The overall (anodic and cathodic) reaction as given below:   
                           𝐌𝐠 → 𝐌𝐠𝟐+ + 𝟐𝐞− (𝐚𝐧𝐨𝐝𝐢𝐜 𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧)……………………….Eq-1 
     𝟐𝐇𝟐𝐎 + 𝟐𝐞
− →  𝐇𝟐 + 𝟐𝐎𝐇
− (𝐜𝐚𝐭𝐡𝐨𝐝𝐢𝐜 𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧)………… Eq-2 
              𝐌𝐠 + 𝟐𝐇𝟐𝐎 →  𝐇𝟐 + 𝐌𝐠(𝐎𝐇)𝟐 (𝐨𝐯𝐞𝐫𝐚𝐥𝐥 𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧)…………......Eq-3 
The evolution of H2 gas reduces the coating stability, which enhances electrolyte 
penetration through the coating, promoting further corrosion. However, increases in pH 
of the medium induce the formation of a protective precipitate of Ca-P and 𝐌𝐠(𝐎𝐇)𝟐 at 
the alloy surface, thereby reducing the degradation of Mg alloy [13]. This results in the 
reduced Mg2+ ion release rate, H2 gas release and pH change especially during a later 
stage of immersion period as observed for both coated and uncoated substrates (Fig. 4-
6(a)). Previous reports also showed that the degradation layer formed during the corrosion 
process reduced the degradation rate of Mg alloys in vitro [19]. This controlled 
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degradation of coated AZ31-MT-A substrate could be attributed to the coating stability 
and in situ formation of protective degradation layers, helping maintain conditions 
required for osteoblast cell growth. 
4.3.3 Cytocompatibility 
For cytocompatibility studies, HA was functionalised onto the AZ31-MT-A substrate to 
develop a biocompatible and osteoinductive surface. Fig. 4-7 (a) shows the live-dead 
staining of MC3T3-E1 cells cultured on uncoated AZ31, AZ31-MT-A-HA1 and AZ31-
MT-A-HA2 coated substrates for 1 and 3 days. For both time points, the AZ31-MT-A-
HA1 and AZ31-MT-A-HA2 substrates showed the HA concentration-dependent increase 
in live cell density (green fluorescence) with very few dead cells (red fluorescence) as 
compared to uncoated AZ31 alloy, indicating an enhanced cell adhesion and proliferation 
of osteoblast cells on HA coated AZ31-MT-A substrates.  
 
Figure 4-7 (a) Fluorescence microscopy images of live-dead MC3T3E1 cells and (b) 
SEM morphology of fixed MC3T3E1 osteoblast cells attached to AZ31, AZ31-MT-
A-HA1, and AZ31-MT-A-HA2 for day 1 and 3.  White arrows are indicating 
osteoblast cells. 
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Fig. 4-7 (b) shows the SEM images of the fixed osteoblast cells on HA coated AZ31-MT-
A and uncoated AZ31 substrates on day 1 and 3. The cells attached to uncoated AZ31 
alloy on day 1 and 3 are sparse and circular in shape (indicated by white arrows), 
indicating very poor adhesion to the substrate. On the other hand, osteoblast cells on 
AZ31-MT-A-HA1 and AZ31-MT-A-HA2 substrates displayed more flattened spread 
morphology, indicating good osteoblast cell attachment. These results suggested that HA 
coated surfaces facilitate greater adhesion of osteoblast cells.  
Fig. 4-8 shows the quantification of the total DNA content of osteoblast cells, which is 
considered as a measure of cell proliferation. A significant increase in the folds of DNA 
content was observed for the HA-coated surfaces on day 3, indicating that such a coating 
favours osteoblast cell attachment.  
 
Figure 4-8 Quantification of total DNA content and ALP activity of osteoblast 
cultured on uncoated AZ31 and coated AZ31-MT-A-P substrates for 3, 7 and 14 
days. One-way ANOVA is followed by post-hoc Tukey test having a significance 
level of ** p < 0.01 between the samples.  
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On HA coated surfaces, adhered cells showed nearly 5 folds increase in proliferation 
between 7 and 14 days relative to AZ31 equivalents. These results were also consistent 
with the live-dead images of osteoblast cells. The ALP activity of osteoblast cells grown 
over 14 days on the AZ31, AZ31-MT-A-HA1 and AZ31-MT-A-HA2 substrates are 
presented in Fig. 4-8. Osteoblasts cultured on HA functionalised substrates displayed 
significantly higher ALP expression (p < 0.01) when relating to the uncoated AZ31 alloy 
over a culture duration of 14 days. ALP is one of the most widely used early stage markers 
of osteoblast differentiation, which participates in ECM mineralisation [20].  HA is one 
of the major ECM component of many cells including osteoblast cells which regulates 
cell adhesion, proliferation and expression of osteoinductive factors including ALP [21]. 
However, very few reports evaluated cell adhesion, proliferation and differentiation 
ability of HA functionalisation on various metal substrates. Chua et al. showed the poor 
adhesion of osteoblasts on HA modified Ti samples as compared to the chitosan/HA or 
chitosan/HA/RGD peptides functionalised Ti surface [2]. Similarly, Hu et al. also 
reported poor adhesion and proliferation of osteoblasts on hyaluronic acid-catechol 
functionalised on Ti surface (Ti-HAC) as compared to the Ti-HAC-VEGF and Ti-CMC-
VEGF [22]. On the contrary, the present study demonstrates remarkable osteoblasta’ 
adhesion, proliferation and differentiation on HA functionalised AZ31 substrates. Zhao 
et al. studied the hyaluronic acid molecular weight dependent differentiation of rBMSCs 
[3]. It has been reported that high molecular weight HA with higher concentration 
promoted cell proliferation and differentiation. The enhanced osteogenic differentiation 
of osteoblast cells on HA1/HA2 coated AZ31 substrate could be attributed to the 
immobilisation of high molecular weight HA.  
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4.4 Conclusion 
In the present work, a multilayered hyaluronic acid functionalised silane coating on AZ31 
Mg alloy was fabricated successfully. Electrochemical corrosion and immersion studies 
demonstrated that the silane component of the coating significantly improved the 
corrosion resistance of the AZ31-MT-A-HA1/HA2 substrates as compared to the 
uncoated AZ31 Mg alloy. Furthermore, immersion studies showed that stability of the 
silane coating as well as in situ formations of passivation layer played an important role 
in the controlled degradation of the coated AZ31 Mg alloy. In comparison to the PLGA-
silane coating (chapter 3), the silane component of the HA-silane coating showed 
effective corrosion protection in a highly corrosive HEPES-modified DMEM. Based on 
electrochemical and immersion studies, the corrosion resistance has decreased 
considerably in this electrolyte in comparison to the PLGA-silane coated surface (DMEM 
was used as an electrolyte), but overall increase when compared to the uncoated surface  
is similar. Moreover, an increase in the degradation of HA-coated AZ31 Mg alloy 
(observed from the electrochemical corrosion study) did not affect the viability of the 
adhered osteoblast cells on its surface. In contrast, osteoblast cells showed a considerable 
increase in cell viability, adhesion, proliferation and differentiation on HA-coated AZ31 
when compared to PLGA-silane, coated substrates. These results showed (a) silane 
component of the coating effectively controlled the degradation of Mg alloy without 
affecting the biocompatibility of the substrate and (b) HA functionalisation on silane-
modified AZ31 substrate provided a biomimetic environment which is evident from an 
improved osteoblast cellular response.  Collectively, these results demonstrated that the 
proposed strategy to develop a multifunctional coating which can improve the corrosion 
resistance and cytocompatibility of AZ31 Mg alloy would be highly desirable for 
orthopaedic applications. 
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Biomimetic hyaluronic acid-lysozyme composite coating on AZ31 Mg 
alloy with combined antibacterial and osteoinductive activities 
 
        
This study presents the covalent grafting of a hyaluronic acid-lysozyme (HA-LZ) 
composite onto corrosion resistant silane coated AZ31 Mg alloy via EDC-NHS coupling 
reactions. The HA-LZ composite coatings created a smooth and hydrophilic surface with 
the increased concentration of functional lysozyme complexed to the hyaluronic acid 
group. This was confirmed by the measurement of AFM, water contact angle, and 
quantification of hyaluronic acid and lysozyme. The colonisation of S.aureus on HA-LZ 
composite coated substrates was significantly reduced as compared to the hyaluronic acid, 
lysozyme coated and uncoated AZ31 controls. This is due to the enhanced antibacterial 
activity of the lysozyme component as observed from the spread plate assay, propidium 
iodide staining and scanning electron microscopy. Furthermore, morphology of the 
osteoblast cells, alkaline phosphatase activity and DNA quantification studies 
demonstrated the improved biocompatibility and osteoinductive properties of  HA-LZ 
coated substrates.  
The work described in this chapter has been published: Agarwal, S., Riffault, M., 
Hoey, D., Duffy, B., Curtin, J. and Jaiswal, S. Biomimetic hyaluronic acid-lysozyme 
composite coating on AZ31 Mg alloy with combined antibacterial and osteoinductive 
activities. ACS Biomaterials Science & Engineering, 2017, 3(12), 3244-3253. 
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5.1 Introduction 
In chapter 4, the corrosion resistance and osteoanabolic properties of hyaluronic acid 
modified silane coated AZ31 Mg alloy were evaluated. The silane coating enhanced the 
corrosion resistance performance in HEPES buffered DMEM and controlled the 
degradation of AZ31 Mg alloy, thereby providing a suitable environment for osteoblasts 
survival. The osteoblasts showed improved functions on the hyaluronic acid modified-
silane coated AZ31 surface. However, concerns have been raised over the implant 
associated microbial infections, which is a major cause of device failure. Therefore, it is 
important to develop antimicrobial coatings which can prevent bacterial colonisation on 
the implant surface without affecting osteoblast functions. Previous studies reported that 
the corrosion of Mg-based alloys causes an increase in the pH of the surrounding medium, 
thereby inhibiting the growth of bacteria [1]. However, biological fluids are stabilised by 
buffer systems that maintain physiological processes. Therefore, highly alkaline 
environments that arise due to corrosion of Mg alloys are buffered under in vivo 
conditions, thereby limiting the antimicrobial activity of the implant [2]. Previous studies 
have also demonstrated that some bare and corrosion-resistant Mg-based alloys are highly 
susceptible to microbial growth on the surface [2–4]. Furthermore, it is important that the 
orthopaedic implant should expedite the healing of any defective bone. The orthopaedic 
implant efficiency in restoring damaged bone is determined by its osteointegration. This 
is characterised by the tight bond between the bone and implant surface, thereby 
minimising the risk of implant loosening over time [5].  
To improve the biological acceptance of orthopaedic implants in terms of osteoinductivity 
and inhibiting bacterial colonisation on the surface, bio-macromolecules such as 
hyaluronic acid and lysozyme can be employed on the corrosion-resistant Mg-based 
alloys. The combination of hyaluronic acid and lysozyme have been explored previously 
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on ocular lenses [6]. Hyaluronic acid is a polyanionic multifunctional polymer present as 
a component of extracellular matrix which plays an important role in promoting 
osteoblast cell motility and proliferation [6,7]. Additionally, its anionic and hydrophilic 
nature also reduces bacterial cell adhesion [6,8]. However, the application of HA onto an 
implant surface cannot completely avoid infections. Lysozyme is a lytic enzyme present 
in egg white, human tears as well as in other secretions [6]. Its antimicrobial properties 
are associated with the hydrolysis of the peptidoglycan layer in the bacterial cell wall, 
thereby perturbing the membrane functions. Moreover, as a part of a natural defence 
system, lysozyme is environmentally friendly and acts with more specificity than 
conventional biocides, such as quaternary ammonium salts and antibiotics, thereby 
preventing the risk of developing multidrug-resistant bacteria. Lysozyme has been 
utilised to modify the surfaces of biomedical devices to prevent bacterial growth [6,9]. 
Previously, adsorption of lysozyme on hyaluronic acid functionalised mesoporous SBA-
15 particles was studied as a therapeutic agent [10]. Therefore, the synergistic 
immobilisation of hyaluronic acid and lysozyme on a corrosion resistant silane coated 
AZ31 Mg alloy surface is proposed for the first time in this work to confer simultaneous 
antimicrobial and osteoinductive properties for challenging biodegradable orthopaedic 
applications. 
In the present study, the biomimetic hyaluronic acid-lysozyme (HA-LZ) composite 
coating was developed on the AZ31 Mg alloy and the combined antibacterial and 
osteoinductive activities were evaluated. The covalent binding of HA-LZ composite with 
the amine-terminated surface AZ31-MTES-TEOS-APTES (AZ31-MT-A) was achieved 
via EDC-NHS coupling reactions. The antimicrobial activity of HA-LZ immobilised on 
AZ31-MT-A coated Mg alloy was evaluated against S. aureus bacteria. Further, the 
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improved biocompatibility of HA-LZ coated surface has been demonstrated with murine 
osteoblasts. 
5.2 Experimental 
5.2.1 Materials 
AZ31 alloy sheets were purchased from Shaanxi Taipu Rare Metal Materials Ltd, China. 
Methyltriethoxysilane  and tetraethoxysilane, 3-aminopropyl-triethoxy silane, 
Hyaluronic acid (HA) from rooster comb (1-4 million Daltons), lysozyme from chicken 
egg white, phosphate buffer saline (PBS), Dulbecco's Modified Eagle's Medium/Nutrient 
F-12 Ham (DMEM/F-12), fetal bovine serum (FBS), Penicillin-streptomycin antibiotics, 
phosphatase substrate and bisBenzimide H 33342 trihydrochloride, NHS (N-
Hydroxysuccinimide), EDC (1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide) and 
MES (2-(N-Morpholino) ethane sulfonic acid) buffer were purchased from Sigma 
Aldrich. Mueller-Hinton agar and nutrient broth were purchased from Lab M.  
5.2.2 Surface modification with hyaluronic acid-lysozyme composite on AZ31 Mg 
alloy 
5.2.2.1 Treatment of AZ31 with NaOH 
The surface treatment was performed according to the method described in section 3.2.2.1 
5.2.2.2  Functionalisation of hyaluronic acid-lysozyme functionalisation on silane 
coated AZ31 Mg alloy 
Preparation of organo-silane coating is mentioned in section 3.2.2.2. Furthermore, the 
hyaluronic acid-lysozyme composite was functionalised to amine terminated AZ31-MT-
A substrates. In this process, lysozyme (LZ) (10% and 20 % w/w of HA), HA (1 mg.ml-
1), NHS (0.1M) and EDC (0.4 M) were sequentially added into a MES buffer (0.01 M, 
pH 5.5) and stirred for 2h [6]. Similar reactions were also performed with respective LZ 
(10% and 20 % w/v) and HA (1 mg.ml-1) concentrations which were considered as 
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controls. Here, we have used the above-mentioned LZ concentrations because at a higher 
concentration flocculation with white precipitate was observed in the solution. The AZ31-
MT-A coating was immersed in the above solution for 4 h. After incubation, substrates 
were rinsed with MES buffer to remove physically adsorbed HA and LZ. The resultant 
HA-LZ (10% and 20%), LZ (10% and 20%) and HA-coated AZ31-MT-A surfaces were 
denoted as AZ31-HA-LZ-10%, AZ31-HA-LZ-20%, AZ31-LZ-10%, AZ31-LZ-20% and 
AZ31-HA respectively.  
5.2.3 Characterisation of AZ31 modified substrates 
5.2.3.1 Surface morphology and wettability of the substrate  
The surface morphology of all modified (AZ31-HA-LZ-10%, AZ31-HA-LZ-20%, 
AZ31-LZ-10%, AZ31-LZ-20% and AZ31-HA) and uncoated AZ31 substrates were 
characterised by atomic force microscopy in tapping mode (AFM, Asylum MFP-3D-BIO, 
USA). The wettability of the samples was determined by static water contact angle 
measurements (FTÅ-200 system) using a sessile drop method (2µl, Milli-Q water).   
5.2.3.2 Quantification of immobilised hyaluronic acid and lysozyme on the AZ31 
surface 
Quantification of hyaluronic acid was performed according to the method described in 
section 4.2.3.2. 
The lysozyme activity of HA-LZ and LZ coatings was determined using 4-
methylumbelliferyl β-D-N,N’, N”-triacetylchitotrioside (4-MU-GlcNAc3) as a 
fluorimetric enzyme substrate [12,13]. The substrate was dissolved at a concentration of 
100 µM in 50 mM sodium acetate buffer of pH 5 and incubated with the HA-LZ coated 
samples at 37 °C for 30-60 mins. The lysozyme activity was stopped by using a glycine-
carbonate buffer at a pH of 10.5 and the fluorescence of 4-methyl umbelliferone was 
measured at Ex/Em =360/445 nm. The amount of 4-MU produced during the enzymatic 
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reaction was determined using its standard curve. One unit of the lysozyme activity for 
4-MU-GlcNAc3 hydrolysis was defined as the amount of enzyme that generates 1 µM of 
4-MU per minute at 37 ˚C at pH 5.  
5.2.4 Cytocompatibility 
5.2.4.1 DNA quantification 
The experimental section of DNA quantification is mentioned in section 3.2.4.4 
5.2.4.2 Alkaline phosphatase (ALP) assay  
The experiment was carried out according to the section 3.2.4.5 
5.2.4.3 Actin Phalloidin and DAPI staining 
The morphology of actin cytoskeleton of osteoblast cells was investigated 24 h after 
seeding. Briefly, cells were washed with PBS, fixed with 10% formalin, and 
permeabilised with 0.1% Triton (Sigma) in PBS. Actin cytoskeleton was stained with 
Phalloidin (1/40 in PBS, AlexaFluor488-Phalloidin, Life Technologies) for 20 minutes, 
and nuclei were stained with DAPI (1/2000 in PBS, Sigma). All cells were imaged using 
an Olympus IX83 epifluorescence microscope fitted with a 10x objective. 
5.2.4.4 Cell morphology imaging by SEM 
This section is similar to that of mentioned in section 3.2.4.3 
5.2.5 Antibacterial activity 
5.2.5.1 Spread plate assay  
The antibacterial activity of uncoated and coated AZ31 substrates was determined using 
S. aureus (ATCC 25923), the most common pathogen associated with orthopaedic 
implant infections. For all the experiments, the substrates were sterilised by exposing UV 
radiations for 40 mins on each side. The substrates were immersed in sterile plastic tubes 
with 20 ml (1 cm2 = 20 ml) of 1 x 106 cells.ml-1 of initial bacterial suspension in PBS and 
 Chapter 5  
128 
 
incubated at 37 °C with constant shaking at 200 rpm. The substrates were removed from 
the tubes after 2, 4 and 12 h to evaluate the antibacterial activity.  
The substrates were gently washed thrice with PBS and sonicated in PBS for 5 mins to 
dislodge the cells from the surface. The 0.2 ml of bacterial suspension in PBS was plated 
onto the triplicate agar plate and incubated at 37 °C for 24 h. This timeline will allow for 
evaluation of the initial bacterial cell attachment and colonisation on the coated and 
uncoated AZ31 substrates. The colonies were counted, and results were expressed as a 
mean of colony forming units (CFU)/ml/cm2 [14]. 
5.2.5.2 Propidium iodide (PI) exclusion assay  
The coated and uncoated substrates (Size: 1 cm2) were incubated with S.aureus bacteria 
(106 cells/ml) in PBS for 2, 4 and 12 h. After the incubation, the substrates were treated 
with PI at a concentration of 60 µM for 30 minutes in the dark.  The substrates were 
washed with PBS twice and placed in the black bottom 24 well plates to measure the 
fluorescence (Ex /Em: 535/617 nm) using Spectramax-M3 microplate reader. 
5.2.5.3 Bacterial cell morphology by SEM 
All the coated and uncoated substrates were incubated for 4 h with bacteria and gently 
washed with the PBS. The bacterial cells were fixed in 10% formalin and dehydrated in 
alcohol gradients before being sputter coated with Au/Pd and imaged using SEM. 
5.2.6 Statistical analysis 
All of the experiments were conducted in triplicate.  All data are expressed as mean ± S.D 
(n=3). The differences between the groups were analysed using one-way analysis of 
variance (ANOVA) followed by post hoc Tukey test. Statistically significance was 
considered at **p < 0.01 and *p < 0.05.  
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5.3 Results and discussion 
5.3.1 Characterisation of AZ31 modified substrates 
Prior to application of HA and LZ coatings, the AZ31 surface was treated with the 
sequential steps of MTES-TEOS and APTES silanes to achieve amine functionalised 
coating. In previous studies, it has been demonstrated that the amino group of such 
coatings can be functionalised with various biomolecules such as hyaluronic acid, bovine 
serum albumin, RGD peptides etc., through amide bonds by EDC-NHS chemistry [15–
17]. The functionalisation of HA-LZ coating onto the amine group of APTES coatings 
was confirmed by AFM, contact angle measurement as well as quantification of HA and 
LZ by enzymatic methods as shown in Fig 5-1 and Table 12 respectively. 
Table 12 Summary of characterization parameters of different substrates 
 
The surface roughness (Ra) of the AZ31 and AZ31-MT-A are 74.5 ± 8.2 nm and 45.7 ± 
0.82 nm respectively. The roughness reduced considerably after coating with HA-LZ 
composite and LZ coatings on AZ31-MT-A substrate ranging from 17.1 ± 1.84 nm to 
25.7 ± 7.3 nm. However, the increase in surface roughness for the composite coatings as 
compared to the AZ31-HA substrate with Ra of 4.86 ± 0.07 nm could be attributed to the 
increased content of LZ. Static water contact angle measurement was used to determine 
the hydrophilic changes of modified AZ31 substrates (Table 12). When compared to the 
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AZ31 alloy, the AZ31-MT-A showed a lower contact angle of 46.4 ± 2.1°, indicating the 
presence of polar amine groups on the surface. The wettability of the HA-LZ and LZ 
modified surfaces decreased ranging from 48.85 ± 1.07° to 55.67 ± 0.92° when compared 
to the AZ31-HA surface with a contact angle of 41.24 ± 2.66°. However, these coated 
substrates showed a considerable increase in wettability when compared to the AZ31 
substrate (74.5 ± 8.2°). The wettability of the substrates is strongly related to the surface 
roughness and can play an important role in bacteria cell adhesion [19]. 
 
Figure 5-1 Surface morphology of uncoated and coated substrates was determined 
using AFM for (a) AZ31, (b) AZ31-HA, (c) AZ31-HA-LZ-10%, (d) AZ31-HA-LZ-
20%, (e) AZ31-LZ-10% and (f) AZ31-LZ-20% substrates. 
Furthermore, the concentration of immobilised HA and lysozyme activity of the coatings 
were quantified ( Table 12). It was found that the concentration of HA immobilised on 
AZ31-HA, AZ31- HA-LZ-10% and AZ31-HA-LZ-20% substrates were very similar and 
found to be ~ 48 µg/ml/cm2. The lysozyme activity of AZ31- HA-LZ-10% and AZ31-
HA-LZ-20% substrates were higher and found to be 0.534 ± 0.042 and 0.588 ± 0.021 
U/ml/cm2 respectively when compared to the activity of AZ31-LZ-10% and AZ31-LZ-
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20% substrates  at 0.465 ± 0.03 U/ml/cm2 and 0.513 ± 0.027 U/ml/cm2 respectively. 
Previous studies have shown that hyaluronic acid can interact electrostatically with 
lysozyme without affecting the activity of lysozyme in the HA-LZ composite [20,21]. 
Therefore, these characterisation studies confirmed the surface modifications of AZ31 
Mg alloy with HA-LZ composite. 
5.3.2 Antibacterial properties 
Results from the analysis of bacterial colonisation on HA, HA-LZ, LZ coated and 
uncoated AZ31 substrates were determined using a spread plate assay and shown in Fig. 
5-2.  
 
Figure 5-2 Viability of adhered S. aureus on different substrates was measured using 
CFU assay 2 h, 4 h and 12 h after immersion in bacterial cultures. One way ANOVA 
with posthoc Tukey test with significance level of ** p < 0.01, * p < 0.05. 
The results demonstrated that bacterial cells adhered to the AZ31 and AZ31-HA surfaces 
markedly increased by 144.6 % and 110.6% respectively over the 12 h period. However, 
the number of bacteria on the AZ31-HA surface is significantly less than the AZ31 alloy. 
In contrast, the AZ31-HA-LZ-10% and AZ31-HA-LZ-20% substrates showed a 
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significant reduction in bacteria cell adhesion as compared to the AZ31 alone during the 
12 h incubation period. Similarly, these substrates also showed a significant decrease in 
bacterial cell adhesion as compared to the AZ31- LZ-10% and AZ31-LZ- 20% controls. 
The overall decrease in the bacterial colonies of the HA-LZ composite coatings is an 
indication of the lysozyme concentration-dependent anti-adhesive and/or anti-bacterial 
properties over uncoated AZ31 and other modified substrates. 
Furthermore, the bactericidal activity of the coated and uncoated AZ31 substrates was 
determined fluorometrically using PI staining or exclusion of the bacteria adhered to the 
substrates as shown in Fig. 5-3.  
 
Figure 5-3 S. aureus viability was measured by fluorescence using the PI exclusion 
assay following incubation on different substrates. One way ANOVA is followed 
with a posthoc Tukey test with significance level of ** p < 0.01, * p < 0.05. 
The uncoated AZ31 substrate demonstrated antibacterial activity in the initial period of 
incubation but it decreases in the remaining period, whereas AZ31-HA-LZ-10% and 
AZ31-HA-LZ-20% showed a significant increase in antibacterial activity as compared to 
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the bare AZ31, AZ31-LZ-10% and AZ31-LZ-20% substrates over 12 h of incubation. 
The AZ31-HA substrate showed minimal antibacterial activity, as there are no 
bactericidal functional groups present in HA.  
Fig. 5-4 shows the morphology of the bacteria on the uncoated and coated substrates after 
4 h of incubation in bacterial suspension. From Fig. 5-4((a)-(b)), the bacteria adhered to 
the AZ31 and AZ31-HA surfaces maintained good shape indicating cytocompatibility of 
the bacteria. On the HA-LZ composite (Fig. 5-4(c-d)) and LZ coated (Fig.5-4(e-f)) 
substrates, only a few bacteria maintained their native shape and morphology (indicated 
by green arrows). In addition, cell debris (indicated by yellow arrows) and affected cells 
presenting distorted morphology (indicated by red arrows) are observed on HA-LZ 
composite and LZ coated substrates. 
 
Figure 5-4 Representative SEM images of S.aureus on (a) AZ31, (b) AZ31-HA, (c) 
AZ31-HA-LZ-10%, (d) AZ31-HA-LZ-20%, (e) AZ31-LZ-10% and (f) AZ31-LZ-
20% substrates after 4h of incubation (Red, yellow and green arrows are indicating 
affected cells, cell debris and unaffected cells respectively) 
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Many studies have reported that antibacterial activity of Mg-based alloys being directly 
related to the increased pH of the medium [1,22]. However, recent studies showed that in 
buffered environments, Mg-based alloys are susceptible to bacterial colonisation under in 
vitro and in vivo conditions [2,3,23]. In this study, an increased bacteria cell adhesion or 
reduced antibacterial activity of uncoated AZ31 substrates during the incubation period 
in bacterial suspension in PBS was observed. This is likely due to the insufficient increase 
in the pH of the medium (8.16 ± 0.15), in addition to the greater roughness and contact 
angle of the surfaces (Table 12). In contrast, the enhanced antibacterial activity of AZ31-
HA-LZ-10% and AZ31-HA-LZ-20% substrates over respective controls AZ31-LZ-10% 
and AZ31-LZ-20% was observed as demonstrated in Fig.5-2 and Fig. 5-4, which could 
be attributed to the higher content of lysozyme immobilisation with hyaluronic acid 
(Table 12). The reduced bacterial cell adhesion on the hyaluronic acid coated AZ31-HA 
surface can be attributed to the bacterial anti-adhesive characteristics of HA polymer due 
to the anionic nature and lubricity of the coating as well as low surface roughness [8].  
As stated previously, the most common pathogen associated with the orthopaedic 
implants is S.aureus [8]. Several studies reported the bactericidal activity of lysozyme 
against S.aureus [24,25]. The antibacterial activity of lysozyme involves its disruptive 
interaction with the bacterial membrane. Lysozyme disrupts the cell wall by catalysing 
the hydrolysis of the β 1-4 linkages between the N-acetylmuramic acid and N-acetyl-D-
glucosamine residues in chitodextrins, thereby increasing the permeability of bacterial 
cell wall and causing the cells to rupture. According to the contact killing mechanism of 
lysozyme, bacteria first adhere to the surface leading to the breakdown of the bacterial 
cell wall [6]. The previous study reported the efficient antibacterial activity of the HA-
LZ coated intraocular lenses against S.aureus for preventing endophthalmitis [6]. 
However, there is limited information available about the efficacy of HA-LZ as a 
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composite coating to prevent the bacterial colonisation for orthopaedic applications and 
their effect on the osteoblast cell response. Having demonstrated the antimicrobial 
properties of HA-LZ against S aureus, the most common pathogen associated with 
orthopaedic implants, we next investigated the cytocompatibility of HA-LZ with 
osteoblast cultures.  
5.3.3 Cytocompatibility 
Fig. 5-5 shows the morphology of osteoblast cells on the uncoated and coated AZ31 
substrates at day 1. The osteoblast cells that attached to the uncoated AZ31 substrate are 
sparse and circular in shape as shown in SEM image Fig. 5-5 I(a), demonstrating the poor 
adhesion to the substrate. The AZ31-HA (Fig. 5-5(b)), AZ31-HA-LZ-10% (Fig. 5-5(c)) 
and AZ31-HA-LZ-20% (Fig.5-5(d)) surfaces demonstrate flattened, extended 
morphology and greater cell-to-cell interaction of adhered osteoblasts. In contrast, AZ31-
LZ-10% (Fig. 5-5(e)) and AZ31-LZ-20% (Fig.5-5(f)) coated substrates displayed an 
elongated morphology.  
 
Figure 5-5 (I) Representative SEM and (II) fluorescent images of the actin 
cytoskeleton of osteoblasts cells  cultured on AZ31 (a-a`), AZ31-HA (b-b`),  AZ31-
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HA-LZ-10% (c-c`), AZ31-HA-LZ-20% (d-d`), AZ31-LZ-10%  (e-e`)  and AZ31-LZ-
20% (f-f`) substrates for day 1 respectively. Actin cytoskeleton was stained with 
Phalloidin (green) and nuclei were stained with DAPI (blue). (Scale bar of SEM 
images is 50 µm) 
Fig. 5-5 (II) series show the actin staining of osteoblast cells on different substrates after 
24 h of incubation. The cellular morphology of osteoblast cells is circular and poorly 
defined on the uncoated AZ31 substrate (Fig 5-5(a`)), without strong actin filament 
staining, indicating the cells adhered poorly and did not develop a filamentous actin 
cytoskeleton on the AZ31 substrate. Similar osteoblast morphology on the uncoated 
AZ31 substrate can be observed from SEM image (Fig. 5-5(a)). On the AZ31-HA, AZ31-
HA-LZ-10% and AZ31-HA-LZ-20% substrates, osteoblast cells appear cuboidal in 
morphology, showing strong actin filament organisation extending in different directions 
as shown in Fig. 5-5(b`, c` and d`) respectively, indicative of an osteoblastic phenotype. 
On the AZ31-LZ-10% (Fig. 5e`) and AZ31-LZ-20% (Fig. 5-5f `) substrates, cells 
displayed somewhat elongated actin filaments. Overall, these results indicate that HA-LZ 
composite coated substrates facilitate improved adhesion and morphological phenotype 
of osteoblast cells as compared to the uncoated substrates. 
Fig. 5-6 shows the DNA quantification of osteoblast cells cultured on the uncoated and 
coated AZ31 substrates which are considered to be a direct measure of cell proliferation 
over a period of 14 days. The coated substrates showed 3 to 6 folds increase in the total 
DNA content as compared to the AZ31 control.  In comparison to the AZ31-LZ-10% and 
AZ31-LZ-20% substrates, a significant increase in the folds of DNA content was 
observed for AZ31-HA-LZ-10% and AZ31-HA-LZ-20% substrates over a period of 14 
days. This indicated the improved osteoblast adhesion and proliferation on the HA-LZ 
coated substrates.   
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Figure 5-6 DNA content was measured following culture of osteoblast cells on AZ31, 
(b) AZ31-HA, (c) AZ31-HA-LZ-10%, (d) AZ31-HA-LZ-20%, (e) AZ31-LZ-10% 
and (f) AZ31-LZ-20%  substrates for 3, 7 and 14 days respectively, One way 
ANOVA with posthoc Tukey test with significance level of ** p < 0.01, * p < 0.05. 
These results showed that even though the osteoblast adhered to AZ31-LZ coatings (Fig. 
5-5), the proliferation of osteoblast cells was not comparable to the AZ31-HA and AZ31-
HA-LZ substrates. Moreover, the change in DNA concentration for the AZ31-HA and 
AZ31-HA-LZ coated substrate is insignificant, thereby indicating that the osteoblast cell 
proliferation was not affected by lysozyme in the HA-LZ composite coatings. 
Furthermore, the ALP activity of osteoblast cells cultured on the uncoated and coated 
AZ31 substrate for 14 days is presented in Fig. 5-7. The ALP activity of osteoblast cells 
cultured on HA coated substrates (i.e. AZ31-HA, AZ31-HA-LZ-10% and AZ31- HA-
LZ-20%) demonstrated significantly higher activity as compared to AZ31, AZ31-LZ-
10% and AZ31-LZ-20% substrates. However, the ALP activity of AZ31-HA coated 
surface was significantly higher when compared to the HA-LZ coated equivalents 
particularly on day 7. The decrease in the ALP activity of the HA-LZ coated surface is 
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likely due to the presence of lysozyme itself as the similar trend was also observed for 
AZ31-LZ-10% and AZ31-LZ-20% coated substrates 
 
Figure 5-7 Intracellular ALP activity was used to measure the differentiation of 
osteoblast cells cultured on AZ31, (b) AZ31-HA, (c) AZ31-HA-LZ-10%, (d) AZ31-
HA-LZ-20%, (e) AZ31-LZ-10% and AZ31-LZ-20%  substrates for 3, 7 and 14 days 
respectively, One way ANOVA with posthoc Tukey test with significance level of ** 
p < 0.01, * p < 0.05. 
This would indicate that the level of ALP activity is affected by the presence of lysozyme. 
However, at a later stage of differentiation (day 14), the ALP activity of HA-LZ coated 
substrate is comparable to the HA-coated equivalent and significantly higher when 
compared to AZ31 Mg alloy alone.  Bone regeneration is a complex process which 
involves the early stages of cell adhesion and proliferation, and later stages of cell 
differentiation and function [26]. From this study, it can be observed that HA-LZ coated 
surface showed comparable and enhanced cell adhesion and proliferation when compared 
to HA-coated and uncoated AZ31 equivalents respectively (Fig. 5-5 and 5-6). Osteoblast 
cells express ALP in the early stage of osteoblast differentiation and participate in the 
mineralisation of the extracellular matrix through the generation of phosphate ions from 
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the hydrolysis of organic substrates [27]. HA is one of the major components of the 
extracellular matrix (ECM) of many cells including osteoblasts which not only plays a 
structural role in the bone matrix but regulates cell adhesion, proliferation, migration, 
wound healing and expression of osteoinductive factors including ALP.  It also possesses 
the receptors for CD 44 (cell surface glycoprotein) and RHAMM (receptor for HA-
mediated motility) which promote the differentiation of osteoblast cells [26,28]. 
Therefore, the decrease in the ALP activity on HA-LZ composite coated substrate in the 
early stage of differentiation is likely due to the interference in the above-mentioned 
interactions of osteoblast cells with the HA due to the lysozyme component. However, an 
in-depth study will be required to elucidate the mechanisms regulating the differentiation 
of osteoblast cells on such composite coatings.  
5.4 Conclusion 
In this study, the HA-LZ composite was functionalised onto a silane-based corrosion 
resistant coating on the AZ31 Mg alloy. Among all coated substrates, the AZ31-HA-LZ-
20% substrate showed a significant higher bactericidal activity against S. aureus bacteria 
without greatly compromising the cytocompatibility of osteoblasts. Improved cell 
adhesion with flattened cuboidal morphology, proliferation and differentiation of 
osteoblast cells was observed on the AZ31-HA-LZ composite coated substrates relative 
to the uncoated AZ31 and AZ31-LZ substrates. At the later stages of osteoblast 
differentiation, the HA-LZ and HA functionalised AZ31 substrates showed a similar level 
of ALP activity. Collectively, these results indicate that such composite coatings are of 
great interest and may prevent bacterial colonisation whilst enhancing the 
cytocompatibility of AZ31 Mg alloy for orthopaedic implant applications. 
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Chapter 6  
 
The effect of high and low molecular weight hyaluronic acid 
functionalised-AZ31 Mg and Ti alloys on proliferation and 
differentiation of osteoblast cells 
 
This study evaluated osteoblast functions such as adhesion, proliferation and 
differentiation in response to high and low molecular weight HA (denoted as h-HA and 
l-HA respectively) functionalised on Ti alloy (h-HA-Ti and l-HA-Ti substrates 
respectively) and corrosion-resistant silane coated-AZ31 Mg alloys (h-HA-AZ31 and l-
HA-AZ31 respectively). The DNA quantification study showed that adhesion and 
proliferation of osteoblast cells were significantly decreased by h-HA immobilised on Ti 
alloy (Ti) or AZ31 Mg alloy substrates when compared to low molecular weight 
counterpart over a period of 14 days. Notably, h-HA significantly increased the 
osteogenic differentiation of osteoblast when compared to the l-HA, as confirmed by the 
enhanced expression of ALP, total collagen and mineralisation of the extracellular matrix. 
In particular, the h-HA-AZ31 substrates greatly enhanced the osteoblasts differentiation 
amongst tested samples (l-HA-AZ31, l-HA-Ti, h-HA-Ti and Ti alone), which is ascribed 
to the osteoinductive activity of h-HA, relatively up-regulated intracellular Ca2+ ([Ca]i) 
and Mg2+ ([Mg2+]i) concentrations as well as the alkalisation of the surrounding cell 
culture medium.  
The work described in this chapter has been published: Agarwal, S., Duffy, B., 
Curtin, J. and Jaiswal, S, Effect of high and low molecular weight hyaluronic acid 
functionalised-AZ31 Mg and Ti alloys on proliferation and differentiation of 
osteoblast cells, ACS Biomater. Sci. Eng., 2018, 4 (11), 3874–3884
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6.1 Introduction 
In chapter 4 and 5, hyaluronic acid showed enhanced osteoblasts’ adhesion, proliferation 
and differentiation. In addition, Mg2+ in the cell culture medium further enhanced the 
osteoblastic activity (as observed in chapter 3). Therefore, it is important to explore the 
effect of AZ31 Mg substrate and hyaluronic acid combination on osteoblasts adhesion, 
proliferation and differentiation.  
Generally, the most distributed form of HA in the normal tissue is high molecular weight 
HA (h-HA) (>103 kDa) [1]. During pathological conditions, including tissue repair, h- 
HA undergoes either hyaluronidase mediated degradation or oxidative hydrolysis to 
produce low molecular weight HA (l-HA) (<103 kDa) [2]. Both forms (h-HA and l-HA) 
regulate different cellular activities such as cell proliferation and differentiation at 
different stages of bone repair or remodelling [3]. During tissue injury, l-HA stimulates 
cell motility and proliferation, exhibiting pro-angiogenic and pro-inflammatory responses 
[4]. In contrast to l-HA, h-HA has been shown to improve the differentiation and enhance 
or maintain the cell-cell communication [5]. However, the exact role of the h- HA during 
tissue healing has not been assessed conclusively. Based on previous studies, h-HA is 
thought to play an important role during later stages of bone remodelling per se by 
enhancing the differentiation of osteoprogenitor cells or osteoblast lineage cells, thereby 
aiding to achieve an original biological state of the tissue [3,6,7]. Since there is a clear 
distinction in the biological activity of HA-based on molecular weight, it is important to 
quantify the effect. This would play a significant role when it is functionalised onto metal 
implants for different applications. Importantly, many reported studies functionalised HA 
on Ti alloys without considering the biological properties of HA [8,9]. This shortcoming 
may have prevented the exploitation of untapped bone forming potential of hyaluronic 
acid for orthopaedic applications. Magnesium-based alloys have been subjected to 
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various surface modifications to enhance their corrosion resistance and biocompatibility 
[10]. In addition, low levels Mg2+ released in the surrounding medium through due to 
controlled degradation of Mg-based alloys has been shown to improve the osteoblastic 
activity [11–13]. However, rapid degradation of Mg alloys leads to alkalisation of the 
surrounding medium (pH > 9) causing toxicity to the bone-related cells [14,15]. Previous 
studies employed various strategies to improve the cytocompatibility and 
osseointegration of Mg-based alloys using surface functionalisation of bio-
macromolecules such as collagen, albumin, heparin, chitosan or their composites [10,16] 
Our previous study showed that hyaluronic acid coatings on treated AZ31 substrates 
enhanced the osteoblastic activity as compared to the bare alloy [17]. This improved 
cytocompatibility is attributed to the osteoinductive property of HA and controlled 
degradation of the AZ31-Mg alloy. However, the assessment of osteoblasts’ functions 
and the mechanisms involved in response to different molecular weight HA and 
extracellular Mg2+ have not been well explored to date.  
In this study, low and high molecular weight HA (denoted as l-/h-HA) was grafted onto 
silane coated AZ31 (l-/h-HA-AZ31) and Ti (l-/h-HA-Ti). The fabrication of the coatings 
on AZ31 Mg alloy involves an initial MTES-TEOS sol-gel treatment, followed by 
APTES to deliver an amine terminated surface (as described previously [15]) which can 
be covalently coated with l-HA and h-HA via EDC-NHS coupling reactions. Our 
previous studies showed that the multi-functionality of this assembly of silane coating not 
only improves the corrosion protection of AZ31 Mg alloy but also facilitates the 
functionalisation of bioactive biomacromolecules. The effect of l-/h-HA functionalised 
Ti and AZ31 Mg alloys on osteoblast cell proliferation, differentiation and functions were 
evaluated. In addition, the cellular mechanisms by which h-HA and l-HA along with Mg2+ 
conditioned medium affecting the differentiation of osteoblasts were also studied.  
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6.2 Experimental 
6.2.1 Material 
AZ31 alloy and Ti alloy (Ti-6Al-4V) sheets were obtained from Shaanxi Taipu Rare 
Metal Materials Ltd, China and Good Fellow Ltd, USA respectively. 
Methyltriethoxysilane, tetraethoxysilane, 3-aminopropyl-triethoxy silane, high molecular 
weight Hyaluronic acid from rooster comb (1-4 MDa), low molecular weight hyaluronic 
acid from Streptococcus equi. spp.(30-50 kDa) phosphate buffer saline (PBS), Dulbecco's 
Modified Eagle's Medium/Nutrient F-12 Ham (DMEM/F-12), fetal bovine serum (FBS), 
Penicillin-streptomycin antibiotics, phosphatase substrate and bisBenzimide H 33342 
trihydrochloride, NHS (N-Hydroxysuccinimide), EDC (1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide) and MES (2-(N-Morpholino)ethanesulfonic acid) 
buffer were purchased from Sigma Aldrich.  
6.3  Surface modifications of AZ31 Mg and Ti alloy  
6.3.1 Treatment of AZ31 and Ti with NaOH 
As mentioned previously in section 3.2.2.1 
6.3.2 Preparation of the hyaluronic acid functionalised silane coating on AZ31 Mg 
and Ti alloy  
Preparation of organo-silane coating is mentioned in section 3.2.2.2. Furthermore, 1 
mg/ml of high and low molecular weight HA solutions were used to functionalise AZ31-
MT-A and Ti-MT-A substrates by a carbodiimide-mediated coupling reaction as detailed 
in the previous study [18][17,19].  The resultant high and low molecular HA 
functionalised AZ31-MT-A or Ti-MT-A substrates are denoted as h-HA-AZ31, l-HA-
AZ31, h-HA-Ti and l-HA-Ti substrates respectively. Here, we used 1 mg/ml of HA 
because of two issues: 
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a) At a higher concentration, high and low molecular weight HA become a gel-like 
solution. This also prevents the complete solubilisation of HA.  
b) Due to the high viscosity, it is difficult to prepare a reproducible and uniform 
coating of HA. 
6.4 Cytocompatibility 
6.4.1 Imaging of osteoblasts morphology by SEM 
This section is similar to that of mentioned in section 3.2.4.3 
6.4.2 DNA quantification 
The experimental section of DNA quantification is mentioned in section 3.2.4.4 
6.4.3 Alkaline phosphatase (ALP) assay  
The experiment was carried out according to the section 3.2.4.5 
6.4.4 Quantification of magnesium and calcium ions 
After 3, 7 and 14 days of cell culture under differentiation conditions, osteoblasts were 
scraped and lysed using cell lysis buffer [20]. The Mg2+ and Ca2+ in the cell lysate were 
determined using respective magnesium and calcium assays kit (Sigma Aldrich). The 
intracellular Mg2+ and Ca2+ concentrations were measured by absorbance at 450 nm and 
575 nm respectively. Standards curves were prepared as per kit instructions. The Mg2+ 
concentration in the culture medium was also determined using a magnesium assay kit 
(Sigma Aldrich). 
6.4.5 Total collagen content 
The total collagen content of all the samples was determined using a hydroxyproline assay 
kit (Sigma Aldrich). Osteoblasts cultured on different substrates for 3,7 and 14 days under 
differentiation conditions were scraped and subjected to acid hydrolysis using 12 N HCl 
for 12 hrs incubated at 100 ºC in a pressure-tight polypropylene vial with PTFE-lined cap 
[21]. Thereafter, following the instruction given in the kit, the absorbance was measured 
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at 560 nm. The total hydroxyproline content was calculated using standards provided in 
the kit (Sigma Aldrich). 
6.4.6 Assessment of osteoblasts mineralisation using SEM-EDX 
After 14 days of culturing, osteoblasts adhered samples were washed thrice with PBS and 
fixed with formalin. The cell-fixed samples were dehydrated in alcohol gradients. After 
the sputter coating with Au-Pd, the elemental content of the adhered cells on different 
substrates was determined using SEM-EDX [20].  
6.5 Statistical analysis 
All of the experiments were conducted in triplicate.  All data are expressed as mean ± 
S.D. The differences between the groups were analysed using one-way analysis of 
variance (ANOVA) followed by post hoc Tukey test.  
6.6 Results  
6.6.1 Characterisation of modified AZ31 and Ti substrates 
The functionalisation of l-HA and h-HA on AZ31 and Ti substrates was confirmed using 
AFM, static water contact angle and HA quantification as shown in Table 13. The surface 
roughness (Ra) of uncoated AZ31 and Ti substrates were found to be 47.43 ± 4.11 nm 
and 14.5 ± 2.11 nm respectively. The l-HA functionalised on AZ31 and Ti substrates 
showed slightly reduced surface roughness as compared to h-HA functionalised AZ31/Ti 
substrates. 
Table 13 Summary of characterisation parameters for different substrates  
Substrates Roughness  
(nm) 
Contact angle 
 (degrees) 
HA  
(µg/cm
2
) 
AZ31 47.43 ± 4.11 59.67 ± 6.99 …. 
h-HA-AZ31 11.29 ± 0.21 44.22 ± 3.58 47.62 ± 1.05 
l-HA-AZ31 7.67 ± 0.17 36.06 ±2.03 41.58 ± 2.05 
h-HA-Ti 8.66 ± 0.58 40.54 ± 3.03 48.51± 0.02 
l-HA-Ti 7.08 ± 0.71 26.62 ± 4.46 40.6 ± 1.49 
Ti 14.5 ± 2.11 45.31 ± 5.92 …. 
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The AFM images of these substrates are given in Figure 6-1. Overall, the roughness of 
substrates reduced for HA-functionalised AZ31/Ti substrates when compared to 
respective uncoated substrates. 
The static water contact angle was determined to confirm the wettability of the uncoated 
and coated substrates as shown in Table 13. The l-HA coated AZ31 (36.06˚ ±2.03 ˚) and 
Ti (26.62˚ ± 4.46 ˚) substrates showed relatively higher hydrophilic surface as compared 
to h-HA functionalised AZ31 (44.22˚ ± 3.58˚) and Ti (40.54˚ ± 3.03˚) substrates. The 
HA-coated substrates showed a considerable increase in the wettability of surface when 
compared to the uncoated AZ31 (59.67˚ ± 6.99˚) and Ti (45.31˚ ± 5.92˚) substrates. 
Furthermore, the concentration of HA immobilised on the surface was quantified as given 
in Table 14. The concentration of h-HA immobilised on AZ31 and Ti substrate were 
found to be similar and found to be ~48 µg/cm2, whereas l-HA showed the lower 
concentration of ~41 µg/cm2.  
 
Figure 6-1 AFM images for uncoated and coated AZ31-Mg and Ti alloys substrates. 
h-HA-AZ31 l-HA-AZ31
h-HA-Ti l-HA-Ti
AZ31
Ti
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6.6.2 Osteoblast cells Adhesion  
Representative SEM images of osteoblasts adhered to AZ31-Mg and Ti alloys treated 
with or without l-HA and h-HA are shown in Fig 6-2 (I). After 24 h of incubation, 
osteoblasts are sparse and showed circular morphology on the uncoated AZ31 Mg alloy 
(Fig 6-2 I(a)), demonstrating poor adhesion to the substrate. The h-AZ31-HA (Fig 6-2 
I(b)) and l-AZ31-HA (Fig 6-2 I(c)) surfaces showed flattened, cuboidal shaped and 
extended morphology of adhered osteoblast cells with greater cell-to-cell interaction. On 
the other hand, h-HA-Ti (Fig 6-2 I(d)) and l-HA-Ti (Fig 6-2 I(e)) surface showed 
triangular or irregular shaped morphology of attached osteoblast cells. The Ti alloy 
substrate control showed a greater number of adhered osteoblasts with spindle-shaped 
morphologies. Fig 6-2 (II) shows the quantification of total DNA content on these 
substrates which is considered a measure of osteoblasts adhered to the surface. The DNA 
content of osteoblasts on the AZ31 Mg alloy was found to be significantly lower when 
compared to all substrates. Poor adherence of osteoblasts to the HA-coated AZ31 surfaces 
was observed when compared to HA-coated Ti or Ti alone substrates. Interestingly, l-
HA-coated Ti substrate showed significantly improved cell adhesion over h-HA-Ti, h-
HA-AZ31 and l-HA-AZ31 substrates.  
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Figure 6-2 (I) SEM and (II) total DNA content of osteoblast cells cultured on 
different substrates for 24 h: (a) AZ31, (b) h-HA-AZ31, (c) l-HA-AZ31, (d) h-HA-
Ti, (e) l-HA-Ti and (f) Ti. The scale of SEM images is 100 µm. Statistical analysis: 
Values are expressed as mean ± SD. One-way ANOVA with posthoc Tukey test with 
significance level of **P < 0.01 versus AZ31 control; #P < 0.05 indicates the 
comparison of l-/h-HA-AZ31 with the l/h-HA-Ti group; ∆P < 0.05 and ∆∆P < 0.01 
indicate the comparison of Ti with the l-/h-HA-Ti group. 
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6.6.3 Osteoblast cell proliferation 
Fig 6-3 shows the quantification of total DNA content of osteoblasts cultured on different 
substrates over a period of 14 days. The quantification of total DNA content was 
considered as a measure of cell proliferation. Since bare AZ31 substrate showed high 
cytotoxicity with very few live cells as observed from Fig 6-2, it was considered futile to 
use this as a control for further studies. From Fig 6-3, it can be noted that osteoblast 
proliferation on l-HA-AZ31 and l-HA-Ti were found to be significantly higher as 
compared to the h-HA-AZ31 and h-HA-Ti respectively over 14 days of cell culture. These 
results agree with SEM images and cell adhesion studies, indicating that l- HA promotes 
osteoblast cell proliferation over h-HA. Amongst all substrates, bare Ti alloy showed 
significantly enhanced osteoblast cell proliferation.  
 
Figure 6-3 Total DNA content was determined following osteoblast cultured on l-
HA-AZ31, h-HA-AZ31, l-HA-Ti, h-HA-Ti and Ti substrates for 3, 7 and 14 days. 
Statistical analysis: Values are expressed as mean ± SD. One-way ANOVA with 
posthoc Tukey test with significance level of *P < 0.05, **P < 0.01 indicating the 
comparison  between l-/h-HA-AZ31 and  l-/h-HA-Ti substrates ; ##P < 0.01 indicates 
comparison between samples (l-/h-HA-AZ31 and  l-/h-HA-Ti substrates versus Ti); 
∆P < 0.05 and ∆∆ P < 0.01 indicate the pairwise comparison of samples.   
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6.6.4 Osteogenic differentiation of osteoblasts 
Differentiation markers of osteoblasts cultured on HA coated substrates under osteogenic 
condition were screened as shown in Fig 6-4. The ALP activity of osteoblasts cultured on 
l-/h-HA-AZ31/Ti coated substrates determined for 14 days presented in Fig 6-4(a). 
Osteoblasts cultured on l-HA-AZ31 and l-HA-Ti showed significantly low ALP activity 
as compared to h-HA-AZ31 and h-HA-Ti respectively, over a period of 14 days. Overall, 
osteoblasts cultured on HA functionalised AZ31 Mg surface exhibited reduced 
intracellular ALP levels as compared to the HA-Ti substrates.  
 
 
Figure 6-4 Evaluation of osteogenic differentiation of osteoblasts cultured on l-HA-
AZ31, h-HA-AZ31, l-HA-Ti, h-HA-Ti and Ti substrates for 3, 7 and 14 days using 
(a) Intracellular ALP activity and (b) Hydroxyproline content. Statistical analysis: 
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Values are expressed as mean ± SD. One-way ANOVA with posthoc Tukey test with 
significance level of *P < 0.05, **P < 0.01 indicating the comparison  between  l-/h-
HA-AZ31 and  l-/h-HA-Ti substrates ; #P <0.05,  ##P < 0.01 indicate comparison 
between samples (l-/h-HA-AZ31 and  l-/h-HA-Ti substrates versus Ti); ∆P < 0.05 
and ∆∆ P < 0.01 indicate the pairwise comparison of samples.  
Furthermore, ALP activity was normalised to total DNA content of respective samples 
(Fig 6-4(a)). This result shows that h-HA coated AZ31/Ti substrates significantly 
enhanced the ALP activity of osteoblasts when compared to the l-HA coated AZ31/Ti 
substrates, whereas the Ti substrate showed lowest ALP activity during 14 days of the 
culture period. The order of ALP expression showed by the coated substrates is h-HA-
AZ31 > l-HA-AZ31 > h-HA-Ti > l-HA-Ti ≥ Ti. These results indicate that the magnesium 
alloy substrate and h-HA synergistically induce the intracellular ALP activity of 
osteoblast cells.  
Furthermore, the expression of total collagen by osteoblasts in response to l-/h-HA coated 
on AZ31/Ti substrates was evaluated using a hydroxyproline assay. The total collagen 
content was normalised to DNA content as shown in Fig 6-4(b). The h-HA-AZ31 surface 
(P<0.01) significantly stimulated the collagen synthesis when compared to l-HA-AZ31, 
h-HA-Ti, l-HA-Ti and Ti equivalents throughout the culture period. Furthermore, h-HA-
Ti also showed a significant increase in total collagen content as compared to l-HA-Ti 
and bare Ti substrates. The expression level of collagen was found to be in the order of 
h-HA-AZ31 > l-HA-AZ31 > h-HA-Ti > l-HA-Ti >Ti. These results are in agreement with 
the intracellular ALP enzyme activity, thereby indicating that h-HA and AZ31 Mg alloy 
induced an enhanced differentiation as compared to the l-/h-HA-coated Ti alloy.  
Fig 6-5 shows the representative SEM images of mineralisation of osteoblasts cultured 
under the osteogenic condition for 14 days.  
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Figure 6-5 Representative SEM images of osteoblasts cultured on (a) l-HA-AZ31, 
(b) h-HA-AZ31, (c) l-HA-Ti, (d) h-HA-Ti and (e) Ti substrates for 14 days in 
osteogenic CCM. The scale of SEM images is 50 µm. Red arrows are indicating Ca-
P deposits. 
Compared with l/h-HA-Ti (Fig 6-5(c) and d)), deposits of calcium (Ca) and phosphate 
(P) mineral nodules can be observed around the osteoblasts cultured on l-/h-HA-AZ31 
surfaces. On the other hand, uniformly distributed Ca-P mineral particles observed on and 
around the osteoblasts adhered to l-/h-HA-Ti and Ti only substrates. Furthermore, 
elemental analysis of osteoblasts cultured on different substrates for 14 days is presented 
in Table 14. From Table 14, Ca and P contents (% At. wt.) detected on l-HA-Ti and h-
HA-Ti were found to be higher than l-HA-AZ31 and h-HA-AZ31 respectively. Notably, 
AZ31-HA, Ti-HA and Ti without cells also showed Ca and P deposition. Since minor 
differences in element deposition on l-HA-AZ31/Ti and h-HA-AZ31/Ti controls were 
observed, an average of their elemental analysis is represented as AZ31-HA (w/o cells) 
and Ti-HA (w/o cells) samples. This indicated a very high content of non-specific Ca and 
P deposits on Ti (w/o cells) and Ti-HA (w/o cells) substrates which makes up ~ 83% of 
(a) (b) (c)
(e)(d)
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Ca and ~76-80% of P deposition of the corresponding substrates (l-HA-Ti, h-HA-Ti and 
Ti) with osteoblasts. 
Table 14 Elemental contents detected by EDX of osteoblasts cultured on different 
substrates for 14 days. Statistical analysis: Values are expressed as mean ± SD. 
 
On the other hand, a considerable low non-specific minerals deposition was observed for 
AZ31-HA (w/o cells) samples, with deposits of ~2-4% of Ca and ~7%-15% of P on the 
l-HA-AZ31 and h-HA-AZ31 substrates respectively. Therefore, osteoblasts cultured on 
l/h-HA-AZ31 substrates showed a greater degree of mineralisation, when compared to 
l/h-HA-Ti equivalent as shown in Table 14.  
Furthermore, Mg-based alloys degrade rapidly under physiological conditions, thereby 
creating an alkaline environment which interferes with the cell physiology [20]. The 
degradation of HA-coated AZ31 Mg alloy (with and without osteoblasts) and change in 
pH of the medium during a culture period of 14 days are exhibited in Fig 6-6. Hereafter, 
the substrates with cells are denoted as l-HA-AZ31, h-HA-AZ31, l-HA-Ti, h-HA-Ti and 
Ti. 
Elements l-HA-AZ31  h-HA-AZ31  l-HA-Ti  h-HA-Ti  Ti alone  Ti-HA-w/o cells  AZ31-HA-w/o cells Ti-w/o cells  
C K  14.02 ± 0.86  8.61 ± 0.88  5.71 ± 0.19  5.56 ± 0.36  13.88 ± 1.60  8.98 ± 1.59  14.08 ± 0.2  16.13 ± 0.72  
Mg K  1.51 ± 0.11  2.86 ± 0.35  0.57 ± 0.05  0.53 ± 0.03  0.26 ± 0.07  0.37 ± 0.07  0.47 ± 0.16  0.64 ± 0.127  
Si K  9.62 ± 3.34  6.84 ± 4.04  -0.07 ± 0.015  -0.1 ± 0.2  0.30 ±0.57  0.47 ± 0.65  43.67 ± 0.25  1.295 ±  0.176  
P K  5.97 ± 1.02  11.66 ± 1.83  16.38 ± 0.13  18.32 ± 0.24  9.53 ± 4.91  13.10 ± 2.3    0.9 ± 0.07  6.92 ± 1.18  
Ca K  8.46 ± 1.31  15.96 ± 1.45  29.11 ± 0.8  30.68 ± 1.25  15.77 ± 2.81  25.33 ±1.18  0.36 ± 0.014  12.725 ± 0.53  
O  60.41 ± 0.25  54.06 ± 1.69  50.29 ± 0.41  45.99 ± 0.7  60.85 ± 0.55  51.74 ± 1.39  40.52 ± 1.5  62.29 ± 1.42  
Elements 
Change with respect to controls (Ti-HA-w/o cells, AZ31-HA-w/o cells and Ti-w/o cells  ) 
l-HA-AZ31  h-HA-AZ31  l-HA-Ti  h-HA-Ti  Ti  
P K  5.07  12.56  3.28  5.22  2.61  
Ca K  8.1 15.6  3.78  5.35  3.02  
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Figure 6-6 (a) Mg2+  release and (b) pH change of CCM containing l-HA-AZ31, h-
HA-AZ31, l-HA-Ti, h-HA-Ti and Ti substrates for 3, 7 and 14 days. Statistical 
analysis: Values are expressed as mean ± SD. One-way ANOVA with posthoc Tukey 
test with significance level of *P < 0.05, **P < 0.01 indicate the comparison of l-/h-
HA-AZ31 substrates versus l-/h-HA-Ti, Ti and culture medium ; #P < 0.05 
comparison of different samples versus culture medium; ∆P < 0.05 and ∆∆ P < 0.01 
indicate comparison of  different samples versus AZ31-HA-w/o cells. 
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The concentration of Mg2+ released from the AZ31-HA substrate (w/o cells) was found 
to be significantly higher than l-HA-AZ31, h-HA-AZ31 and cell culture medium (CCM) 
samples over a period of 14 days, as shown in Fig 6-6(a). Moreover, the release of Mg2+ 
from l/h-HA-AZ31 and AZ31-HA (w/o cells) decreased steadily with the culture period. 
The concentration of Mg2+ in CCM containing l/h-HA-Ti and Ti substrates is lower than 
the CCM control, indicating that osteoblasts are using Mg2+ present in the culture medium 
for the normal physiological process. Furthermore, change in the pH of CCM affects the 
osteoblasts functions. Fig 6-6 (b) shows the bulk change in pH of the CCM containing 
different substrates (with and without osteoblast cells) over a period of 14 days. The pH 
of the CCM for the Ti-based substrates remains constant around 7.4. On the other hand, 
the AZ31-based substrates showed alkaline behaviour which decreased gradually over 14 
days of the culture period. It can be seen that l/h-HA-AZ31 (w/o cells) showed relatively 
higher alkaline pH (~8.1) when compared to l-HA-AZ31 (with cells, pH~7.7) and h-HA-
AZ31 substrates (with cells, pH ~7.8) after 14 days of incubation. These results indicated 
that osteoblasts monolayer functions as a corrosion inhibitor of AZ31 Mg alloy and/or 
using Mg2+ for cellular growth and development.  
Previous studies showed that extracellular Mg2+ (here, Mg2+ concentration in CCM is 
denoted as [Mg2+]e) affects the cell behaviour by regulating intracellular Mg
2+ and Ca2+ 
concentrations (denoted as [Mg2+]i and [Ca
2+]i respectively). To understand the effect of 
molecular weight of HA and [Mg2+]e, the [Mg
2+]i and [Ca
2+]i of osteoblasts cultured on l-
/h-HA-AZ31, l-/h-HA-Ti and Ti substrates for 3, 7 and 14 days were examined, as shown 
in Fig 6-7. Firstly, it can be seen that at each time point, l-/h-HA-AZ31 showed a 
significantly higher [Mg2+]i as compared to l-/h-HA-Ti and Ti substrates.  
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Figure 6-7 (a) [Mg2+ ]i and (b) [Ca2+ ]i of osteoblasts cultured on l-HA-AZ31, h-HA-
AZ31, l-HA-Ti, h-HA-Ti and Ti substrates for 3, 7 and 14 days. Statistical analysis: 
Values are expressed as mean ± SD. One-way ANOVA with posthoc Tukey test with 
significance level of *P < 0.05, **P < 0.01 indicate the comparison  between  l-/h-HA-
AZ31 and  l-/h-HA-Ti substrates; #P < 0.05, ##P <0.01 indicate comparison of 
different samples (l-/h-HA-AZ31 and  l-/h-HA-Ti substrates vs Ti); ∆P < 0.05 and 
∆∆ P < 0.01 indicate the pairwise comparison of samples. 
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Secondly, l-/h-HA showed a higher level of [Ca2+]i  as compared to l-/h-HA-Ti and Ti 
substrate (Fig 6-7(b)), which is inversely proportional to [Mg2+]i of l-/h-HA-AZ31 
substrates (Fig 6-7(a)) over 14 days of the culture period. Notably, without much change 
in [Mg2+]i , h-HA-Ti showed a significant increase in [Ca
2+]i  when compared to the l-HA-
Ti, whereas Ti alone showed the least increase in [Ca2+]i . These results indicated that 
[Mg2+]e acts as a pro-osteogenic agent irrespective of the type of HA employed on the 
surface, whereas h-HA enhanced the pro-osteogenic differentiation as compared to l-HA 
(Fig 6-7(b)). 
6.7 Discussion 
The biological acceptance of the orthopaedic implants in terms of osteoblasts’ functions 
plays a vital role in the expediting bone tissue healing surrounding the implants (Ti and 
Mg-based implants). In order to improve the cytocompatibility of the implants, various 
biopolymers including HA have been functionalised onto metal implant surfaces 
[16,21,22]. HA is present in various body tissues including synovial fluid, the vitreous 
body of eye, brain and cartilage [23]. It also plays an important role in regulating various 
biological processes including osteoblasts’ cell adhesion, proliferation and differentiation 
[1]. In previous studies, hyaluronic acid was functionalised with Ti surfaces, to improve 
osteoblastic activity [8, 18, 21]. However, these were fundamental studies and molecular 
weight of HA was not considered while employing it as an osteoinductive agent. 
Furthermore, deposit coatings improve the corrosion resistance and cytocompatibility of 
the biodegradable Mg-based alloys which are widely used for orthopaedic applications 
[10]. In this work, we used previously reported corrosion resistant sol-gel coating to 
develop l-/h-HA functionalised AZ31 and Ti substrates [4, 14,15]. According to previous 
reports, Mg2+ supplements induce the proliferation and differentiation of osteoblast cells 
[11,24,25].  
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6.7.1 Effect of molecular weight of hyaluronic acid-functionalised-AZ31 and-Ti 
substrates on osteoblast cell adhesion and proliferation. 
In addition, reports also demonstrated that h-HA stimulate the differentiation as compared 
to l-HA [3,7]. However, these studies didn’t consider the properties of HA to be used for 
the functionalisation of Ti [8,18,21]. This is the first report evaluating the osteoblast 
cellular response to (a) l/h-HA functionalised on Ti and corrosion resistant AZ31 
substrate and (b) Mg2+ stimulated CCM of h/l-HA-AZ31 substrates (produced due to the 
corrosion of AZ31 Mg alloy). Characterisation of l-/h-HA coated AZ31-Mg and Ti alloys 
using AFM, contact angle measurements and quantification of hyaluronic acid confirmed 
the HA-functionalisation on the silane coated AZ31 and Ti substrates.   
Furthermore, we found that osteoblasts’ adhesion decreases on h-HA coated AZ31 and 
Ti alloy as compared to l-HA coated substrates, whereas osteoblasts showed enhanced 
cell adhesion on bare Ti surface amongst all other substrates. Previous reports showed 
that the resistance to cell adhesion on h-HA surfaces over l-HA is probably due to the 
greater repulsion effect of the negatively charged proteoglycan of the cell with the h-HA 
[21]. Previous reports also showed that the wettability of the surface affects the adhesion 
of the osteoblast cells [26]. Therefore, improved osteoblasts cell adhesion on l-HA over 
h-HA coated substrate may be also attributed to the relatively greater hydrophilicity of 
the former substrate. The cell shape of osteoblasts was found to be flattened, extended 
and interconnected on HA coated substrates. However, osteoblasts adhered to bare AZ31 
Mg alloy were circularly shaped and sparsely viable, which is likely due to its rapid 
degradation in HEPES DMEM [14,15,17]. Furthermore, cell adhesion and proliferation 
of osteoblasts on different substrates were determined in terms of increase in DNA 
concentration during the culture period. It was seen that cell adhesion density decreased 
on l-/h-HA coated AZ31 substrates as compared to the l/h-HA coated or uncoated Ti 
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substrates. A similar trend was observed in the proliferation of osteoblasts monitored over 
a period of 14 days. The cell proliferation on l-HA-AZ31/Ti was significantly increased 
when compared to h-HA-AZ31/Ti substrates. Kim et al. showed that in comparison to 
high molecular weight HA (i.e 200 kDa), low molecular (50 kDa) counterparts may 
provide favourable conditions for osteoblast proliferation [27]. Likewise, Zhao et al. also 
demonstrated the higher osteo-proliferative activity on low molecular weight HA (≤ 110 
kDa) as compared to high molecular weight HA (≤ 2500 kDa) [3]. The findings of the 
present study are in agreement with those of the previous studies and suggest that 
osteoblasts can actively proliferate on low molecular weight HA functionalised AZ31 and 
Ti substrates. However, the proliferation of osteoblasts on l-/h-HA-AZ31 was decreased 
significantly when compared to l-/h-HA-Ti equivalents. This could be attributed to the 
biodegradable nature of the AZ31 substrate producing corrosion by-products (evolution 
of H2 gas and pH change), thereby affecting cell viability and adhesion. In addition, 
functionalisation of hyaluronic acid on biodegradable Mg alloy is not just to support the 
growth of the bone-related cells but also the degradable nature of Mg and its alloy is 
beneficial for orthopaedic implant applications.   
6.7.2 Effect of molecular weight of hyaluronic acid-functionalised-AZ31 and-Ti 
substrates on the osteogenic differentiation of osteoblast cells. 
The effect of HA molecular weight functionalised on Ti and AZ31 substrates on the 
osteogenic differentiation of osteoblast cells was evaluated by ALP activity, expression 
of collagen and formation of mineral nodules.  Contrary to the trend of osteoblasts 
proliferation, h-HA-AZ31 and l-HA-AZ31 showed enhanced differentiation efficiency 
over l-HA-Ti and h-HA-Ti substrates respectively, whereas the Ti substrate showed the 
least ALP activity. The results indicated that there are two factors stimulating the 
intracellular ALP activity, namely (a) functionalisation of the substrate with h-HA and 
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(b) higher concentration of [Mg2+]e in CCM of AZ31 substrates (Fig 6-8). Osteoblasts 
express the ALP enzyme in the early stages of osteogenic differentiation, which 
participates in the mineralisation of the extracellular matrix (ECM) [28]. Previous studies 
showed that h-HA enhanced the differentiation of osteoblasts by upregulating the ALP 
activity as compared to the l-HA [3]. In addition, it has been reported that [Mg2+]e (5mM- 
10mM) in CCM stimulate the intracellular ALP activity [12].  
 
Figure 6-8 Effect of l-HA, h-HA and [Mg2+]e on the differentiation markers of 
osteoblast cells. In comparison to l-HA, h-HA enhanced [Ca2+]i and other 
differentiation markers. Presence of [Mg2+]e(AZ31) augmented the [Ca2+]i and 
differentiation of osteoblasts.  
Furthermore, the synthesis of collagen during osteogenic differentiation of osteoblasts on 
different substrates was evaluated by hydroxyproline assay. Collagen is the most 
abundant extracellular matrix synthesised by osteoblast cells and essential for ECM 
mineralisation [29]. Generally, the synthesis of collagen increases throughout the culture 
period and is a strong indicator of osteoblasts differentiation. Osteoblasts cultured on h-
HA-AZ31 and l-HA-AZ31 showed significantly higher collagen synthesis as compared 
to the h-HA-Ti and l-HA-Ti substrates respectively, whereas uncoated Ti substrate 
showed the lowest hydroxyproline content amongst other substrates.  Previously Zhao 
and Lai et al. reported that in comparison to l-HA, cells in response to h-HA induced a 
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greater expression of collagen [3, 21]. In addition, the Mg2+ ions conditioned CCM has 
also been reported to enhance the collagen synthesis [12, 20]. The presented results are 
in agreement with the previous studies, which indicated that h-HA and extracellular Mg2+ 
synergistically enhanced the differentiation of osteoblasts. In an ordered sequence of 
events observed during osteoblast differentiation, the increased ALP activity in the early 
stage is followed by the increased synthesis of collagen, which participates in the 
mineralisation of ECM [20]. The effect of the molecular weight of hyaluronic acid 
functionalised AZ31 and Ti substrates on the mineralisation of ECM after 14 days of cell 
culture was evaluated by SEM-EDX analysis. It was observed that the deposition of Ca 
and P minerals were higher on l/h-HA-AZ31 substrates as compared to l/h-HA-Ti 
substrate (Fig 6-8). The enhanced matrix mineralisation activity of h-HA in presence of 
extracellular Mg2+ (h-HA-AZ31 substrate) was accompanied by greater expression of 
intracellular ALP and collagen during various stages of the differentiation process (Fig 
6-8). These results support the enhanced differentiation of osteoblast cells cultured on the 
h-HA-AZ31 substrate.  
Furthermore, various studies have been conducted to evaluate the effect of l/-h-HA 
concentration on osteoblasts differentiation [3,4,7]. In this study, the grafting amount of 
l-HA functionalised on AZ31 and Ti substrate is less than the h-HA counterpart. Since 
we have used an enzymatic method to quantify HA, it is expected to get a relatively higher 
grafted amount of high molecular weight HA due to long chain length when compared to 
the low molecular weight HA surface. According to previously reported literature, a given 
level of osteoblast differentiation induced by h-HA observed at a significantly lower 
concentration as compared to l-HA [3,4,7]. Interestingly these studies also demonstrated 
that improved osteoblast functions induced by h-HA over l-HA have been maintained; 
even if the concentration for l-HA is at a higher level to that of h-HA. Thus, an improved 
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osteoblast function in response to h-HA functionalised on AZ31 and Ti surface as 
compared to l-HA counterparts can be attributed to the effect of molecular weight instead 
of grafting levels of l-/h-HA. The abovementioned differentiation results indicate that 
irrespective of the AZ31 or Ti metal substrate studied, h-HA significantly enhanced the 
differentiation of osteoblasts over l-HA. It is well known that hyaluronic acid interacts 
with receptors expressed by bone-related cells, such as CD44 (cell membrane-tethered 
glycoprotein) and RHAMM (receptor for HA-mediated motility), which are expressed by 
osteoblast lineage cells [30]. Hyaluronic acid is a principal ligand for the CD44 receptor 
[31]. Previous studies reported that h-HA can enhance the differentiation markers of the 
osteoblast cells through the stimulation of CD44 [4]. Similarly, Chen et al, demonstrated 
the reduced mineralisation of CD44 knocked out dental pulp cells in response to h-HA, 
thereby emphasising the role of the CD44 receptor in the differentiation of osteoblasts 
[31].  Another study reported that several CD44 receptor binding sites are proportional to 
the molecular weight of hyaluronic acid, thereby increasing CD44 receptor density, and 
more differentiation can be achieved. RHAMM is another prominent receptor which 
could make up the loss of CD44 [4]. Therefore, the enhanced differentiation activity of 
h-HA functionalised surface as compared to low molecular weight counterpart can be 
attributed the CD44-related cell signalling. The results also show that osteoblasts cultured 
on l/h-HA AZ31 substrates further enhanced the HA-induced differentiation. Generally, 
Mg-based alloys in the chloride-rich aqueous environment can rapidly degrade to release 
Mg2+ ions, thereby increasing the solution alkalinity and inducing toxicity in the 
surrounding cell/tissues [10]. Therefore, it is important to control the degradation of Mg 
alloys under physiological conditions for potential biodegradable orthopaedic implants.  
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6.7.2.1 Role of the molecular weight of hyaluronic acid and extracellular Mg2+ on 
intracellular Ca2+ and Mg2+ in the osteogenic differentiation of osteoblast cells 
Many reports demonstrated enhanced differentiation of osteoblasts cultured in Mg2+ ions 
conditioned CCM with alkaline pH (7.6-8.5) [20,32]. In this study, we determined the pH 
and Mg2+ released in DMEM from l/h-HA coated-AZ31 and l-/h-HA coated-Ti substrates 
seeded with and without osteoblasts for 3, 7 and 14 days. It was observed that [Mg2+]e  for 
all of the AZ3-based substrates decreased steadily at each of the time points, however, 
the concentration was still higher than CCM of Ti-based substrates and CCM alone. The 
decreasing release rate of Mg2+ ions with the incubation time can be attributed to Mg 
alloy forming a protective surface passivation layer [33]. Interestingly, the immersion 
medium of l/h-HA-AZ31 seeded with osteoblasts showed a significant decrease in 
[Mg2+]e  when compared to AZ31-HA substrate without cells at each time point. 
Similarly, the pH decreased significantly for l/h-HA-AZ31 substrates with osteoblasts as 
compared AZ31-HA substrate without osteoblasts. These results indicate that the 
corrosion of l/h-HA-AZ31 with osteoblasts reduced significantly as compared to the 
counterpart without cells. There are few explanations for such enhanced corrosion 
protection of l/h-HA-AZ31 (with osteoblasts). Firstly, mono-layer of osteoblast cells can 
act as a corrosion protection layer by depositing Ca-P minerals on the surface through the 
process of ECM mineralisation and/or formation of passivation layer due to the 
degradation of the AZ31-Mg alloy as observed from EDX elemental analysis [15,34,35]. 
Secondly, osteoblasts use Mg2+ for various metabolic activities. Previous studies 
demonstrated the influence of living cells in preventing the degradation of Mg alloy 
through the enhanced metabolic activity of cells (reducing the pH of the medium) and 
deposition of corrosion products on the surface [34,35]. These previous studies conducted 
experiments in non-osteogenic medium condition, whereas the present study showed the 
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influence of ECM mineralisation on the corrosion protection of AZ31 Mg alloy in the 
differentiation CCM. It has been suggested that moderate [Mg2+]e  can be tolerated by 
bone-related cells and give rise to the higher expression of differentiation markers 
[12,24]. However, excessive release of Mg2+ ions resulting from rapid degradation of Mg 
alloy is a concern and can cause cell damage jeopardising the bone healing process [36–
38]. Regarding pH values, it has been reported that differentiation of osteoblasts 
significantly enhances with the pH increase up to 8.5 [20,32]. Previous work described 
that the excessive corrosion of AZ31 Mg alloy lead to the alkalisation of CCM and can 
cause the pH to increase above 9.0, which is detrimental to cell adhesion, proliferation 
and differentiation [36–38]. The results presented in this study showed the controlled 
degradation of Mg alloy, which provided favourable conditions such as appropriate pH 
(< 8.5) and optimum [Mg2+]e  for enhanced osteoblast differentiation when compared to 
the Ti-based samples.  
In order to understand the effect of l-/h-HA and/or [Mg2+]e  on the mineralisation of 
osteoblasts, we determined the [Mg2+]i  and [Ca
2+]i  of osteoblasts at different time periods. 
The results showed that h-HA significantly stimulate [Ca2+]i as compared to l-HA samples 
during 14 days of cell culture (Fig 6-8). Previous studies reported that increased CD44 
receptor density on h-HA illicit greater mineralisation of osteoblasts [3,4]. 
Boonrungsiman et al, explained not only the genesis and role of intracellular Ca2+ in 
propagating the nucleation of mineralised nodules within the ECM but also identified 
higher [Ca2+]i during osteogenic differentiation of osteoblast cells [39]. Therefore, in 
comparison to l-HA coated surfaces, enhanced differentiation of osteoblasts in response 
to h-HA can be attributed to increased CD44 receptor density on h-HA-coated Ti/AZ31 
substrates. The influence of [Mg2+]e  on osteogenic differentiation of osteoblast by 
regulating [Mg2+]i,  and [Ca
2+]i  has been explained by previous studies [11,20,23]. 
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However, reports showed different [Mg2+]e improving the differentiation of osteoblast 
ranging from <1 to 10mM [11,12]. In this study, we found that decreasing [Mg2+]e  (~12 
mM (day 3) to 5mM (day 14) ) throughout the culture period also match this trend for 
[Mg2+]i, but reveal contrary  for [Ca
2+]i.  This indicates that (a) [Ca
2+]i is regulated by 
[Mg2+]e and (b) lower [Mg
2+]i stimulates the [Ca
2+]i. This also showed that at an optimum 
concentration of [Mg2+]e ions enhanced the differentiation of osteoblasts as observed in 
the case of AZ31 substrates (Figure 6-5 and 6-7). Our findings are in agreement with the 
previous studies which reported the [Mg2+]e dependent increase of [Mg
2+]i and [Ca
2+]i. 
[11,20,23]. Deficient [Mg
2+]i  was reported to reduce the osteoblastic activity and impair 
bone remodelling [13]. However, an overdose of [Mg2+]i is detrimental to the viability of 
cells and retarding the ECM mineralisation of bone-related cells [11,40]. Therefore, 
enhanced mineralisation showed by the h-HA-AZ31 substrate can be attributed to the 
Mg2+ released from the AZ31 substrate and positive effects of h-HA.  
In chapter 3, the enhanced proliferation of osteoblasts on PLGA-silane coating was 
considered as the likely reason of higher intracellular levels because PLGA does not have 
an intrinsic property to stimulate the cell differentiation as compared to other bioactive 
polymers including hyaluronic acid. On the other hand, we have shown the comparison 
of the differentiation and proliferation activities of h-HA and l-HA functionalised-AZ31 
and Ti substrates. In comparison to l-HA, h-HA enhanced the differentiation of osteoblast 
cells and vice-versa for proliferative activities. As discussed in the introduction section, 
based on the molecular weight, HA has unique functionalities and role during the bone 
regeneration process. Moreover, l-HA and h-HA also have a varying effect on the 
osteoblasts’ response in terms of [Ca2+]i and [Mg2+]i  regulating the osteogenic 
differentiation of osteoblast cells as explained in the discussion. These are the few reasons 
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which explain the deviation in the osteoblasts’ response on l-/h-HA coated AZ31/Ti 
substrates to that of PLGA-silane coated AZ31 substrates.  
6.8 Conclusion 
This study illustrated the proliferation and differentiation of osteoblast cells in response 
to the hyaluronic acid of different molecular weight immobilised on silane coated AZ31 
Mg and Ti alloy substrates. The proliferation of osteoblasts on l-HA coated AZ31/Ti 
substrates significantly enhanced when compared to the h-HA counterpart. However, the 
overall proliferation of osteoblasts was significantly low on HA-coated (low and high 
molecular weight HA) AZ31 Mg substrates when compared to HA-coated Ti substrates, 
which is attributed to the corrosion of AZ31 Mg alloy in the culture medium. On the 
contrary, osteogenic differentiation was enhanced in response to h-HA over l-HA 
modified AZ31 and Ti substrates. The steady decrease of extracellular Mg2+ over 14 days 
regulated the concomitant increase in [Ca2+]i with the corresponding decrease in [Mg
2+]i, 
however, the latter showed a significant increase for HA-coated AZ31 substrates (h-HA-
AZ31 and l-HA-AZ31) when compared to the Ti-based substrates (h-HA-Ti, l-HA-Ti and 
uncoated Ti). Particularly, h-HA coated AZ31 substrates (h-HA-AZ31) greatly enhanced 
the osteoblasts differentiation and mineralisation of ECM, which can be ascribed to the 
osteoinductive activity of h-HA, alkaline cell culture medium as well as upregulated 
[Ca2+]i. These findings are critical to understanding the role of hyaluronic acid molecular 
weight functionalised on different metal substrates affecting bone healing.     
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Chapter 7  
 
Summary, general conclusions and future work 
7.1 Summary of the PhD work 
Previous studies showed that Mg-based alloys have been widely explored for several 
advantages over non-degradable metal implants such as (a) their biodegradable nature (b) 
mechanical properties closer to that of bone and (c) osteopromotive activity. However, 
Mg-based alloys rapid degrade in chloride-rich physiological conditions, especially 
during early implantation period (2-3 weeks). Corrosion results in the formation of H2 
gas and alkalinity of the surrounding medium which together promote toxicity towards 
the surrounding tissue. In this PhD work, we designed bio-functionalised (PLGA and 
hyaluronic acid) corrosion-resistant sol-gel coatings on AZ31-Mg alloy to optimally 
control the degradation during early immersion period which could improve the 
osteoblasts’ functions, instead of becoming detrimental to the cell growth.  Furthermore, 
previous studies demonstrated the susceptibility of Mg-based biodegradable alloy to 
bacterial colonisation in vivo. On the contrary, many studies reported that corrosion of 
Mg alloy causes an increase in the pH of the medium, thereby inhibiting the bacterial 
growth. However, this increase in the pH can affect the viability of the osteoblast cells. 
Therefore, this problem is addressed by functionalising the corrosion resistant coating 
with hyaluronic acid-lysozyme composite to prevent the initial bacterial cell adhesion and 
colonisation on the surface.  
This improvement was achieved through a series of investigations as now summarised: 
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7.1.1 Corrosion resistant properties of PLGA and HA-modified sol-gel silane coated 
AZ31 Mg alloy for orthopaedic implants applications (Chapter 3 and Chapter 4) 
To enhance the corrosion resistance of AZ31 Mg alloy, a layer-by-layer coating of 
MTES-TEOS and APTES sol-gel was employed and characterised using contact angle 
measurements and FTIR and AFM to confirm the successful assembly of silane coating. 
Furthermore, the corrosion resistant properties of the biofunctionalised-sol gel-silane 
coating were evaluated using electrochemical corrosion study in DMEM and HEPES-
buffered DMEM. In the case of PLGA-silane coated surface (chapter 3), electrochemical 
corrosion analysis (EIS and PDS) showed a progressive increase in the corrosion 
resistance (AZ31-MT-A-P > AZ31-MT-A > AZ31-MT >AZ31) in DMEM electrolyte. 
For the HA-silane coated AZ31 substrate (chapter 4), the change in the corrosion 
resistance of AZ31 Mg alloy showed a trend AZ31-MT-A > AZ31-MT-A-HA1 > AZ31-
MT-A-HA2 >AZ31-MT > AZ31. Coatings with increasing concentration of hyaluronic 
acid were unable to provide additional corrosion resistance. This is due to the hydrophilic 
nature of the hyaluronic acid which failed to prevent the electrolyte penetration into the 
coating. Overall, the corrosion resistance decreased in HEPES modified DMEM 
electrolyte when compared to the DMEM. However, the silane component of HA-silane 
coatings (AZ31-MT-A) showed a ~2 order of magnitude increase in the corrosion 
resistance when compared to the uncoated AZ31 alone in both electrolytes. Based on the 
electrochemical corrosion study, AZ31-MT-A coated substrates showing the greatest 
corrosion resistance were selected for the immersion experiment. 
 In comparison to the uncoated AZ31 substrate, the PLGA-silane coating on AZ31 
reduced the release of Mg2+ and H2 gas by 4 to 5-fold in DMEM during the immersion 
period of 21 and 14 days respectively. In contrast, the Mg2+ and H2 gas release from 
AZ31-MT-A substrate in HEPES-modified DMEM showed a considerable increase when 
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compared to the PLGA-silane coated substrate in DMEM over a period 21 and 10 days 
respectively. This increase in the degradation of AZ31 Mg alloy is due to the corrosive 
nature of the former electrolyte. However, the fold increase in corrosion resistance when 
compared to the uncoated substrate is similar to that PLGA-silane coated substrate. 
Furthermore, the alkalinity induced by the PLGA-silane and AZ31-MT-A substrates was 
found to be ~pH 8.1 on day 21 in the respective electrolytes. The resistance to change in 
pH with the increase in Mg2+ release is due to the buffering nature of HEPES. In addition, 
osteoblast cells prefer a slightly alkaline pH for optimal growth. Furthermore, SEM-EDX 
analysis was used to evaluate the morphology and passivation level of corroded samples. 
Both PLGA-silane and AZ31-MT-A substrates immersed in the respective electrolytes 
exhibited occurrence in crack formation in the coating during the immersion period. 
However, a passivation layer containing a relatively high content of Ca-P were observed 
on the coated substrate which prevented the degradation of AZ31 during the later 
immersion period, which is also evident from the immersion studies. Based on the 
corrosion studies, it can be observed that the silane component of the coating optimally 
controlled the degradation alloy which could support the growth of the osteoblast cells. 
7.1.2 Biocompatible properties of PLGA, HA and HA-LZ functionalised-sol gel 
silane coated AZ31 substrates (Chapter 3 to 6)  
Furthermore, the cytocompatibility of biofunctionalized sol-gel silane corrosion resistant 
coated AZ31 Mg alloy was evaluated during the degradation phase of Mg alloy. In 
comparison to the PLGA-silane coated substrate (chapter 3), osteoblast cells showed 
more flattened morphology, better cell attachment and ~ 3 folds increase in proliferation 
and differentiation on the HA-coated substrate (chapter 4). Moreover, both PLGA-silane 
and HA-coated AZ31 substrates showed a significant improvement in osteoblast cells’ 
functions when compared to the uncoated AZ31 equivalents. Based on these results, 
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following observations can be made (a) degradation of AZ31 alloy did not affect the 
osteoblastic activity over a period of 14 days and (b) hyaluronic acid provided a 
biomimetic environment for enhanced the cytocompatibility of AZ31 Mg alloy.  
To further evaluate the osteoblastic activity of hyaluronic acid, the effect of hyaluronic 
acid-molecular weight and Mg2+ was studied (chapter 6). It was observed that l-HA and 
h-HA enhanced cell proliferation and differentiation respectively. Particularly, h-HA 
functionalised on HA coated substrate showed the highest differentiation activity in terms 
of ALP and collagen expression during 14 days of cell culture. This upregulated 
differentiation response of osteoblast cells was attributed to upregulated intracellular Ca2+ 
by (a) h-HA and (b) optimum extracellular Mg2+ (or release from the AZ31 surface) and 
pH (~8.1). These studies showed that corrosion resistant coating optimally degrades the 
Mg alloy during a period of 2-weeks which represent the early implantation period and 
bioactive coatings along with Mg2+ improved the functions of osteoblast cells.  
The problem associated with bacterial colonisation on the implant surface was addressed 
by functionalising hyaluronic acid-lysozyme composite on the silane coated AZ31 
substrate (chapter 5). The lysozyme component of the composite coating acted as an 
antimicrobial agent and exhibited concentration-dependent antimicrobial activity when 
compared to the uncoated, HA and lysozyme alone controls over a period of 12 h as 
confirmed by PI exclusion assay, spread plate assay and SEM. Furthermore, the HA-LZ 
composite coating showed ~2 to 4-fold increase on the proliferation and differentiation 
of osteoblast cells when compared to the lysozyme control only. However, the 
osteoblastic activity on the composite coated substrates was found to be similar to that of 
HA-coated substrates. Based on these results, it can be observed that the lysozyme 
component of the coating reduced the bacterial adhesion without showing a detrimental 
effect on the osteoblastic activity.  
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In a nutshell, bio functionalised sol-gel silane coatings optimally controlled the 
degradation of AZ31 Mg alloy, improved the osteoblasts’ functions and prevented the 
bacterial colonisation on the surface. These coatings overcome the drawbacks associated 
with the biodegradable Mg alloy (H2 gas release, alkalinity, cell cytotoxicity and implant 
associated bacterial infection), especially during early implantation period which deterred 
their clinical applications.  
However, there are practical limitations of this work which would be require further 
investigation improve the corrosion resistant efficiency and biocompatibility of the sol-
gel silane coating on AZ31 Mg alloy. Firstly, the degradation of Mg alloy undergoes rapid 
degradation under a cyclic load. Therefore, the corrosion resistance of the Mg alloy needs 
to be evaluated under a cyclic mechanical load to check the efficiency of the coating in 
preventing the implant failure. Secondly, the mechanical properties (Hardness, elastic 
modulus, adhesion energy, residual stress) of the coatings should be tested because it 
plays an important role in the reliability of the product. In the case of coating failure, its 
function may be affected. Thirdly, immune response to a foreign body (coatings and metal 
implant) affects the functionality of the implants in vivo. In this study, we have modified 
the surface by biomolecules (hyaluronic and lysozyme) to enhance the osseointegration 
and reduce the inflammatory response. However, the degradation products of a 
biodegradable metal implant can induce several types of immune response and it is 
important to evaluate this aspect of biocompatibility. All these limitations of the present 
study are recommended to be explored in and the methodology to achieve these objectives 
are given in the future work. 
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7.2 General conclusions 
The quality of patient care has increased dramatically in recent years due to the 
development of lightweight orthopaedic metal implants. The purpose of this study is to 
improve the corrosion resistance and biocompatibility of the AZ31 Mg alloy by 
developing multi-functional coatings on AZ31 Mg alloy.  
General conclusions drawn from this study are given below: 
 The degradation of AZ31 Mg alloy can be controlled by fabricating a multilayer 
MTES-TEOS and APTES sol-gel silane coating. 
 The cytocompatibility of AZ31 Mg alloy can be improved by fabricating bioactive 
polymer (PLGA, hyaluronic acid and hyaluronic acid-lysozyme composite) 
coatings on it.  
 These coatings were characterised using SEM, AFM, FTIR and contact angle 
studies.  
 The coating thickness and morphology of PLGA-silane on AZ31 Mg alloy were 
determined using SEM. The formation of the siloxane network in sol-gel silane 
coating and an amide bond between APTES and hyaluronic acid was confirmed 
by FTIR studies.  
 The low surface roughness of hyaluronic acid and hyaluronic acid-lysozyme 
composite coated AZ31 Mg alloy over uncoated AZ31 Mg alloy was confirmed 
by AFM measurements. Furthermore, the hydrophobicity and hydrophilicity of 
sol-gel silane coating and bioactive polymer coating (PLGA, hyaluronic acid and 
hyaluronic acid-lysozyme composite) were determined by contact angle 
measurements.  
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 The silane coated AZ31 Mg alloy improved the corrosion resistance in DMEM 
and HEPES modified DMEM over a period of 14 to 21 days as observed from 
electrochemical corrosion studies and immersion experiments.  
 The reduced rate of Mg2+ release in the cell culture medium and slightly alkaline 
pH (< 8.5) in case of silane coated AZ31 Mg substrates improved proliferation 
and differentiation of osteoblast cells. 
 The high degradation rate of uncoated AZ31 Mg alloy creates toxicity to the 
osteoblast cells owing to the increase in the pH of the cell culture medium (pH > 
8.5). 
 PLGA-modified silane coated AZ31 substrate showed enhanced osteoblast cell 
adhesion, proliferation and differentiation when compared to the uncoated AZ31 
Mg alloy equivalents.  
 Biomimetic hyaluronic acid (HA)-silane coated AZ31 Mg alloy enhanced the 
osteoblast cell adhesion with more flattened morphology and greater cell to cell 
interactions. 
 The level of cell adhesion and proliferation of osteoblasts increased with the 
concentration of hyaluronic acid employed for the modification of silane coated 
AZ31 Mg alloy. 
 Similarly, hyaluronic acid enhanced the expression of intracellular levels of ALP 
activity as compared to the uncoated AZ31 Mg alloy. 
 Susceptibility of the hyaluronic acid-silane coated AZ31 surface to the bacterial 
colonisation was reduced by the incorporation of antimicrobial lysozyme protein, 
which formed antimicrobial hyaluronic acid-lysozyme composite coated surface. 
 S.aureus adhesion on uncoated AZ31 surface increased with the incubation 
period. 
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 Antimicrobial activity against S.aureus increased with the concentration of 
immobilised lysozyme (10% and 20% w/w of HA).   
 Hyaluronic acid-lysozyme composites showed enhanced antimicrobial activity as 
compared to respective lysozyme and uncoated AZ31 controls. This is attributed 
to the greater affinity of lysozyme in the presence of hyaluronic acid-silane coated 
AZ31 surface when compared to the lysozyme control.  
 Hyaluronic acid-lysozyme composite showed osteoinductive activity comparable 
to the hyaluronic acid-silane coated AZ31 surface. 
  This showed that the lysozyme component of the coating did not affect the 
osteoinductive properties of hyaluronic acid while it was acting as an 
antimicrobial coating and preventing the bacterial colonisation on the AZ31 
surface.   
 Hyaluronic acid and Mg2+ -dependent osteoblastic activity was studied in-detail 
by functionalising high and low molecular weight hyaluronic acid onto AZ31 Mg 
and Ti alloys. 
 High molecular weight-hyaluronic acid reduced the proliferation of osteoblast 
cells as compared to low molecular weight hyaluronic acid functionalised 
surfaces. 
 Overall, hyaluronic acid (low and high molecular weight) functionalised AZ31 
substrate showed lower osteoblast proliferation as compared to HA 
functionalised-Ti surface. This reduction in osteoblast proliferation is attributed 
to the degradation of AZ31 Mg alloy during the culture period. 
 On the contrary, high molecular weight HA-functionalised surface showed 
improved osteogenic differentiation of osteoblast cells as compared to the low 
molecular weight counterpart.  
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 Overall, HA-coated (low and high molecular weight) functionalised AZ31 surface 
showed enhanced osteoinductive activity when compared HA-coated Ti surface.  
 Osteoblasts cultured on high molecular weight HA showed significantly higher 
intracellular Ca2+ concentration as compared to the low molecular weight HA. 
 Overall, osteoblast cultured on HA coated AZ31 substrate showed a significant 
higher intracellular Ca2+ and Mg2+ concentrations when compared to the HA-
coated Ti surface. 
 In addition, the pH of the cell culture medium containing HA-functionalised AZ31 
substrate was found to be alkaline (< 8.5).  
 This showed that enhanced osteoblasts functions observed on high molecular 
weight HA-AZ31 substrates which can be ascribed to the osteoinductive activity 
of high molecular weight HA, high intracellular Ca2+ concentration and alkaline 
cell culture medium. 
7.3 Future work 
As explained in section 7.1, the aim of enhancing the corrosion resistance and 
cytocompatibility of Mg alloy using multifunctional silane-based coatings has been 
achieved under in vitro conditions. However, it is important to validate the functionality 
of these corrosion-resistant AZ31 substrates in vivo in terms of the mechanical properties 
of the coatings as well as corroded implants and immunological response against the 
coated-AZ31 substrates.  
7.3.1  Corrosion fatigue behaviour of the surface modified AZ31 Mg alloy in cell 
culture medium 
The corrosion resistant properties of the coated and uncoated AZ31 Mg alloy have been 
demonstrated in chapter 3 and 4. In general, the failure of orthopaedic implants is 
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associated with corrosion fatigue, which is the synergistic effect of cyclic mechanical 
loading and corrosion [1]. Therefore, it is important to evaluate the corrosion fatigue of 
the modified substrates employed in vitro. Such tests should be carried out as per ASTM-
F2477-07 [2]. This test will allow simulating the load that an orthopaedic implant will 
experience in vivo.  
7.3.1.1 Preparation of samples 
Corrosion fatigue test can be performed on the specimen with a circular cross-section 5 
mm in diameter and 10 mm gauge length as per ASTM E466 [2]. The surface of these 
samples can be modified with bioactive and sol-gel silane coating as per the method 
described in previous chapters.  
7.3.1.2 Corrosion fatigue test 
For this test, it is recommended to prefer an electrolyte which will be used for cell culture 
studies. In the present work, HEPES-modified DMEM was preferred because it has 
provided a buffered condition which an implant will experience in vivo. The setup 
required to conduct this test can be adopted from Gu et al [2]. The release of Mg2+ during 
the corrosion fatigue test and the surface of the fatigue fractured samples can be 
determined by ICP-OES and SEM respectively.  
7.3.2 Evaluation of mechanical properties of the deposit coatings on AZ31 Mg alloy. 
The mechanical properties of the bio-functionalised (PLGA, HA and HA-LZ) sol-gel 
silane coated AZ31 Mg alloy (Elastic modulus, the hardness of the coatings, fracture 
toughness and residual stress) can be determined using nanoindentation technique.  
7.3.3 Immunological response to the biofunctionalised sol-gel silane coated AZ31 Mg 
alloy under in vitro and in vivo conditions 
In previous chapters, the biocompatibility in terms of osteoblasts proliferation and 
differentiation of bio-functionalised (PLGA, HA and HA-LZ) sol-gel silane coated AZ31 
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Mg alloy was demonstrated. However, it is known that degradation products of Mg-based 
alloys can induce various immunological response which includes immune suppression 
through the apoptosis of immune cells, hypersensitive reactions and foreign-body 
reactions. It is a pre-requisite to achieve desired biocompatibility with minimum foreign 
body response to biodegradable Mg-based alloy for orthopaedic implants applications 
7.3.3.1 Evaluation of immune response to the bioactive polymer (PLGA, hyaluronic 
acid and hyaluronic acid-lysozyme) functionalised sol-gel silane coated AZ31 Mg 
alloy substrates in vitro conditions 
a) Cytocompatibility of surface modified AZ31 Mg alloy substrates: Two cell 
lines THP-1 cells and THP-1 macrophages can be used to evaluate the effect of 
Mg extracts of these substrates on cell viability, differentiation, cell cycle and cell 
migration. In addition, these cells can also be cultured directly on the coated 
surface to perform this experiment 
b) The inflammatory response to surface modified AZ31 Mg alloy substrates: 
Inflammatory cytokines such as TNF-alpha can be quantified in the cell cultured 
medium upon exposure of magnesium extracts to these cells.  
7.3.3.2 In vivo evaluation of immunological response to the bioactive polymer 
(PLGA, hyaluronic acid and hyaluronic acid-lysozyme) functionalised sol-gel silane 
coated AZ31 Mg alloy substrates 
a) Bone remodelling and corrosion analysis: micro-CT can be used to determine 
new bone formation, loss of implant volume and gas formation in vivo.  
b) Evaluation of inflammatory markers in blood serum:  Several inflammatory 
markers such as TNF- alpha IL-1beta and IL-6 can be quantified using ELISA. In 
addition, other markers such as TGF-beta and PDGF can also be quantified which 
have an influence on the initiation of bone healing [3]. 
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c) Phagocytic activity: The high phagocytic activity of neutrophils is very important 
for appropriate bone healing because it helps both in clearing the dead cells and 
recruitment of progenitor cells to maintain the homeostasis. This test is based on 
ingesting GFP-tagged E.coli by neutrophils, thereby generating fluorescence 
signal which can be quantified by flow cytometry.  The details of this experiment 
are given in Pichler et al [4].  
7.3.4 Evaluation of PLGA-silane and hyaluronic acid coated AZ31 Mg alloy in vivo 
From chapters 3, 4 and 6, the PLGA and hyaluronic acid –silane coated AZ31 substrates 
showed the controlled degradation as well as stimulated the osteoblast differentiation and 
functions. Therefore, the corrosion properties and bone-forming activity of these 
substrates need to be evaluated in rat or other animal models.  
7.3.4.1 The bone-forming activity of PLGA or Hyaluronic acid-silane coated AZ31 
alloy under in vivo conditions 
Generally, biodegradable implants are temporary fixtures such as screw, plates or pins. 
These fixtures can be coated and implanted in either proximal metaphysic region of the 
tibia or distal femur epiphysis to study the bone-fracture healing. The following 
experiments can be performed to evaluate the bone-forming activity of corrosion resistant 
AZ31 substrates against uncoated AZ31 Mg alloy. 
a) Evaluation of H2 gas release: The formation of gas during the implantation 
period can be detected by x-ray imaging and micro-CT.  
b) Bone remodelling studies: Remodelling of bone and new bone formation can be 
evaluated by analysis of bone morphometric parameters using micro-CT. 
c) Surface bioactivity of coated samples: Pathological examinations using 
hematoxylin and eosin staining of slice tissue and immunohistochemistry 
stainings (BMP2, TGF-β1, PDGF and TRAP) 
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7.3.5 Susceptibility to biofilm formation and bone-forming activity of hyaluronic 
acid-lysozyme composite-silane coated AZ31 Mg alloy 
In chapter 5, the hyaluronic acid-lysozyme composite coating on AZ31 Mg alloy showed 
a significant reduction in S.aureus colonisation on the surface without affecting 
osteoblasts functions. The efficacy of the composite coating can be further validated in 
an in vivo model. The following methods can be used to testify the antimicrobial and 
osteoinductive properties of composite coating in vivo:  
a) Implant preparation: The hyaluronic acid-lysozyme coated AZ31 Mg alloy 
device could be treated with bioluminescently labelled bacterial strains 
(S.aureus) for the appropriate time. The coated implant can be inserted into the 
long bones or beneath the skin folds.  
b) Determination of antibacterial activity: The antibacterial activity or bacterial 
infection surrounding the implant can be determined using Bioimagers. The 
luminosity associated with the bacterial growth levels can be recorded during the 
implantation period. In addition, implants can be carefully removed after 
euthanization of animals and subject to the quantification of bacterial growth 
using spread plate assay, live-dead bacteria staining or SEM.  
d)  Surface bioactivity of coated samples: Pathological examinations using 
hematoxylin and eosin staining of slice tissue and immunohistochemistry staining 
(BMP2, TGF-β1, PDGF, TRAP etc.) 
e) Bone remodelling studies: Remodelling of bone and new bone formation can be 
evaluated by analysis of bone morphometric parameters using micro-CT. 
f) Evaluation of H2 gas release: The formation of gas pockets during the 
implantation period can be detected by x-ray imaging and micro-CT.  
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Appendix I 
 
Calibration curves 
 
S1: Bovine serum Albumin (BSA) 
 
 
S2: para-nitro phenol (p-nP) 
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S3: Hyaluronic acid (HA) 
 
S4: Calf thymus DNA 
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S5: Magnesium ion quantification (colorimetric) 
 
S6: Calcium ion quantification (colorimetric) 
 
S7: Hydroxyproline (Collagen quantification) 
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S8: 4-Methyl umbelliferon (4-MU) (Lysozyme activity determination) 
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